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C H A P T E R  1 
INTRODUCTION
"The aetiology of atherosclerosis is of prime importance if anything 
is to be done to prevent this common disability of declining years, but in 
spite of a vast amount of work the problem remains unsolved."
So writes Boyd (1947) in his Textbook of Pathology. Thirteen years 
later and after an even vaster amount of work this statement is not only 
still true, but more urgent, for atherosclerosis and its complications of 
ischaemia and thrombosis are no longer regarded as disabilities only of the 
declining years. Their greatest toll in terms of death, invalidism and eco­
nomic suffering is imposed on the active middle-aged male afflicted with 
occlusive coronary atherosclerosis, with or without subintimal haemorrhage 
or thrombosis.
Cholesterol deposits were first recognised in arteries by Vogel (1847) 
but nearly 70 years elapsed before Anitschkow and Chalatov (1913), by the 
production of atheroma in rabbits given a cholesterol enriched diet, demons­
trated a relationship between these cholesterol lesions and the serum lipids. 
This work on a herbivorous animal having normally low chole sterol levels 
though not strictly relevant to the problem as it presents in the omnivorous 
human with much higher normal cholesterol levels, nevertheless released a flood 
of research which flows just as strongly today and at times comes near to engul­
fing medical literature.
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As a result of this great body of research there can be little doubt 
that the circulating blood lipids are in some way or ways involved in the 
problem of atherosclerosis. It is impossible in what must be no more than 
a concise introductory chapter to give an exhaustive account of the accumu­
lated knowledge of this topic. But it is necessary to outline the framework 
on which this knowledge has been built. The brief account which follows is 
amplified in subsequent chapters*
LIPIDS AND THE LESION
The atherosclerotic plaque contains not only cholesterol, but other 
lipids also, namely phospholipids, triglycerides and fatty acids (Buck and 
Rossiter, 1951; Duff and McMillan, 1951). More recent work with silicic 
acid and gas-liquid chromatography has further characterised the nature and 
proportion of these lipids. Normal intima has a lipid distribution almost 
identical with the plasma lipids, as indeed has the early intimal lesion, 
but in the fibrous and ulcerous lesions the cholesterol content is much 
higher (Hirsch and Weinhouse, 1943). This may be due to the selective removal 
of the other lipids by phagocytosis and autolytic changes accompanying necro­
sis and ulceration. But cholesterol can be synthesised by aorta (Siperstein 
et al., 1951) and this may contribute to its deposition, for although phago­
cytes and foam cells at the plaque can slowly remove other lipids by engulf - 
ment and oxidation, it is not certain that they can degrade and remove 
cholesterol which cannot be oxidised to completion, in mammalian tissue, to 
any significant extent. (Lehninger, A. L., 1954).
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LIPID TRANSPORT
Although early studies had suggested some relationship between blood 
lipids and the plasma proteins (Chick, 1914; Theorell, 1926) it was not until 
1929 that Macheboeuf isolated a well defined serum lipoprotein. Virtually 
all lipids found in tissues and body fluids in a normal state exist in the 
form of lipoproteins or lipid-protein complexes. (Oncley et al., 1947; Gurd 
et al., 1949). Possible exceptions to this statement may be the neutral fat 
droplets in adipose tissue or the large chylomicrons, but even here there is 
some evidence that protein plays a part in stabilising these finely emulsi­
fied droplets of fat. Plasma lipoproteins constitute the transport system for 
the circulating lipids and comprise cholesterol (free and esterified), phos­
pholipids and fatty acids conjugated within the protein shell - beta globulin 
in the case of the beta lipoproteins and alpha-1 globulin in the case of the 
alpha lipoproteins. Dervichian (1949) has explained the physico-chemical 
theory underlying this association of non-ionic lipids (cholesterol, cholest­
erol esters and glycerides) with ionic lipids (phospholipids and fatty acids).
Lipoproteins have shape and size, and can permeate not only capillary 
membranes but the intimal and medial layers of arteries (Pappenheimer, 1953; 
Page, 1954). It was thought at first that the membranes acted as semi-permeable 
structures containing pores which permitted the restricted.diffusion of protein 
molecules and Pappenheimer who first advanced this Pore Theory calculated that 
the pores had a mean diameter of 60-90 But more recent work (Grotte, 1956) 
indicates that there may be a smaller number of pores with a calculated radius 
of from 116 X to 350 2. and this is adequate for the passage of the large beta- 
lipoprotein, a sphere with a diameter of 185 That lipoproteins can and do
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diffuse from the blood into the tissue fluid through such leaks or pores 
has been shown indirectly by the analysis of lymph (Page et al., 1953).
The chylomicrons with a diameter of 0.5-ly* are much larger than the mole­
cules of beta-lipoprotein, but there is evidence that even they may gain 
restricted access to the tissue fluid and lymph by pore leakage (Courtice 
and Morris, 1955).
There is however another metabolic pathway for chylomicrons suggested 
by the heparin-clearing reaction first demonstrated by Hahn (194-3). Follow­
ing the injection of heparin intravenously an enzyme appears in the blood, 
probably a lipoprotein lipase, which hydrolyses the chylomicron triglyceride 
to glycerol and unesterified fatty acids which combine with the serum albumin 
(Robinson and French, 1953). It is not proven that this hydrolytic breakdown 
of chylomicrons occurs normally, for chylomicron clearing can still take place 
when hydrolysis is inhibited (French and Morris, 1957). Nevertheless it seems 
that an enzyme with the properties of clearing factor must have a function in 
lipid transport.
It seems established therefore that normal blood vessels contain the 
various plasma lipids and that the transport of lipids through, and their meta­
bolism within the vessel wall, is a normal occurrence. What happens then to 
transform this physiological process into a pathological one? This is where 
we enter the complex and often confusing realm of hypothesis. Nevertheless 
the theories of atherogenesis merit some mention if a full understanding of 
the problem is to be achieved and a rational, rather than an empirical approach
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to therapy adopted. Themain possible aetiological factors have been collated
in one theory by Page (1954) a description and brief exposition of which now
follows.
FILTRATION THEORY OF ATHEROGENESIS 
Atherogenesis depends on the following factors: -
1. The anatomy, biochemistry and physiology of the vessel wall, all of 
which are hereditarily conditioned.
2. The composition of the plasma filtrate. When the circulating plasma 
contains increased amounts of the biochemically less stable beta-lipo- 
protein,increased breakdown of this lipoprotein is liable to occur in 
the vessel wall with increased deposition of lipid.
3. The height of the lateral pressure and the amount filtered. That is, 
the higher the blood pressure the greater the amount of lipid forced 
through the wall. This partly accounts for the increased incidence of 
atherosclerosis in hypertension.
4. The metabolic capacity of the vessel wall. The vessel is no longer 
regarded merely as a passive membrane but as an organ. Lehninger'(1954) 
postulates the release of excess lipoprotein splitting enzymes in vascu­
lar tissue, stimulated by anoxia.
5* The response of intimal tissue to filtered products and their metabolites.
6. Changes in the ability of the vessel wall to transport filtered substances.
This might result from age, or hypertensive and metabolic disease such as 
diabetes. It might equally result from the organisation of mural thrombi 
(Duguid, 1954) and may also involve disorders in fibrinolysis, the normal
process by which clot is broken down in the body (Kwaan and Me Fadzean, 1957).
Having brought our survey of the problem to this point two rather differ­
ent but extremely relevant fields remain to be charted.
LIPIDS AND COAGULATION 
There are many in vivo and in vitro studies on both normal and abnormal 
coagulation. Fullerton and Anastasopoulos (1949) showed that fatty neals 
given to human subjects caused a definite and consistent shortening of the 
clotting time of plasma in the presence of Russell's viper venom. These obs­
ervations have been fully confirmed by other workers (Fullerton et al., 1953; 
O'Brien, 1955; Maclagan and Billimoria, 1956; and Merskey and Nossel, 1957).
But against this the evidence for the shortening of the whole blood clotting 
time in silicone coated tubes is contradictory and in any case if the change 
is real, it is not a large one. (Fullerton et al., 1953; O'Brien, 1955; 
Manning and Walford, 1954). Present knowledge about changes in blood coagu­
lation in man following fatty meals seems to indicate that there is indeed a 
definite shortening of the plasma clotting time in the presence of Russell’s 
viper venom, but no other clotting test shows any unequivocal change. The 
work of Robinson et al., (1955) suggests that it is the rise in the free 
fatty acids of plasma after a fatty meal which contributes to the shortened 
stypven clotting time.
The in vitro studies of Poole (1955) showed that the presence of chylomicra 
shortened the clotting time of plasma. Subsequent studies (Poole and Robinson, 
1956; Marcus and Spaet, 1958) have shown that the phospholipids, phosphatidyl
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ethanolamine, a constituent of chylomicrons, and phosphatidyl serine, hasten 
plasma coagulation. These phospholipids are two of the lipids normally 
present in platelets•
Although the evidence presented is tenuous and indirect it probably 
implicates lipids in the mechanism of coagulation, but not necessarily of 
course in thrombosis, which is an intravascular phenomenon.
LIPIDS AND THE EPIDEMIOLOGY OF ISCHAEMIC HEART DISEASE 
"In the triangular relationship between diet, serum cholesterol levels
atherosclerosis and ischaemic heart disease ....  there is strong evidence
for a direct association between diet and serum cholesterol trends in man.
Far less convincing is the strength of the other links in this triple associ­
ation" (Bronte-Stewart, 1958). The evidence is vast however and what is given 
here is a highly selected and radically summarised account of some of the 
major and representative observations which have been made in this field.
Perhaps the most important single factor which stimulated interest in 
the role of diet in the production of ischaemic heart disease was the sharp 
fall in death rate from circulatory disease in many European countries during 
the Second World War (Malmros, 1950; Strom and Jensen, 1951)• This was 
accompanied by a fall in the consumption of milk, butter, cheese and eggs. 
Changes in serum cholesterol were reported from severely rationed areas•
(Brull et al., 194-5). It must be remembered that many other environmental 
changes occurred during this time, including for example longer hours of work, 
and more walking as well as a reduction in the total amount of calories consumed.
In groups consuming little fat, such as the South African Bantu (Bronte- 
Stewart et al., 1955) and the Japanese (Keys et al., 1958) severe athero­
sclerosis is rare and the rise in serum cholesterol with ageing is insignificant. 
At birth Bantu and European serum cholesterol levels are the same (Bersohn and 
Wayburne, 1955). Differences appear early in life, and by the age of 20 sig­
nificant differences are seen not only between races but between income classes 
within each race. The incidence of severe atherosclerosis is different, also, 
in the same race living under different environmental conditions. It is much 
higher in Japanese who have emigrated and sampled the American way of life 
(Larsen, 1957).
The association between abnormalities in the serum lipoproteins and 
coronary atheroma has been the subject of much discussion in recent years 
(Gofman et al., 1950). The ultracentrifugal studies of this group and others 
have shown an increase in the low density (mainly beta) lipoproteins in indi­
viduals with ischaemic heart disease. Oliver and Boyd (1953)? in this country, 
have demonstrated a significant increase in the serum lipids of men and women 
with coronary artery disease at all ages, with the exception of women in the 
sixth decade, and Besterman (1957) found a highly significant increase in the 
pre-beta lipoprotein in 198 out of 200 cases with coronary artery disease.
It seems reasonable to condense the data outlined above as follows.
Lipids occur in the atheromatous lesion, they have access to the lesion, they 
are found in increased amounts in the blood of many (but not all) individuals
with clinical or post-mortem evidence of the lesion and they may participate
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in intravascular coagulation or act as inhibitors of normal .fibrinolysis.
For these reasons, and others given later, it is a widely held opinion that 
some fbrm of control of serum lipids is therapeutically desirable, and that 
this should achieve lowering of.the serum cholesterol and beta-lipoproteins> 
without unwelcome side effects.
AIMS AND P U N  OF THE THESIS 
This study is primarily concerned with the nature, effectiveness and 
feasibility of certain methods of controlling the serum lipids. In Part I 
the role of oestrogens, certain thyroid analogues and the unsaturated fatty 
acid, linoleic acid, is studied in this context, both in man and in the experi­
mental animal. During this work some ideas were conceived which although per­
tinent were slightly out of the mainstream of the investigation. They are 
examined experimentally in Part II. These include an appraisal of the effect 
of post-prandial lipaemia on blood viscosity, the relationship of the tissue 
mast cell to hyperlipaemia and lipidosis and the effect of long term impair­
ment of fet absorption on the lipids•
It was not possible to study phospholipids, cholesterol and lipoproteins 
in every investigation, but with one exception, the lipoproteins have been 
followed throughout, and all analyses carried out by the author personally.
In all other studies, apart from those reported in Chapters 3 and A? the cho­
lesterol estimations were a personal task. These statements are made partly 
in recognition of technical help received in some of the work but partly also 
to underline the continuity of technique throughout the major part of this 
work. (See Acknowledgements.)
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Three methods are generally used for the separation of the plasma 
lipoproteins, zone electrophoresis (Kunkel and Slater, 1952; Swahn, 1953), 
ultracentrifugal flotation (described in detail by De Lalla and Gofman,
1954) and chemical fractionation by salting out procedures (Cohn et al., 
1950). For a number of reasons paper electrophoresis is the method which 
commends itself to the clinical investigator and was used in this group of 
studies. It is important to understand not only the technical details of 
the method, but some of the theory underlying its different stages and also 
to have a clear notion of its limitations. For these reasons an account of 
the method, with a note of the structure and composition of the serum lipo­
proteins and an indication of the inter-relationships between the lipoprotein 
nomenclatures employed in the different methods available, should be included 
now, rather than postponed to an Appendix.
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C H A P T E R  2
THE ESTIMATION AND COMPOSITION OF SERUM LIPOPROTEINS 
Lipoproteins are complex molecular substances. The general reader is 
much less familiar with them than with, by comparison, the relatively straight­
forward lipid substances cholesterol and phospholipid. Neither is their 
measurement so simple, or if simplified so accurate a procedure. Because 
some understanding of the main technical and physico-chemical details about 
them is essential if much of the discussion in the following chapters is to 
be fully comprehended, it seems desirable to discuss them now rather than 
relegate them to an appendix.
1. The Estimation of Lipoproteins
The method of lipoprotein analysis by paper electrophoresis throughout 
this work is essentially that described by Swahn in 1952 and amplified in 
his monograph of 1953. In many respects it corresponds to the method of 
Kunkel and Slater (1952) with however one major difference. They used Sudan 
III as the staining agent. At the outset of this study I used all three of 
the fat stains suggested by various authors, namely Sudan Black B (Swahn,
1952), Sudan III (Kunkel and Slater, 1952), and Oil Red 0 or Sudan II (Durrum 
et al., 1952). I had no doubt that Sudan Black B was the best for this par­
ticular purpose and thereafter used it solely. Partly for this reason and 
because all the lipoprotein analyses have been done personally a certain deg­
ree of quantitative comparison between lipoprotein data of separated studies 
is permissible.
TABLE I. The results of 18 lipoprotein analy
on a single serum sample (Case So.77. Chapter 13; 
The average deviation from the mean is * 0.11 or 
* 6.5 per cent.
BETA:ALPHA 
LIPOPEOTEIN RATIO
1.36 
1-52 
1.54 
1.60 
1.62
1.63
1.63
1.65
1.66 
1.67 
1.69 
1.73 
1.78 
1.80 
1.81 
1.83 
1.86 
1.93
Ifean 1.68
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However the method is not especially accurate for reasons which will he 
mentioned but it is simple and inexpensive and is suitable for the preli­
minary separation of lipoprotein fractions which may then be analysed by 
more accurate biochemical techniques.
At different times during the four years of this work the reproduci­
bility of the method was tested by 12 to 20 estimations of different serum 
samples. The average experimental error for the betasalpha lipoprotein 
ratio ranged from ± 6 to i 10 per cent. The results of 18 analyses on the 
serum from patient no. 77 of Chapter 13 are shown in Table I. The average 
percentage error in this test group is + 6.5.
Instruments and Materials
1. Horizontal Electrophoresis Tank of conventional design with a tightly 
fitting heavy glass lid and platinum electrodes.
2. A Power Unit producing a stabilised voltage ranging from 110 to 200 
Volts. The electrical conditions of the system were such that the usual 
working voltage of 120 Volts, gave a current of 0.8 milliamperes (ma.) 
through each 5 cm. wide strip of filter paper.
3. A Double Beam Reflectance Densitometer, manufactured by Joyce, Loebl 
and Co. Ltd. of Newcastle. This instrument is used to ’'scan" the stained 
lipoprotein electrophoresis strips. A photoelectric cell measures the 
amount of light reflected from the paperj the more lipid, the blacker the 
stain on the paper, therefore the smaller the amount of reflected light and 
the greater the deflection of the recording point of the machine. The
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information appears as waves or peaks corresponding to the different lipo­
protein "bands” on theeLectrophoresis strip. Because the intensity of 
staining of the lipoproteins is a measure of the amount on the paper (Swahn,
1953) the areas under these curves are indirect measures of the relative 
amounts of lipoprotein present, and while not usually employed to give 
absolute values for these lipids they are suitable for comparisons of the 
individual lipoprotein complexes in any one serum. However, because of a 
number of experimental factors which are largely outwith the control of 
the investigator the lipid-dye uptake quotient is not so constant as Swahn 
suggests and this is the main reason for the experimental error previously 
referred to.
U . An Amsler Planimeter,a precision instrument used for the measurement
of areas bounded by irregularly curving lines. This instrument can be used 
for the measurement of absolute units of area (e.g. square yards, acres, etc.) 
by reference to appropriate conversion tables. But here it is sufficient to 
get a number only, which is a "unit of area” and which can be compared with 
other numbers representing proportionately larger or smaller areas.
The instrument was used at the same setting continuously. Provided it 
is used on a flat smooth board, in a good light, with a steady hand and within 
the optimum angle of use, the margin of error is trivial being not more than 
* 1 per cent.
5. Whatman No. 1 Filter Paper of Chromatography Grade and provided in 2”
broad strips, - this is a finer grade of paper than Whatman 3 mm. which is 
widely used as the supporting medium in paper electrophoresis. It is slightly
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more difficult to handle than the thicker paper since it tears more easily 
when wet, but this minor drawback is quickly overcome by experience and is 
offset by the greater definition of the serum bands and by the whiter back­
ground which can be achieved with lipid and protein stains.
6. Veronal Buffer of pH 8.6 made by dissolving sodium barbitone (10.3 0) 
and barbitone (1.84- 0) in 1 litre of distilled water. The buffer was kept 
in stock bottles in a refrigerator. This prevented the growth of moulds.
7. Sudan Black B, 0.1 per cent in 55 percent ethanol, prepared exactly as 
described by Swahn (1953). Not more than 1 litre of the stain was made up 
at a time. The effective life of this amount of stain, if in constant use, 
is about one month.
8. Bromo-Phenol Blue, 0.01 per cent in a solvent containing 5 per cent
zinc sulphate in 5 per cent acetic acid, and used for the identification
of the serum proteins.
9* A Hot Air Oven maintained at 100° C.
10. Pipettes, beakers, washing trays, etc.
Method
Preparing the Tank
The electrophoresis tank is charged with buffer, the reservoirs at either 
end being filled to equal levels. This limits the osmotic flow of buffer along 
the paper which tends to occur when the reservoirs are at different levels.
The meticulous accuracy of siphon levelling, suggested by some workers, is 
hardly necessary however. The paper strips are placed in the tank with their
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ends dipping into the buffer compartments and allowed to moisten by capil­
larity. This takes time but it is the best way of ensuring homogeneous 
wetting of the paper. The cathode end of the paper is slung over a glass 
rod which is 2 cms. higher than the anodal end. This imparts a slight slope 
to the paper sufficient to prevent the pooling of buffer which tends to occur 
in wet and therefore sagging filter paper.
Applying the Serum
Once the papers are completely moistened the current is switched on for 
about 1 hour before the serum is applied. The procedure for applying the 
serum is perhaps the most critical part of the entire method and requires 
considerable practice. Since at least 0.1 ml. of serum must be used for 
satisfactory lipoprotein analysis it is best applied directly from a pipette 
moved to and fro across the application point, and not in instalments from 
the edge of a glass slide, though this technique is suitable for the single 
application of small amounts of serum (0.015 ml.) used in protein electro­
phoresis .
The application zone of the wet paper (where it rests on the glass rod) 
is partially dried by firm pressure with a pad of dry filter papers, 5 or 6 
strips thick. If serum is applied topaper which is saturated with buffer it 
cannot be absorbed by the paper and tends to run over its surface. It is 
then impossible to obtain clearly defined bands. Furthermore the serum should 
be applied to the centre of the paper only, avoiding the outside edges by at 
least 1 cm. on each side.
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Conditions during Electrophoresis
After the samples (an electrophoresis tank can take up to 6 strips)
have been applied, the glass lid is placed in position and the current
switched on at once. A normal run lasts 16 hours from 5 p.m. overnight
to 9 a.m. The usual voltage applied is 120 Volts. After a run the current
is switched off, the paper strips are removed, rolled end to end in an open
cylinder and stood on edge on clean filter paper. They are immediately 
o
dried at 100 C. for 30 minutes, before staining.
At first many papers were spoiled by buffer condensing on the glass 
lid and falling in large drops on to the underlying papers. This was over­
come by applying a light coating of silicone grease to the glass surface.
The buffer vapour then condenses in a fine film which adheres to the glass 
surface.
Staining
When the strips are dry they are divided longitudinally. One half is 
stained for protein with bromophenol blue and the other for lipoprotein with 
Sudan Black B. The lipoproteins are identified from their position alongside 
the corresponding protein band. However the lipoprotein pattern is simple 
and standard enough to be recognised in its own right and, in the main, strips 
were stained for lipoproteins only. The double staining procedure was carried 
out as a check from time to time, and always when a new investigation or expe­
riment was begun.
Lipoprotein staining was carried out essentially as described by Swahn 
(1953). Dried paper strips, usually in batches of 12 rolled together, are
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placed for three hours in an air tight jar containing 0.1 per cent ethanolie 
Sudan Black B. They are next washed three times in 50 per cent industrial 
spirit, but not necessarily for the rigid 15 minute periods described by 
Swahn. There is no point in doing this unless newly prepared stain of iden­
tical concentration is used each time, for repeated use of the stain lowers 
its strength so that the intensity of the lipoprotein staining diminishes.
The principle adopted then was to rinse in such a way that the blank area of 
filter paper was brought to a fairly standard light blue-black tone. This is 
best done using visual judgement rather than employing a rigid methodology in 
the presence of important variables, such as the strength of the stain and 
room temperature, to mention two of the most important.
Selection and Measurement of Suitable Strips
After rinsing, the strips are dried and examined, unsatisfactory strips 
being discarded. The investigator’s own judgement seems to be the simplest 
and yet most accurate way of maintaining a satisfactory quantitative standard. 
Strips which pass inspection are trimmed to a width which fits the sample- 
holder in the densitometer. They are ’'scanned”, the lipoprotein peaks delin­
eated and the areas corresponding to the lipoprotein bands demarcated by 
dependent lines drawn to the base line. Systems employed for the construction 
of the base line vary widely among different workers. It is for each investi­
gator to establish his own practice and adhere to it. Mine was to draw a line 
joining the mean level of the blank areas at either end of the strips. A 
typical lipoprotein strip with its superimposed linear pattern divided into 
lipoprotein areas is shown in Fig. 1.
prebctachylomicrons
Upoproiem
gamma beta alpha-2  albumin
Fig. 1. An example of lipoprotein electrophoresis showing the
neutral fat, beta, prebeta and alpha bands with the pattern 
obtained by densitometry. The protein pattern is shown 
alongside. The leading edge of the alpha-lipoprotein 
band is often called the lipalbumin zone.
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Lipoprotein Nomenclature
Fig. 1. shows four distinct lipid staining areas. Beta-lipoprotein 
which is closely associated with beta-globulin is the predominant lipoprotein 
of adult serum. Alpha-lipoprotein runs in the alpha-1-globulin:albumin zone 
and is generally regarded as a relatively stable lipoprotein and less liable 
to qualitative or quantitative fluctuations than beta-lipoprotein. Its choles­
terol content may however be affected by oestrogens (See Chaps. 3 and U )• 
Prebeta-lipoprotein was first definitely recognised and described by 
Dangerfield and Smith (1954)* It does not have a close relationship to any of 
the serum proteins and its characteristic position is adjacent to, but ahead 
of beta-lipoprotein and between beta and alpha2 -globulin.
The lipid zone between the point of serum application and beta lipoprotein 
consists of chylomicrons, lipomicrons and very low density beta-lipoprotein 
molecules, in that order. The chylomicrons are the lipid droplets, consisting 
mainly of neutral fat, which are responsible for the serum turbidity of post­
prandial lipaemia. The lipomicrons, which also consist mainly of neutral fat, 
are much smaller and add little to this turbidity. In moving boundary or 
starch block electrophoresis the chylomicrons and lipomicrons occur in the 
alpha2 ~globulin zone. They are strongly adsorbed to filter paper however and 
this force seems to be sufficient to disrupt their alphag-globulin linkage.
This 'heutral fat” zone of the electrophoresis strip is principally affected 
by fatty meals. It is also increased in such conditions as nephrosis, myxoedema, 
diabetes mellitus and essential hyperlipaemia where neutral fat as well as 
serum cholesterol is augmented.
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Alpha2 -lipoprotein when present is associated with alphag-globulin 
This lipoprotein is encountered most frequently in the cholesterol-fed, 
oestrogerised chickens of Chapter U* Its role in human beings is neither 
constant nor clear.
System for Reporting Lipoprotein Values
The lipoprotein value most frequently referred to in this thesis is the 
betasalpha lipoprotein ratio. When prebeta lipoprotein is present it is 
included as part of the ,,beta, component of the ratio. Where a survey of 
prebeta-lipoprotein values is made the amount of prebeta-lipoprotein present 
is assessed as a fraction of the entire beta-lipoprotein complex. Besterman 
(1957) employs a scheme in which he relates each of the three main lipoprotein 
bands to their joint totals. In some studies only an estimated grading of the 
prebeta-lipoprotein band is used in which the values are 0, +, and ++. I 
tested this arbitrary judgement against the calculated ratios in a number of 
analyses and found that the prebeta: beta ratio 0.19-0.20 was the one at which 
transition from + to almost constantly occurred.
Normal chickens do not show a beta-lipoprotein band corresponding to 
that in adult humans, although one does develop as a result of chole sterol 
feeding. (Chapter U )• But they do have a lipid zone which lies between the
starting point and the region where beta-lipoprotein ultimately appears. So
that a nominal value can be given to the beta:alpha lipoprotein ratio of 
normal chicken sera the nbeta-lipoprotein area" is regarded (in the chickens
only) as the whole area between the starting point and the distal margin of
the actual beta-lipoprotein band.
TABLE II. Interrelationship in nomenclature of various methods of 
lipoprotein analysis.
DENSITY
OOIMAN
ULTRACENTRIHJGATION
STARCH
ELECTROPHORESIS
COHN
FRACTIONATION
ISf) (globulins)
LOW DENSITY LIPOPROTEINS
< 1.006 
(chylomicrons)
> 20 alpha - 2 I + III
1.006 - 1.019 12-20 beta - 1 I + i n
1.019 - 1.063 0 - 1 2 beta - 1 I + i n
HIGH DENSITY LIPOPROTEINS
1.063 - 1.125 hil 2 alpha - 1 IV + V
1.125 " 1.21 HDL 3 alpha - 1 IV + V
 ^; • • ' I ■ -• . , ' ; • ■ j' ; t' ----- T
rb.. :'0.b!,v:\ bob.U;olx.r. : b. e.i:;
 ^ odo :> \r 0 Z . r ~ c ~. :) c' . . :yy. r t r -o -dc-si" o .tebb J .n -'c l b n ;
■.h w i r a ' o  ' “j'Jnr-jrriO f' v ’ :onI::- 4 '*" ob ,-v niv-f r n 
:/.!.■• ■Toobb-i.b'ob c ’..'orb .1 -v cb ,!b
i o.*ro io .p- on-'v , : n -cbt' J bub.;:
t : ; b : b i /b : l  uvun- oh b b b r ' ’ '. (.u - .b - jb '')
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Rats have a lipoprotein pattern quite distinct from that in humans or 
chickens and only qualitative variations in this animal’s serum are described.
2. The Composition of Lipoproteins
Because most of the analytical biochemistry of lipoproteins has been 
performed in fractions obtained by methods other than electrophoresis it is 
important to understand clearly how the nomenclatures of the different frac­
tionation techniques are related to one another. Table II gives the equivalent 
terminology for the lipoprotein fractions obtained by starch electrophoresis,
ultracentrifugal flotation and Cohn fractionation. It is constructed according 
*
to the recommendations for lipoprotein nomenclature made by the Committee on 
Lipid and Lipoprotein Nomenclature of the American Society for the Study of 
xltherosclerosis (1956). The low density lipoproteins (D <1.063) correspond to 
the Gofman Sf classes > 0. All these lipoproteins have the electrophoretic 
mobility of beta-globulins. Chylomicrons (D < 1.006) have the mobility of 
alphag-globulin on starch electrophoresis but run differently on paper. The 
lipids in Cohn fractions I and III correspond closely to those of density 
<1.063. The lipoproteins of D > 1.063, the high density lipoproteins, have 
the mobility of alpha-]_-globulin and are usually found in Cohn fraction IV and V.
There is good presumptive evidence that the Sf 12-20 class of lipoproteins 
and pre-beta-lipoprotein are identical. Gofman et al., (1950) reported a highly 
significant increase of the former and Besterman (1957) a similar increase of 
the latter in patients following myocardial infarction. In addition, the
TABLE III. The percentage composition of serum lipoprotein fractions.
LIPOPROTEIN 
FRACTION 
(by density)
TOTAL
CHOLESTEROL PHOSPHOLIPID TRIGLYCERIDE PROTEIN
CHOLESTEROL
PHOSPHOLIPID
RATIO
< 1.006 9.1 7.1 81.3 2.5 0.95
1.006 - 1.019 22.2 17-9 51.8 7.1 0.90
1.019 - 1.063 46.9 23.1 9.3 20.7 1.30
1.063 - 1.21 19.4 26.1 8.1 46.4 0.48
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biochemical data for the Sf 10-20 lipoproteins shown in Table III are com­
parable to the more limited data obtained for prebeta-lipoprotein by Besterman. 
Chemical Properties of the Lipoproteins
Table III is compiled from data obtained by Bragdon et al., (1956). It 
gives a detailed account of the normal lipid composition of the different lipo­
protein classes. Chylomicrons consist mainly of triglyceride with much smaller 
amounts of cholesterol and phospholipid and only a trace of protein. The Sf 
10-20 group of lipoproteins ( prebeta-lipoprotein) contain major cholesterol 
and phospholipid components and about three times the amount of protein in 
the chylomicrons, as well as a large triglyceride fraction. Beta-lipoprotein 
is characterised by a high ratio of cholesterol to phospholipid (C/P ratio). 
Alpha-lipoprotein has the highest protein content of any of the lipoprotein 
fractions and it is probably this and its much lower C/P ratio which confer 
upon it the biochemical stability it is generally regarded as possessing.
Attempts have been made to characterise the major lipid fractions in 
greater detail. Steele and Kayden (1955) studied the phospholipids and found 
a higher proportion of sphingomyelin to lecithin in the beta fraction than in 
the alpha fraction. Gillies et al., (1956) determined the fatty acid compos­
ition of the low density lipoproteins and found that beta lipoprotein con­
tained large amounts of linoleic in addition to stearic, palmitic and oleic 
acids. Chylomicrons on the other hand contained stearic, palmitic, oleic and 
palmitoleic acids but no linoleic acid. These differences are probably due to 
the fact that cholesterol is esterified chiefly with linoleic acid and is of
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course present in largest amounts in beta-lipoprotein, whereas the chylomi­
cron fatty acids derive mainly from triglyceride.
Physical characteristics of the lipoproteins
The high density lipoproteins have molecular weights ranging from 
165,000 to 4-35,000 (Shore, 1956). The low density lipoproteins have much 
higher molecular weights, the lowest being about 2,100,000, hydrated (Oncley, 
1956) and this may increase to as high as 250 million for the chylomicrons 
(Shore, 1956). Oncley et al., (194-7) have shown that beta-lipoprotein is 
60 per cent water by weight and that this water has an important structural 
role in the molecule since, if removed, much of the lipid splits off.
From their measurements they concluded that the molecule was a sphere with 
a diameter of 185 ft. They suggested that since the molecule had so maiyof 
the properties of a protein, the polypeptide chains must be arranged on the 
surface with the lipid inside. They concluded that the alpha-lipoprotein is 
ellipsoid in shape with a long axis of 300 ft and a short axis of 50 ft.
With this account of the composition and structure of the serum lipopro­
teins we now turn to our investigation of some of the factors which influence 
the concentration and distribution of the serum lipids.
SERUM LIPIDS IN PREGNANCY AND THE PUERPERIUM
Although it is known that the various lipid fractions of blood may 
be altered by the administration of substances such as heparin, (Hahn,
194-39 Boyle et al.. 1952; Nikkila, 1952), and oestrogens, (Eilert, 194-9;
Barr, 1953), a full account of physiological variations is lacking. During 
pregnancy it is possible to study the serum lipids under the influence of 
profound, though physiological, hormonal and metabolic disturbances.
Earlier studies have produced results which are not entirely in 
agreement. Boyd (1934-) stated that there was a rise in serum lipids, phos­
pholipid during the first trimester and cholesterol later. He also noted 
an increase in neutral fat. Dieckmann and Wegner (1934) concluded that 
serum cholesterol increased later in pregnancy because there was either 
faulty elimination by the liver or retention for lactation. They quote 
Denecke (1924) who found that after delivery cholesterol was rapidly excreted 
in milk, bile and urine, and had returned to normal levels by the fourteenth 
day. Oliver and Boyd (1955) after a careful study of 1 2  normal primigra- 
vidae stated that between the 3 1 st and 3 3 rd weeks of pregnancy there was a 
highly significant rise in the plasma ester and total cholesterol, the 
cholesterol:phospholipid ratio (C/P ratio) and the beta-lipoprotein choles­
terol. By the 20th week postpartum these values had decreased considerably, 
but were still higher than the levels at the 1 2 th week of pregnancy.
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It seemed relevant to repeat these studies in a large, homogeneous 
group of women, to extend them to include observations on the beta, prebeta, 
and alpha lipoprotein complexes and to examine any possible relationship 
between these observations and such factors as maternal weight gain, baby’s 
birth weight, breast feeding or any others which might arise.
Material and Methods
This investigation includes IS primigravidae between the ages of 17 and 
29, the mean age being 22 years. They were enrolled at times varying from 
the 1 1 th to the 3 3 rd week and all were in good general health with normal 
blood pressure, urine, chest X-ray and electrocardiogram. In 6  cases preg­
nancy developed abnormally and the findings are considered separately.
Each woman was seen in the afternoon of her monthly visit to the ante­
natal clinic (and, in some cases, more frequently nearer term); on admission 
in labour, if possible; 6 - 7  days after delivery; and at the routine post­
natal visit 5-7 weeks later. Difficulties inherent in the organisation of 
a series of this size, and the occasional absence of a case from clinic atten­
dance, account for small numerical deficiencies at each stage.
On each occasion a sample of venous blood was taken for estimation of 
haemoglobin, packed cell volume, serum cholesterol and for electrophoresis. 
Total serum cholesterol was measured by the micro-method of King (1951) and 
electrophoresis, preparation and evaluation of the lipoprotein patterns as 
described elsewhere (Chapter 2). Wasserman and Kahn reactions were tested as 
part of the routine ante-natal care, as was blood grouping.
TA‘-LE IV. kean total serum cholesterol values and beta:alpha lipoprotein ratios of 42 normal 
' priraigravidas during pregnancy and the puerperiuir..
£
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2, Graph of results in Table IV. The circled figures
give the number of subjects in each sample.
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RESULTS
The principle adopted by Oliver and Boyd (1955) in fixing the zero 
point of each pregnancy is followed here. Parturition is taken as the first 
day of the 40th week and prepartum stages calculated retrospectively. The 
results are grouped in periods of four weeks, the week named being the first 
of each period. The sequential serum cholesterol and lipoprotein results for 
each subject are given in Appendices I and II.
Total Serum Cholesterol (Table IV and Fig. 2)
Total serum cholesterol rose from a mean of 191 mg. per cent (S.D. 28) 
at the 13th week to a mean of 252 mg. per cent (S.D. J+L)a.t the 29th week, 
and remained at about this level until term. It fell after parturition and 
by the 6 th to 8 th week had reached a mean of 228 mg. per cent (S.D. 4-3).
This was still much higher than the mean at the 13th week of pregnancy.
The same 22 women were seen both at the 17th and 29th weeks of preg­
nancy. The mean cholesterol values of this group were 206 mg. per cent and 
252 mg. per cent respectively. The mean difference of J+6 mg. is significant 
(P < 0.01). The form of the cholesterol curve (Fig. 2) suggests that by the 
1 3 th week, the effective starting point of this investigation, the serum 
cholesterol had already begun to rise.
Lipoprotein Ratio (Table IV, Fig 2)
The mean beta:alpha lipoprotein ratio rose from 1.14 (S.D. 0.19) at the 
13th week to 1.85 (S.D. 0.44) at the 37th week. This difference is signifi­
cant (P^O.Ol). The ratio fell to 1.43 (S.D. 0.26) in the week before term.
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However only 12 of those subjects seen at the 37th week were seen again 
at the 3 9 th and the mean lipoprotein ratios at those times were 1 . 7 6  and 1 . 5 1  
respectively. This difference is unlikely to be significant (0.1>P >0.05). 
The slight rise from 1.47 at the 3 9 th week to 1.55 at labour in another
sequential group of 12 is not significant (P>0.5). By 6 - 8  weeks post-partum 
the mean ratio had fallen to 1.37 (S.D. 0.43). This figure is considerably 
higher than at the 1 3 th week of pregnancy.
The form of the lipoprotein curve (Fig. 2) gives less indication that 
a change in beta:alpha lipoprotein ratio has occurred before the 1 3 th week 
and suggests that it continues to rise for some time after the serum choles­
terol has attained its maximum. This could be attributed to increases in 
either the phospholipid or fatty acids of beta-lipoprotein during the weeks 
preceding labour.
Pre-beta liooorotein
It proved difficult to devise a wholly consistent method for the assess­
ment of this lipoprotein moiety, and the scheme eventually adopted is no 
better than a rough working guide. Thus, if no pre-beta lipoprotein was 
seen in any electrophoresis strip in a subject series the grading was 0 ; 
where pre-beta lipoprotein appeared with some frequency and one or more of 
the bands could be graded ++ the entire series was given that grading. Inter­
mediate patterns were accorded a + grading. On this basis, of the 42 normal 
subjects 8  were classed as 0, 24 as + and 10 as ++. The subjects in the 2 
groups of 8  and 1 0  were compared in respect of the following values: a)
lowest total serum cholesterol recorded; b) highest serum cholesterol recorded,
TABLE V. ;/ean values of a) lowest serum cholesterol, 
b) highest serum cholesterol, c) weekly weight gain, 
and d) babies' birth weights of 2 groups of 
primigravidae selected on the degree of pre-beta 
lipoproteinaemia.
(a) (b) (0) (d)
GROUPS
Lowest
serum
cholesterol
(mg.c)
Highest
serum
cholesterol
lmg.%)
Mother's
weekly
weight
gain
(lbs.)
Birth
weights
(lbs.)
Ho pre-beta 
lipoprotein 
(8 oases)
Range
181.5
139-242
281.5
212-358
1.05
0.33-1.60
7.12
6.25-8.45
2+pre-beta 
lipoprotein 
(10 oases) 
Range
203.9
157-253
313.7
267-394
1.30
0.75-2.00
7.19
5.95-8.25
t = 1.84
o.i >p>0.05
t = 1.31 
p > 0.10
t = 1.30
p > 0.10
TABLE VI. Cholesterol and lipoprotein values at the 33rd. week of 
pregnancy and 6-6 weeks post-partum of 5 women whose average weekly 
weight gain during pregnancy exceeded 1.4 lb.
Case
Ko.
Average
weight
gain
lb/week
33ru.
Cholesterol
mg. £
week
Lipoprotein
ratio
6-8 Weeks ]
Cholesterol
mg. %
ost-partum
Lipoprotein
ratio
1 1.85 260 2.62 266 2.21
8 1.63 225 1.87 262 1.76
26 1.42 343 2.75 219 1.59
35 1.42 256 2.16 248 1-98
46 1.80 231 2.00 242 1.47
Kean 1.62 263 2.28 247 1.80
Series
Kean
1.10 243 1.72 228 1.37
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c) mother’s average weekly weight gain, and d) baby’s birth weight. The 
results are summarised in Table V.Statistical analyses of the two sets of 
figures do not demonstrate a significant difference between the groups 
but nevertheless there seems to be a trend of significance insofar as three 
of the values, namely the highest and lowest serum cholesterol readings and 
the mother’s average weekly weight gain are all highest in the group charac­
terised by a pre-beta lipoprotein band which persists at high levels through­
out pregnancy.
Weight change (See Appendix I)
The average weekly weight gain during pregnancy was 1.1 lb. (0.5 kg.).
The average weight loss from the maximum recorded during pregnancy to the
weight at 6 - 8  weeks post-partum was 22.4 lb. (10.2 Kg.).
Table VI shows the cholesterol and lipoprotein value at the 33rd week and
in the phase 6 - 8  weeks post-partum of 5 women whose average weekly gain in 
weight exceeded 1.4 lb. (0.64 Kg.). At both times their average cholesterol 
values exceeded the series mean by 8  per cent, (263 and 247 as against 243 
and 228) and their average lipoprotein ratios exceeded it by 3 1  per cent (2 . 2 8  
and 1.80 as against 1.72 and 1.37). The 33rd week cholesterol and lipoprotein 
values of those women were tested against the corresponding values of 5 of 
the women whose average weight gains were grouped nearest to the mean. This 
small sample had an average cholesterol level of 2 6 1  mg. per cent and there 
was obviously no difference between the groups, but the average lipoprotein 
ratio was 1 .8 2 , the difference between them being marginally significant 
(t = 2.42; 0.05> p> 0.02). Four of the 5 women with increased weight gain
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had slight ankle swelling towards term but none was considered by the obs­
tetrician managing the case to be utoxaemicn. The birth weights of the 5 
babies were normal.
The corresponding figures for those whose weekly gain in weight was 
less than 0.8 lbs. (0.36 Kg.) show nothing of note. No connection was dis­
covered between lipid trends and weight loss after parturition.
Birth Weight (See Appendix II)
The babies’ weights ranged from 5 lbs. 9 oz. (2.5 Kg.) to 8  lbs. 15 oz.
(4.0 Kg.). There was no obvious relationship between maternal lipid values
and the birth weight of the child.
The effect of feeding
Only 6  of the women were still breast feeding their bahies at the time 
of the final post-natal visit; 1 9  had transferred to bottle feeding before 
leaving hospital and the remainder some time thereafter. All of the 19 and 
most of the others x^ ho had gone on to bottle feeding had been given stilboes- 
trol. Because of this, and also because of the disparity in the group sizes, 
and the scatter of the times at which the feeding transition occurred, no 
valid conclusions could be drawn regarding the effect of infant feeding or 
the serum lipid values.
Pregnancy developed abnormally in 6  of the subjects and the main details
of these cases are given in the folloxdmg brief accounts.
Case 10 (J.C.) Normal until term. Sudden onset of eclampsia during labour, 
which was three weeks later than the expected date. Spontaneous delivery of 
a live, female child weighing 9 lbs. 2 oz. (4*15 Kg.), the heaviest of the 
series.
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Uneventful puerperium. Mother and child in good health at the post-natal 
visit.
The serum lipids conformed to the general pattern, apart from a steep 
rise in the lipoprotein ratio from 1 . 7 3  at the 3 9 th week to 2 . $ 6  during 
labour. There was no associated rise in serum cholesterol. Pre-beta lipo­
protein grading 0 .
Case 13 (H.S.) Rather nervous woman, but otherwise normal until she was 
admitted at the 37th week with mild pre-eclampsia. Discharged improved 
after one week. Spontaneous delivery of a macerated, male foetus,weighing 
6  lbs. 14- 6 z. (3.1 Kg.). No obvious cause apart from pre-eclampsia. Normal 
puerperium.
The lipoprotein ratio remained fairly constant near the 1 3 th week level, 
throughout pregnancy and the puerperium. Pre-beta lipoprotein grading +.
Case 20 (J. McC.) Normal throughout pregnancy. Spontaneous delivery of a 
limp, asphyxiated male child weighing 5 lbs. 12 oz. (2.6 Kg.) which died 
soon after birth. Autopsy revealed a large diaphragmatic hernia and patent 
foramen ovale.
The serum cholesterol rose from 217 mg. per cent at the 2 0 th week to 
355 mg. per cent at the 3 8 th week and the lipoprotein ratio reached the very 
high values of 3.27 and 3.34- at the 35th and 38th weeks, respectively. Pre­
beta lipoprotein grading ++.
Case 4.5 (J.G.) Normal until near term. Caesarean section performed because 
of severe pre-eclampsia. Live female child weighing 6  lbs. 9 oz. (3.0 Kg.).
There was no significant variation of the lipids from the general pat­
tern. Pre-beta lipoprotein grading 0  .
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Case 2L (C .C.) Mild thyrotoxicosis suspected on clinical grounds at the 
25th week. Labour induced by artificial rupture of the membranes because 
of mild pre-eclampsia, 14- days after the expected date of delivery. Live 
male child weighing 8  lbs. 1 1  oz. (3.9 Kg.). Remission of thyrotoxic symp­
toms after delivery.
The lipoprotein ratio ranged closely about a mean value of 0.83 until 
term. One week after delivery it had risen to 1.82 and was 1.81 seven 
weeks later. The serum cholesterol, which ranged closely about 158 mg. per 
cent until term, was 182 mg. per cent one week post-partum and 3 0 6  mg. per
cent seven weeks later. Pre-beta lipoprotein grading 0.
The average weekly weight gain in this case was 0.55 lbs. (0.25 Kg.), the
second lowest in the entire series.
Case 4.9 (A.M.) Moderate enlargement of thyroid noted. ’’Nervous" but not 
convincingly thyrotoxic. Given small doses of phenobarbitone. Spontaneous, 
normal delivery of a live male child weighing 8  lbs. 15 oz. (4-.0 Kg.). At 
the post-natal visit she was more composed. There was no change in the size 
of thethyroid.
Serum cholesterol rose from 225 mg. per cent at 1 6  weeks to 389 mg. per 
cent at term, but fell normally thereafter. The lipoprotein ratio was slightly 
above average throughout. Pre-beta lipoprotein grading : ++.
DISCUSSION
This study confirms that significant changes occur in the serum lipids 
during normal pregnancy and mainly in those lipids which comprise the beta- 
lipoprotein' complex. For although the paper electrophoretic method of studying
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the lipoproteins is only semi-quantitative it is clear from an overall 
assessment of the stained paper strips that the increase in the beta:alpha 
ratio is due to an increase in beta lipoprotein and not to a decrease in 
alpha lipoprotein, which seems to remain fairly constant throughout. The 
experimental conditions of the work reported in the next chapter allowed 
some degree of quantitative comparison of changes in alpha lipoprotein but 
these will not be anticipated.
Beta-lipoprotein may be increased by increases in its cholesterol, 
phospholipid or fatty acid components. Since the increase in serum choles­
terol seems to reach its maximum about the 2 9 th week of pregnancy while the 
whole beta-lipoprotein fraction goes on increasing up to the 3 7 th week, it 
is reasonable to infer that either the phospholipid or fatty acid components, 
singly or together are increasing up to this point.
Oliver and Boyd (1955) give an excellent account of the endocrine factors 
which may affect serum lipids. These are so complex that any attempt to use 
them to account for the lipid changes reported here can be no more than specu­
lative oversimplification. Among other things they draw attention to the para­
dox that the large physiological increases in circulating oestrogens which 
occur in pregnancy (Preedy and Aitken 1957) are associated with an increase in 
the blood lipids, while administered oestrogen acts conversely (Eilert, 194-9). 
But there is no proof that the augmented oestrogen level is the only lipogenic 
factor. The possible effect of altered secretions of the pituitary and 
adrenal hormones cannot be discounted. On the other hand the abnormal lipid 
pattern of case 2 4 , the woman with thyrotoxicosis, suggests that however
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potent these other endocrine secretions may be as lipogenic factors, they 
can be effectively over-ruled by increased thyroxine production.
Cairns and Constantinides (1954) and Sundberg (1955) have shown that 
the mast cell content of female arteries during the years of reproductive 
activity is greater than in males of the same age group. Oestrogens may 
to some extent determine this difference and herein lies another theoretical 
approach to an explanation of the lipid changes, for mast cells contain 
heparin (Holmgren and Wilander, 1937; Oliver et al.. 1947 Ehrich et al.. 
1 9 4 9 ) and heparin can reduce the levels of circulating beta-lipoprotein 
(Nikkila, 1952). If the relationship between blood oestrogen levels, mast 
cells and heparin production was a direct and simple one, rising blood 
oestrogen levels should increase heparin production and so lower the beta: 
alpha lipoprotein ratio; the reverse, in fact, of the changes observed in 
this study. It Is possible however that the very high blood oestrogen 
levels of pregnancy exhaust the mast cells, depress their activity, or 
reduce the number in the tissues, thus lowering heparin production and so 
contributing to the lipoprotein changes demonstrated. The slow return to 
normal lipoprotein values during the puerperium may be due to delayed rec­
overy of mast cell function.
There is some experimental support for this idea in the work of Westin 
(1955), Westin and Odelblad (1956) and Bergstrom et al.. (1958) who have 
shown that the administration of oestrogens to oophorectomised mice sig­
nificantly lowers the mast cell content of uterus and vagina. It is also
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supported by the studies of Baglioni and Lorenzoni (1955) on the Walker 
cell tumour. They showed that whereas small doses of oestrogen were 
followed by an increase in the number of mast cells at the periphery and in 
the capsule of the tumour, larger doses led to a fall in the number of mast 
cells in the same regions. The possible role of the tissue mast cell in 
atherosclerosis and lipaemia is examined experimentally later in this thesis.
The small group with maximum weight gain invites comment but again this 
can be little more than speculative. If the weight gain is not solely a 
manifestation of mild toxaemia, it may reflLect increased growth hormone acti­
vity, which may also cause the high lipoprotein ratio. But in this case we 
might have expected big babies. The birth weights of the 5 babies were, 
however, normal. And Oliver and Boyd (1954) were unable to produce a rise 
in blood cholesterol by the intravenous injection of growth hormone, the 
activity of which had previously been demonstrated by injection into rats.
Lastly it must be observed that the pre-beta lipoprotein band first 
reported by Dangerfield and Smith (1955) and later shown by Besterman (1957) 
to be an almost invariable finding in the serum of patients following myo­
cardial infarction, occurs more often than not in the serum of normal primi- 
gravidae.
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C H A P T E R  A
THE EFFECT OF EPI-OESTRADIOL BENZOATE ON THE SERUM 
LIPIDS OF CHOLESTEROL FED CHICKENS 
While the previous study was in progress the opportunity arose to 
investigate the uncomplicated effect of a semi-synthetic oestrogen on the 
serum lipids of the chicken. Tm _s substance, epi-oestradiol benzoate, was 
one of a series of substances being tested for their anti-atherogenic effect, 
by a group of workers led by Mr. R. S. F. Campbell of the Department of 
Veterinary Pathology, Glasgow University, and I am grateful to him and the 
group for the chance to associate with them in a small part of their long­
term investigations. The complete account of this particular experiment is 
reported in Campbell et al. (1959). Only that part of it concerned mainly 
with the biochemical aspects is reported here.
METHODS
Sixty Golden Legbar - Light Sussex cockerels, one month old, were allo­
cated to 5 groups of 12 birds and housed in individual cages. Weight was dis­
tributed comparably in each group. Each group was subjected to an experimental 
regime of 16 weeks’ duration. The birds were weighed at weekly intervals. One 
of the groups used in the complete study has no relevance for this report. The 
groups included were as follows
(B) Fed a lipogenic diet of commercial chick mash supplemented 
by 1  per cent cholesterol for 1 6  weeks•
TABLE VII. Konthly average weights of each group 
of chickens (in gas.)
Weeks B C D E P
0 307 310 305 307 310
4 642 66 2 641 628 63»
8 1187 1138 1243 1288 1262
12 1580 1565 1527 1731 1755
16 1777 1351 1361 1973 2001
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(G) Diet as (B) for 16 weeks. After the 8 th week given
epi-oestradiol, 1  mg. intramuscularly daily.
(D) Diet as (B) for 16 weeks. After the 8 th week given
epi-oestradiol, 5 mg. intramuscularly daily.
(E) Commercial mash only for 16 weeks.
(F) Commercial mash for 16 weeks. After the 8 th week 
given epi-oestradiol, 1  mg. intramuscularly daily.
Blood for lipid analyses was withdrawn from an alar vein at the start
of the experiment and at 4-weekly intervals thereafter. Total serum chol­
esterol was estimated by a modification of the Sperry-Schoenheimer technique- 
(1934) and lipid phosphorus by the method of King (1951). Total phospholipid 
was estimated as 2 5  times the lipid phosphorus value and the cholesterol - 
phospholipid ratio (C/P ratio) calculated from these figures. Lipoproteins 
were analysed by paper electrophoresis as described in Chapter 2. Complete
sequential lipoprotein analyses were carried out only in groups B, D, E and
F. Group C was included after the 8 th week.
All birds were sacrificed at the 16th week for detailed histopathological
examination of the heart and main vessels and the condiHon of comb, wattles 
and teste.s was noted.
RESULTS
Weight
The monthly weight averages are shown in Table VII. During the first
8  weeks there is no difference between the birds fed normal and cholesterol
enriched mash. During the next 8  weeks however the cholesterol fed birds
tm-rt.r VTTT- Kean monthly lipid values of all experimental groups. for
reasons which are explained in the text) the betaialpha lipoprotein ratios 
of group D, at the end of the 3rd. and 4th. months, were not oaloulable.but 
vere obviously immense.
GROUP WESXS CHOLESTEROL 
mg. £
PHOSPHOLIPID 
mg. %
C/P RATIO BETA1ALPHA RATIO
0 209 237 0.88 0.61
4 1028 380 2.71 2.96
B 8 931 327 2.84 3.06
12 426 203 2.11 2.18
16 299 155 1.93 1.67
0 188 223 0.85 -
4 773 337 2.29 -
C 8 781 313 2.50
12 440 295 1.49 2.26
16 289 203 1.42 1.90
0 193 230 0.84 0.63
4 650 288 2.24 3.11
D 8 576 270 2.31 2-53
12 2513 3970 0.63 -
16 3032 4300 0.70 -
0 205 237 0.90 0 .61
4 145 242 0.60 0.59
E 8 178 247 0.72 0 .73
12 I85 215 0.86 0.91
16 164 182 0.90 O.69
0 180 237 0.76 0 .59
4 158 257 0.61 0 .94
T 8 196 285 0.69 0 .77
12 175 265 0.66 1 .70
16 177 275 O.65 1.83
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weigh on average 172 g. less than the others. It proved impracticable to 
keep accurate records of food intake but the lighter birds seemed to eat 
less. The cholesterol fed birds receiving oestrogen (C and D) were heavier 
than those receiving cholesterol alone.
Oestrogenic Effects
All birds receiving 5 mg.epi-oestradiol per day (D) showed marked 
hypoplasia of combs, wattles and testes. Seven birds in group C and 3 in 
group F showed similar changes. Three of the birds in group B showed par­
tial inhibition of sex characters, but none showed changes as severe as in 
the oestrogenised animals.
Lipids
The mean monthly values of the serum cholesterol, phospholipid, C/P 
ratio and beta: alpha lipoprotein ratio are given in Table VIII. It can be 
seen from the table that the various lipid values in each group were satis­
factorily comparable at the start of the experiment.
For simplicity of reporting the biochemical results will be described 
first, and the electrophoresis results next. The relationship between the 
two will be educed in the discussion.
Cholesterol. Phospholipid, and C/P ratio
Group E In this, the normal control group, there was no noteworthy change 
in either of the 3  levels during the experiment, apart from a slight fall in 
the cholesterol level with a corresponding fall in the C/P ratio at the end
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of the first month and some lowering of the phospholipid level at the end 
of the 4 -th month.
Group F The administration of 1 mg. of epi-oestradiol per day to birds 
receiving normal diet was followed by a slight though doubtfully significant 
fall in the C/P ratio compared with group E. This seemed to be due to mini­
mally divergent tendencies in the phospholipid levels of the two groups, those 
in group F rising slightly, and those in group E falling.
Group B The inclusion of 1 per cent cholesterol into the normal diet
produced a steep rise in the cholesterol levels but a less profound rise in 
the phospholipid levels so that the G/P ratio rose to more than three times 
its normal value during the first and second months of abnormal feeding. 
Thereafter, presumably because of enhanced cholesterol elimination there was 
a spontaneous return to more normal cholesterol levels, in spite of the con­
tinuation of cholesterol in the diet. There was also some reduction in the 
phospholipid levels during the 4 -th month, so that although the serum choles­
terol was about one and a half times its starting value the C/P ratio was
more than twice the initial figure.
Group G During the pre-oestrogen phase of the cholesterol diet the serum 
cholesterol levels in this group did not rise to quite the same high figure 
as in group B. Nevertheless they were high enough to give C/P ratios which 
once again were about three times normal values. During the period of oes­
trogen administration (l mg./day) the serum cholesterol fell to levels simi­
lar to those in group B,  but the phospholipid levels fell to a lesser degree
Protein and lipoprotein patterns of normal chicken serum
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so that the C/P ratio was somewhat lower. (1.4-2 compared to 1.93). It is 
doubtful if these figures are significant in themselves, but it is interes­
ting that the same tendency is apparent in the two groups E and F, and B and 
C, namely that this particular dose of oestrogen (l mg./day) while having no 
effect on the serum cholesterol seems to have a slight effect in maintaining 
the serum phospholipid and so tends to lower the C/P ratio.
Group D It is clear from an examination of the results in groups G and D 
that the higher dose of oestrogen has evoked a radically different response 
which is qualitative rather than quantitative. There is an enormous rise in 
serum cholesterol and phospholipid, associated with great milkiness of the 
serum, ^he increase in phospholipid is of a greater degree than the increase 
in cholesterol, so much so that in spite of the gross hyperlipaemia the G/P 
ratio is actually slightly lower than the comparable normal of group E (0.70 
as against 0 .9 0 ).
Lipoproteins
Group E Fig. 3 illustrates the normal protein and lipoprotein patterns of 
the chicken and is representative of the patterns in the control group, through­
out the four months. While these cannot be regarded as identical with corres­
ponding human patterns there is sufficient similarity to allow some equivalence 
in nomenclature, with this major difference - the young chicken has nothing 
which corresponds to human gamma globulin. The protein bands therefore comprise 
only f - globulin, 2 -globulin, o41-globulin and albumin.
Fig* 4» Lipoprotein pattern of chicken E6  showing a well- developed
beta-lipoprotein hand.
Fig. 5 . Lipoprotein pattern after 1 month of oestrogen
administration (bird F4). There is a prominent beta- 
lipoprotein band and the alpha band has regressed. An 
alpha- 2  lipoprotein is clearly detected by scanning.
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While the typical normal chicken lipoprotein pattern contains an 
alpha-lipoprotein band which corresponds to human alpha-lipoprotein, both 
in amount and in its association with the albumin - oCl globulin complex, 
there is no exactly comparable beta-lipoprotein. The stainable lipid which 
is present in a position intermediate between the starting point and beta- 
globulin is probably that part of the beta-lipoprotein complex which consists 
mainly of low density lipoproteins. However, there is some spontaneous vari­
ation and Fig. 4 shows the lipoprotein pattern in chicken E 6  where there is 
a well developed beta-lipoprotein complex and a higher lipoprotein ratio.
Group F During the first 2 months the lipoprotein patterns were similar to 
those in Group E. Fig. 5 shows the striking change in the pattern after 1 
month of oestrogen (bird F4)• The difference is essentially due to the emer­
gence of a prominent beta-lipoprotein band, although the degree of increase in 
the betaialpha lipoprotein ratio may also be due in part to a reduction of the 
alpha lipoprotein. Now since there has been no rise in the cholesterol levels 
of this group and only a marginal increase in phospholipid it is reasonable to 
infer that the denser beta-lipoprotein band is perhaps due to some increase 
in the triglyceride or fatty acid component of the complex, and it is worth 
comment that some of the sera in this group were slightly turbid or opaque.
This tendency reached its peak in group D where all the sera were a dense 
milky white.
Group B. On the cholesterol diet the lipoprotein pattern was grossly abnor­
mal by the end of a month. There were three aspects to this change. Firstly 
an increase in the main beta lipoprotein band itself, an increase in the band
BIRD BI2 beta alpha
Fig. 6 . Lipoprotein pattern after 1 month of cholesterol
feeding and 3 months later, to show the spontaneous 
regression of beta-lipoprotein which has occurred during 
the continuous administration of cholesterol.
Lipoprotein
Protein
BIRD D ll Albumin
F ig .  7 * Serum p r o t e in  and l ip o p r o t e in  p a t te r n s  ( b i r d  D l l )  showing
th e  g ross in c r e a s e  i n  b e t a - l i p o p r o t e i n ,  th e  d is a p p e a ra n c e  o f  
a lp h a - l ip o p r o t e in  and th e  em ergence o f  an a lp h a  2 - l i p o p r o t e in .  
The p r o te in s  a re  a ls o  a l t e r e d .  A lp h a  2 - g lo b u l in  p re d o m in a tes  
w h ile  a lb u m in  and b e t a - g lo b u l in  a re  much d im in is h e d .
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between the starting point and beta-lipoprotein (the neutral fat, low density 
lipoprotein area) and possibly also a slight decrease in alpha lipoprotein 
(Fig. 6 ). But during the third and fourth months the beta:alpha ratio fell, 
due mainly to a reduction in beta lipoprotein.
Group G The lipoprotein patterns in this group were not studied during 
the first two months. But during the second part of the experiment they 
were, and differed in no important respect from the corresponding lipoprotein 
patterns of group B.
Group D This was the group given 5 mg. of epi-oestradiol benzoate daily 
while on the 1% cholesterol enriched diet. The serum became grossly lipaemic 
and seemed to be considerably more viscous than in any of the other groups.
It was technically impossible to electrophorese the usual 0.1 ml. of serum 
and only 0.02 ml. was analysed. With this smaller amount of serum no alpha 
lipoprotein was visible and it is impossible to say whether this was due to 
the smaller quantity of serum applied or whether it represented a real dis­
appearance of the lipoprotein. But attempts to run slightly larger amounts 
of serum seemed to indicate that there was a real and probably profound reduc­
tion of the amount of alpha lipoprotein present. Beta lipoprotein stained 
intensely and a new band appeared running ahead of it and quite separate from 
it. This band corresponds with alpha2 -globulin which is also much increased. 
Fig. 7  shows the striking alteration in the lipoprotein and protein electro­
phoresis patterns compared with the normal in Fig. 3. This was the only group 
in which the serum proteins were significantly affected and it can be seen 
from Fig. 7  that alpha2 -globulin has increased to being the largest fraction
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and albumin has diminished to being the smallest, with beta globulin inter­
mediate .
For the reason given above no beta: alpha lipoprotein ratios were cal­
culable in this group at the end of the 3 rd and 4 th months, but they were 
obviously immense.
Because the lipid stain is never exactly at the same strength from one 
staining procedure to another, and because of the intrinsic limitations of 
the method itself accurate quantitative comparison of similar lipoprotein 
complexes at different time intervals is not possible. However the various 
monthly batches of electrophoresis strips were stained from the common stock 
of Sudan Black B in use at that time, under the same laboratory conditions 
and given the same cleaning rinses with 50 per cent ethanol. Fig. 8  therefore 
is at least a rough indication of changes in the alpha and beta lipoprotein 
complexes relative to one another at the different monthly stages of the expe­
riment. This suggests two tendencies in the alpha lipoprotein complex; 
firstly that it is reduced by the administration of the oestrogen to normal 
birds (group F) and secondly that it falls as beta lipoprotein rises (group B). 
Its virtual disappearance from group D may be attributable to the combination 
of these effects.
DISCUSSION
The main background to this study was an attempt to reverse the athero­
sclerosis which is easily induced in chickens by a cholesterol enriched diet 
(Dauber and Katz, 1942). But my personal interest in this work and the aspects
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which I shall discuss here were those concerned with the oestrogen control 
of the serum lipids, particularly the lipoprotein complex and a comparison 
with the changes in pregnancy, and following the therapeutic administration 
of oestrogens to human adults.
It must be realised at the outset that such a comparison is full of 
pitfalls. Firstly in pregnancy we are dealing with an increase in a physiol­
ogically produced group of oestrogens while in this study and in most other 
human and animal studies the oestrogens under test are synthetic or semi­
synthetic. Secondly, while in the experimental animal rigorous control of 
potentially effective agents is possible, in pregnancy the intrinsic inter­
play of mutually augmentary and antagonistic factors is unpredictable. Thirdly, 
it is virtually impossible to achieve comparable circulating blood oestrogen 
levels. The truth of this can be understood from the following facts. The 
average circulating oestrogen levels in the last week of pregnancy, about 
1 5 /*g/l0 0  ml. are 4-0 - 5 0  times greater than the circulating oestrogen levels 
of the normal sexually active woman about the 25th day of the menstrual cycle 
(Preedy and Aitken, 1957). On the rough basis of a circulating blood volume 
of 5 litres the total amount of circulating oestrogen in the pregnant woman 
just before term, the time at which she is considered to be most highly oes- 
trogenised, is about 750 yug. Doses of oestrogen used in human trials have 
ranged from 10/xg. ethinyl oestradiol/day (Marmorston et al., 1958) and 1 
mg./day (Steiner et al., 1955, Oliver and Boyd, 1956) up to 20 mg./day of a 
mixture of conjugated oestrogens such as Premarin (Robinson et al., 1956) with
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apparently similar effects on the serum lipids. In the experimental animal 
doses have ranged from 17^u,g./day of oestradiol benzoate in rats (Priest et 
al. 1957) to 5mg. daily of epi-oestradiol benzoate to chickens, as in this 
study.
The results of this experiment conform in the main to that of other workers 
in the animal field. Pmest et al. (1957) distinguish between the effects of low 
and high doses of oestrogen in rats. While both produce an increase in lipaemia 
the low dose tends to produce a greater increase in cholesterol and higher doses 
a greater increase in phospholipid. In their extensive experience of oestrogens 
in chicken atherosclerosis Katz and Stamler (1953) also find that oestrogens inc­
rease the serum lipids, but a relative increase in phospholipid is an almost inv­
ariable feature. The remarkable thing about the chicken studies of Katz and his 
co-workers is that in spite of the increase in circulating lipid which is usually 
associated with the administration of oestrogen the incidence of atherosclerotic 
lesions can be reduced and even reversed (Pick et al., 1952 a, b,). The reason 
given for this is that the increased phospholipid maintains the stability in 
solution of the excess cholesterol.
The physio-chemical theory of this explanation has been postulated by 
Dervichian (1949), who writes f,The natural lipoproteins contain ionic lipids 
(i.e. phospholipids and fatty acids) and non ionic lipids (cholesterol esters, 
cholesterol, glycerides)... It appears that non-ionic lipids cannot associate by 
themselves with proteins while they can associate with the other ionic lipids." 
The stability of the non-ionic lipids therefore seems to depend not only on the 
presence in the blood of adequate amounts of the ionic phospholipids, a concept
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widely appreciated by clinicians and biochemists, but also on the presence 
of ionic fatty acids, a less widely appreciated chemical concept which may 
prove to be the functionally important role of fatty acids in the treatment of 
human atherosclerosis, if this is successful.
The possible suppression of alpha lipoprotein and the emergence of an alpha- 
2-lipoprotein in the D group of animals in this study seem to represent a quali­
tative difference rather than a quantitative difference in the lipoprotein pat­
terns. Does the large dose of oestrogen inhibit in some way the enzymatic con­
version of the beta-lipoprotein to alpha-lipoprotein by lipoprotein lipase, 
which is thought to be mediated by heparin? If heparin is reduced in amount is 
it because the mast cell content of the tissues is lowered? Two observations 
are of some interest in this respect. Firstly, blood withdrawn from the normal 
chicken clots with great rapidity and secondly, mast cells are very scanty in the 
tissues of normal chickens and are found to be completely absent from the myo­
cardium (Campbell and Watson, 1957). These observations led to the work on 
mast cells which is reported later. But at the moment they make it difficult 
to answer the questions just asked, because if the normal chicken is lacking in 
mast cells, and consequently in mast cell heparin, what is there for the admini­
stered oestrogen to- suppress? And in any case why is the action of administered 
oestrogen on human lipids quite the reverse, in so far as it lowers the total 
serum cholesterol level and at the same time increases the fraction of choles­
terol in the alpha lipoprotein (Eilert, 1949 and many others). The only effect 
of administered oestrogens which seems to be common to human and animal studies 
is that of increasing the circulating phospholipid to a greater or lesser degree 
and at the same time reducing the cholesterol: phospholipid ratio.
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The large dose of oestrogen used in this study has also produced a major 
alteration in the balance of serum proteins. How far this is a primary effect 
and how far a result of the altered requirement of protein for lipid carriage 
must be left unanswered. Moore (194-8) noted a comparable change in cocks given 
oestradiol propionate, but no reciprocal change in hens given testosterone 
propionate. In an earlier paper (Moore, 194-5) he shows that not only may serum 
protein patterns be characteristic of the species but in some cases characteris­
tic also of the strain (e.g. the rat) and in others of the sex (e.g. the chic­
ken) .
Whatever the effect of oestrogens on the serum lipids and however beneficial 
from the purely biochemical point of view, there is as yet no convincing claim 
that they are of value in lowering the morbidity from atherosclerosis, while 
their feminising effects generally render them unacceptable for long term 
therapy.
THE EFFECT OF CERTAIN MARINE AND VEGETABLE OILS 
ON THE SERUM LIPIDS OF THE CHICKEN
As evidence accumulated for the effectiveness of certain oils as hypo- 
cholesterolaemic agents in humans, workers sought for a common property in 
different oils which would explain their action. Kinsell and Sinclair (1957) 
argued that the effective factor was linoleic acid and that atherosclerosis 
and hypercholesterolaemia were manifestations of a deficiency of essential 
fatty acids. This simple $nd attractive hypothesis is difficult to sustain 
however when the following evidence is considered. Firstly significant low­
ering of serum cholesterol, phospholipid and beta-lipoprotein occurs in hum­
ans following the ingestion of sardine oil (Keys et al., 1957), whale oil 
(Malmros and Wigand, 1957), and pilchard oil (Bronte-Stewart et al., 1956), 
oils which are poor in "essential" fatty acids although rich in other unsatu­
rated fatty acids, (Thomasson, 1953). Secondly serum lipid levels have been 
depressed by olive oil, rapeseed oil and linseed oil (Ahrens et al., 1957; 
Malmros and Wigand, 1957) which consist of mono- and tri-unsaturated fatty 
acids and non-essential linolernc acid. And so the emphasis has swung away 
from the presence of essential fatty acids as the important lipid lowering 
factor, to the idea that the total mean unsaturation of the fat is the criti­
cal requirement.
This is an account of a small pilot study carried out at the Veterinary 
School in 1957 to assess the relative effectiveness of seal, pilchard and 
corn oils as hypocholesterolaemic agents. The iodine values of these oils
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(taken from Bronte-£tewart, 1958, as compiled from various authors) are 
130-170, 160-183 and 103-128 respectively. The iodine value of a fat is 
regarded as an index of its degree of unsaturation. In addition to the 
study of these oils, and in view of a paper by Jones et al., (1956) which 
seemed to show that maize germ was a more potent hypocholesterolaemic agent 
than the expressed oH, we included maize germ, wheat germ and extracted 
maize germ in the dietary regimes.
MATERIALS AND METHODS 
Thirty Golden Legbar - Light Sussex Cockerels, one month old, were 
allocated to 6 groups of 5 birds and housed in individual cages. Weight 
was distributed comparably in each group, and equal amounts of food given. 
Each group was fed on standard chicken mash containing 1 per cent choles­
terol and supplemented as follows:
(G) 10 per cent seal oil.
(H) 10 per cent pilchard oil.
(I) 10 per cent corn oil.
(J) 10 per cent whole maize germ.
(K) 10 per cent extracted maize germ.
(L) 10 per cent whole wheat germ.
This experiment was carried out at the same time as that reported in 
Chapter 4 and 2 of the groups in that study were used as controls. These were 
group E, which was fed normal mash only and group B, which was given the mash 
supplemented with 1 per cent cholesterol.
TABLE IX. (a) Cholesterol levels (mg.P and (b) lipoprotein ratios of 
cholesterol fed chickens whose diets were supplemented with seal oil 
(G), pilchard oil (H)i corn oil (I), maize germ (j), artracted maize 
germ (k) and wheat germ (L). The comparable figures for normal 
birds (group E, chapter 4) were 178 tng.^  and 0.73t and for cholesterol 
fed birds (group B) 931 mg. % ash 3.06.
G H I J K L
BIRD SO. a b a b a b a b a b a b
1 400 3.01 319 4.50 757 4.92 504 2.52 1097 3.56 362 1.55
2 333 2.00 703 3.14 411 1.76 394 1.30 943 3.78 238 1.50
3 433 1.28 638 6.64 1035 4.04 305 1.17 2810 8.00 316 0.50
4 447 1.77 281 2.31 765 2.84 366 1.56 1680 6.15 300 1.45
5 304 2.63 366 2.50 940 4.53 369 0.98 819 4.45 564 1.22
AVERAGE 383 2.14 461 3.82 781 3.62 388 1.51 1470 5.19 356 1.24
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After 8 weeks of the dietary regimes blood was withdrawn from an alar 
vein and cholesterol and lipoprotein estimations carried out. The birds 
were killed at this point for examination of vascular pathology. This 
aspect of the study is not strictly relevant to the main theme of this thesis 
and is not reported here.
RESULTS
The cholesterol and lipoprotein values are shown in Table IX and a 
representative lipoprotein pattern from one bird in each group in Fig. IX.
The smallness of the group precludes worthwhile statistical analysis of the 
figures but nevertheless certain facts seem obvious enough to be valid.
If the mean cholesterol values of groups G, H,J and L are compared with 
those of group B it seems clear that the addition of seal and pilchard oils 
and maize and wheat germ to a cholesterol enriched diet retards the expected 
rise in the serum cholesterol. Such an effect is not so obviously obtained 
with corn oil (group I). The most striking result is the greatly enhanced 
hypercholesterolaemia associated with the administration of the extracted 
maize germ (group K).
There is a rough but certainly not direct relationship between the chol­
esterol and lipoprotein values in individual sera. This is obvious from a 
comparison of groups G and H where the mean cholesterol values are not dis­
similar (383 and 4-61 mg. per cent respectively) while the mean beta: alpha 
lipoprotein ratios are much further apart 2.IX and 3.82 respectively). The 
almost normal appearance of the lipoprotein patterns in group L in spite of 
the raised cholesterol levels is worth comment. In fact there may be some
Fig. 9. Representative lipoprotein patterns from each group of
chickens on oil and cereal germ supplemented diets. Note 
the appearance of alpha 2-lipoprotein in group K.
-  is -
increase in the alpha lipoprotein of this group. It is also worth noting that 
of all the groups only K shows a distinct alpha-2 lipoprotein, the lipoprotein 
band which emerged in the highly oestrogenised and grossly hypercholesterolaemic 
chickens of group D in Chapter X*
DISCUSSION
Despite the small number of birds used this study seems to confirm that 
the serum cholesterol is influenced by the nature of the dietary fat involved. 
There is no convincing evidence here of the effectiveness of corn oil in lower­
ing the hypercholesterolaemia of the cholesterol-fed chick, but the highly unsa­
turated seal and pilchard oils seem to be active as cholesterol lowering agents• 
These facts are in keeping with the belief that the degree of unsaturation of 
a fat is to some extent a measure of its effectiveness as a cholesterol lower­
ing agent.
This experiment does not reveal how these substances act, whether by 
increasing the excretion of cholesterol into the gut, inhibiting its absorption 
depressing its synthesis or promoting its sequestration in other body tissues.
The disparity in the lipoprotein values of the seal and pilchard oil 
groups (G and H) considered with the reasonably comparable cholesterol values 
provides tenuous evidence that these oils may have different capacities for 
cholesterol esterification. The larger amount of beta-lipoprotein in group H 
could be due to a larger amount of fatty acid esterified with the lipoprotein's 
cholesterol. It must be stressed that the mass of a lipoprotein will be inc­
reased by an increase in the mass of any one of its lipid components. It is not 
known what increments occur in the Sudanophilia of a lipoprotein when equal
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amounts of cholesterol, phospholipid and fatty acid are incorporated in it. 
There is no reason to assume that they are similar. While this question of 
the nature and degree of cholesterol esterification by different dietary oils 
may be critical its solution requires the appropriate analytical techniques, 
the silicic acid column and gas-liquid chromatography being particularly suit­
able .
The two cereals tested proved particularly effective not only in limiting 
the degree of hypercholesterolaemia but also in limiting the development of 
the beta-lipoprotein fraction. This experiment confirms the work of Jones et 
al., (1956) for the hypolipaemic effect of the whole maize germ is clearly 
greater than the extracted corn oil alone. Whether this enhanced activity is 
due to the presence of sitosterols, tocopherols, carotenoids or other non- 
saponifiable materials can only be a matter for conjecture. Certainly beta- 
sitosterol which is present in maize germ has a cholesterol lowering effect 
(Beveridge et al., 1957).
The appearance of alpha-2 lipoprotein in group K, the group with the 
highest cholesterol levels is an interesting phenomenon. It will be recalled 
that this occurrence was observed in cholesterol-fed chickens given 5 mg. doees 
of epi-oestradiol benzoate (group D, chapter U ) • The oneapparent similarity 
between these groups is the very high cholesterol level produced by the expe­
rimental regimes. One wonders if the alpha-2 lipoprotein is a sort of "spill- 
over” product due to saturation of the beta-lipoprotein with cholesterol, or 
alternatively if it represents an intermediate stage in the incomplete metabolic 
transfer of fatty acids from beta to alpha-1 lipoprotein.
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The most surprising result of this study however is the apparent hyper- 
cholesterolaemic effect of the extracted germ. This suggests that there may 
be a powerful hypercholesterolaemia promoting substance in the maize germ 
which is normally blocked by the extracted constituents. It also prompts 
the suspicion that breakfast cereals which are now commonplace in the Western 
diet may contribute to the endemic hypercholesterolaemia of Western civilisa­
tion. This idea is currently being followed up.
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C H A P T E R  6
AN ASSESSMENT OF CORN OIL IN THE MANAGEMENT 
OF PATIENTS AFTER CARDIAC INFARCTION
The success of long-term anticoagulant administration in the after- 
treatment of patients who have suffered cardiac infarction (M.R.C., 1959) 
complicates alternative approaches to this therapeutic problem. Many physi­
cians already feel committed, on ethical grounds, to a treatment which has 
been shown to diminish the recurrence and mortality rates in such patients, and 
are justifiably reluctant to experiment with other forms of treatment, whose 
value is not yet proved, if this means withholding anticoagulant therapy. Never­
theless the administration of anticoagulants involves a new hazard for the pati­
ent, that of haemorrhage; requires strict control of dosage, which if the treat­
ment is to become generally available will mean a national laboratory service; 
and does not, so far as is known, affect the underlying pathological condition 
of atherosclerosis. This investigation was started before the M.R.G. report had 
been published. But in any case there is considerable justification for the 
assessment of a treatment which operates naturally through dietary means, 
requires no essential laboratory control and which may correct or improve the 
basic pathology.
Statistical advice was taken as to how many patients would be required to 
render significant a fall in the 2-yearly mortality rate from 20 to 5 per cent, 
after a myocardial infarction. It was considered that only a reduction of this 
order, in the 2-year mortality, would afford unequivocal justification for the
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projected treatment. However two groups of 70 patients each would have been 
necessary, one on treatment and one an untreated control group. Such a large 
number was neither available nor manageable if even the simplest systematic 
biochemical study was to be undertaken.
The outcome therefore was a less ambitious trial which had these aims:
1. Is some kind of long-term dietary programme feasible,
and if so, what?
2. Does it have a sustained or merely transient effect on
the serum lipids?
3. Are its clinical results encouraging? For there is as
yet no proof that the ingestion of unsaturated fats
has a beneficial effect on arterial disease (Morrison,
1955).
THERAPEUTIC PLAN
At the outset it was decided not to arrange an inflexible therapeutic 
scheme, but to be guided by experience and modify where necessary. At this 
time there was much disagreement among authors about the most effective die­
tary methods for the manipulation of serum lipids. Armstrong et al. (1957) 
and Williams and Thomas (1957) claimed respectively that the addition of 57 
gms. of corn oil or 100 gins, of sunflower seed oil to an ordinary diet reduced 
the serum cholesterol, while Shapiro et al. (1957) found that 70 gms. of corn 
oil per day added to a normal diet increased the serum cholesterol. There 
was evidence that a low fat diet alone would lower serum cholesterol (Keys 
et al., 1955; Wolmot and Swank, 1952) but that the addition of corn oil to
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such diets greatly augmented this effect. (Beveridge et al., 1955; Ahrens 
et al., 1957; Keys et al. 1957).
Eventually three dietary schedules were tried before the third one, 
still in force, was accepted as satisfactory. A bigger number of dietary 
variations could have been devised, but one had to avoid the speculative 
multiplication of schedules, which, if distributed among the limited number 
of patients available, could not have been evaluated adequately.
Corn oil (Maize Oil B.P. - linoleic acid content 56 per cent) was cho­
sen as the supplementary dietary oil. Messrs. Boots Ltd. undertook to supply
and distribute it to all patients included in the trial and to guarantee its 
fatty acid composition. There was doubt at first if patients would find the 
pure oil palatable and it was made up as a 50 per cent emulsion. The emul­
sion formula was Acacia 10%, Na Saccharin 0.003%, Prep. Vanilla 0.025%, Delax 
Flavour 0.06%, Benzoic Acid 0.1% and Chloroform 0.2% and water to 100%. The 
c'orn oil emulsion (C.O.E.) proved quite unacceptable and was replaced by the 
plain oil (C.O.). The three schedules tested in sequence were: -
In Phase I : 8 ozs. C.O.E. per day (i.e. U ozs. of corn oil)
plus normal diet.,.
In Phase II : 2 ozs. C.0. per day plus normal diet.
In Phase III : 2 ozs. C.0. per day supplementing a low animal fat diet.
Two diets were prepared, one of 1630 calories (155 gms.
C, 65 gms. P, 80 gms. F) and the other of 2080 calories 
(24-5 gms. C, 75 gms. P, and 85 gms. F). When 2 ozs. of 
corn oil is added to the® diets the daily caloric intakes
TABLE X. Low animal fat diet sheet issued to patients taking 
2 ozs. of corn oil per day.
Low Animal Eat Diet. 1630 calories.
155c, £5^ So P.
Eoods to avoid!-
Animal fats, including butter, dripping, lard, cream, fat meat, egg yolk, 
whole-tnilk cheese.
Poods which may contain animal fat, such as ice-cream, cakes made with 
eggs, pastry.
Use daily:
Skimmed milk - f- pint.
Vegetarian margarine - f- oz.
"Karmite" - 1 teaspoonful - as drink or sandwich.
Wholemeal bread, rolls, biscuits - as indicated.
Sample Menu
Breakfast
1 cup cereal, eg. porridge, cornflakes.
Bread, 1-J thin slices or/2 oatcakes or/ 3 Hyvitas or/ 1 wheaten roll. 
Milk, margarine from allowance.
Tea. Ho sugar.
Hid a.m. Tea with milk.
1 plain biscuit, eg. digestive.
Dinner
1 cup fat-free soup.
Good helping lean meat, fish, chicken, tripe.
2 small potatoes.
Vegetable - good helping fruit or/ jelly or/ milk pudding using milk 
from allowance.
Tea
Lean meat with salad or/ fish or/ tripe or/ chicken or/ skim milk 
(cottage) cheese.
Emit if liked. Vegetables if liked.
1 thin slice wholemeal bread or/ 2 Hyvitas or/ 2 Vitaweats.
Milk and margarine from allowance.
Tea with milk.
Supper
Remainder of milk allowance 
1 plain biscuit.
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become 204-5 and 2595 calories respectively and the oil 
comprises 41.5 per cent of the total fat in the former 
and 4 0 . 0  per cent of the total fat in the latter. This 
small percentage difference is plainly of no practical 
significance. A diet was allocated according to the 
height, build and occupation of the patient and in this 
way some degree of metabolic parity was achieved. It 
seemed more realistic to do this than to give all sub­
jects the same diet when individual needs were obviously
quite diverse. The 1630 calorie diet sheet is reproduced
in Table X.
Each man was given a 2 oz. medicine glass and told to take the oil as and 
when it suited him. Some took the full dose first thing each morning, some 
divided it out over the day, others did otherwise. All were encouraged to give 
an honest and frank opinion of the 'treatment*. Each man understood that if he 
wished he could withdraw from the study at any time, but that while still par­
ticipating in it he was expected to adhere to his treatment schedule meticul­
ously. The men, as a group, were co-operative and conscientious and I feel
sure that the general adherence to the diet was as good as one could expect to
achieve, and probably much better than the response of patients in general to 
routine dietary prescribing. Some dietary relaxation was permitted at Christmas 
and New "fear and during summer holidays. One patient (J.D. No.3) abandoned a 
Continental holiday since its main purpose was to have been culinary pleasure.
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THE SUBJECTS
All subjects were men between the ages of 4-0 and 65 admitted with, 
and surviving, a first attack of acute myocardial infarction. The diagnosis 
of infarction rested on a typical history and unequivocal electrocardiographic 
evidence of myocardial infarction. In one case only (S.B. No. 10) the diagno­
sis was accepted, although the electrocardiogram showed nothing more definite 
than acute ischaemia, because following the acute clinical attack the E.S.R.
and leucocyte count rose and the blood pressure fell. Men with diabetes or
l60renal disease or whose blood pressures exceeded /100 after 4- weeks in hos­
pital were not included. If the blood pressure rose to higher levels subse­
quently the subjects were not discarded from the trial. The severity of the 
acute illness did not exclude a patient. For example one man (A.L. No. 6) 
developed paroxysmal ventricular tachycardia during the second week of his 
illness which was reversed by intravenous procaineamide. This post-infarct 
arrhythmia usually carries a bad prognosis, but 20 months after it this man is 
still doing a full and hard day1s work•
2 4  patient s have been studied for at least 8 months and most of them for 
much longer. 9 are in Group I, 5 in Group II and 10 in Group III. One patient 
in Group I (R.R. No. 8) was eventually put on anticoagulants because of worsen­
ing angina which might have denoted impending reinfarction. None of the others 
has received anticoagulants apart from the treatment of the acute illness.
INVESTIGATIONS
Before being discharged from the ward each patient*s height and weight were 
recorded. He was seen thereafter at monthly intervals for the first few months
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and after a time every 2 months. He attended at the same time of the morning 
and on the same day of the week. He was asked specifically about angina, 
dyspnoea, ankle swelling or indigestion. Blood pressure and weight were recor­
ded and blood was withdrawn for cholesterol and lipoprotein estimations. Elec­
trocardiograms were taken at intervals or when indicated.
Standard weights were calculated from height and age according to British 
Tables (Levine, 1923). The serum cholesterol, in this, and all subsequent stu­
dies reported here, was estimated using Henly’s (1957) modification of the method 
of Zlatkis et al. (1953). This method is much simpler than that used hitherto 
and much more reproducible. All cholesterol estimations were done in duplicate 
and the mean value recorded. When readings differed by more than 10 mg. per 
c&nt the estimation was repeated. Lipoprotein analysis was carried out as in 
Chapter 2•
ORGANISATIONAL PROBLEMS 
8 ozs. of Corn Oil Emulsion per day is almost 3 pints per week. From 
the beginning Messrs. Boots undertook the regular delivery of supplies at monthly 
intervals. Later when the dose was reduced to 2 ozs. of plain oil per day the 
problem of bulk was not so critical, but by this time the delivery system was 
well established and was kept in operation. This may have been a factor in 
maintaining a 100 per cent participation rate.
The problem of selection of a suitable base line for pretreatment lipid 
levels will be discussed presently. It might have been advisable to begin 
treatment one to three months after the patient’s discharge from hospital, but
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there were advantages in establishing the regime before he left hospital, 
especially when the low animal fat diet was introduced.
The problem of whether or not to have an untreated control group also arose. 
Such a group would have been essential if conclusions about morbidity and morta­
lity were to be drawn. But as mentioned earlier the number available would have 
been too small for this purpose, and considering the stated and limited aims of 
this study a control group was unnecessary. Each subject acted as a control for 
his own serum lipid readings and the practical issue of the feasibility of the 
treatment was plainly a personal problem. In any case it would have been diffi­
cult to justify the prescription of 8 ozs. of a bulky inert material simula­
ting corn oil emulsion while at a later stage some other oily substance would 
have been required to simulate plain corn oil, and in this connection no oil 
could be regarded as inert.
ESTABLISHING A CONTROL LEVEL
Considerable and spontaneous variations may occur in the serum cholesterol 
of normal individuals under normal conditions. (Gordon and Brock, 1958; Thompson 
et al., 1959). But the conditions which ensue in an acute case of myocardial 
infarction are extremely complex and there is no reason why lipid variations 
should be more predictable. The patient admitted to hospital following an infar­
ction is usually given anticoagulants and powerful analgesics, forbidden smoking, 
allowed only a small diet at first, and put at fairly complete rest. In some 
cases he may be given noradrenaline. The serum cholesterol falls after myocar­
dial infarction (Biorck et al., 1957) and other forms of acute physical stress 
such as surgery (Kyle et al., 1952) and pneumonia (McQuarrie and Stoesser, 1932).
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The changes observed by the last named author occurred when the diet was kept 
constant. Smokers have significantly though not grossly higher cholesterol 
levels than non-smokers (Gofman et al., 1955; Bronte-Stewart, 1956) and with­
drawal of tobacco may reverse this difference. The information on caloric 
restriction is conflicting. Walker et al. (1953) claimed that small diets 
reduced the serum cholesterol by a mean value of 17 mg. per 100 ml. in a group 
of 39 subjects. On the other hand Moore et al., (1954) found that weight loss 
was frequently associated with an increase in cholesterol levels and some of 
the subjects in Walkerfs group also showed a rise in cholesterol levels alth­
ough their weights fell.
The normal anticoagulant regime employed for patients ultimately admitted 
to this study was a combination of heparin and phenindione for the first 24 
hours and thereafter phenindione alone. Heparin has a striking though rela­
tively short lived effect on the lipoproteins. (Nikkila, 1952) but none 
on the total serum cholesterol (Soffer and Murray, 1954; Kuo et al, 1956; 
Herbert et al., 1959). The last group of authors also studied the effect of 
phenindione and the coumarin compounds Acenocoumarin and Ethyl Biscoumacetate 
on the total serum cholesterol. They found that the coumarins produced a 
temporary elevation of serum cholesterol but that phenindione had no effect.
It is obvious from this short account of factors pertinent to the patient 
with acute myocardial infarction that a hypothetical synthesis of the informa­
tion would be valueless if not actually misleading. An independent study was
TATTC-'ft X I. Data fo r  8 male patients during the 4 weeks period following an acute myocardial in fa rction .
a -  serum cholesterol in  mg.^f b -  betaxalpha lipoprotein  ratio? o •  pre-beta*beta lipoprotein  ra tio
PATIENTS GIVEN HEPARIN AND PHENINDIONE
DAT 1 DAT 2 DAT 3 DAT 6 DAT 9 DAT 12 DAT 15 DAT 22 DAT 29
a b 0 a b 0 a b c a b c a b c a b c a b 0 a b o a b 0
P.D. 324 254 255 1.92 0.33 232 3 .6 l 0.26 229 2.36 “ 285 2.47 ~ 25<> l .S l 0.24 267 2.31 0.25 263 1.83 0.20
J.H . 232 2.59 0.16 273 1.47 0.22 215 1.97 0.22 209 1.82 0.25 196 1.65 0.16 250 2.73 0.26 215 2.14 0.22 280 2.12 0.23 249 2.64 0.26
T.H. 180 2.50 0.20 173 2.13 0.26 174 2.32 0.26 182 3.04 0.13 201 3.36 0.26 184 2.76 0.14 215 2.50 0.10 219 1.78 0.24
I .E . 243 2 . 2d 0.23 230 2.45 0.37 214 2.43 0.26 246 2.19 0.25 246 2.42 0.39 241 3.60 0.16 303 2.86 0.21 291 3.04 0.22 291 3.38 0.20
T.S. 210 194 2.09 0.10 145 1.07 0.16 121 101 1.24 - 166 2.28 0.28 172 1.84 0.14 207 1.74 0.16
AVERAGf*3 7 .8 2.46 0.20 224.8 2.04 0.26 214.5 2.16 0.27 202.8 2.35 0.21 198.6 2.45 0.20 219.3 2.51 0.11 224. £ 2.37 0.22 245.0 2.36 0.19 245.8 2.00 0.17
NO ANTICOAGULANTS
W.B. 242 3.05 0.15 259 2.52 0.22 251 2.84 0.14 258 2.36 0.22 204 1.82 0.35 207 1.94 0.12 208 1.62 0.32 242 I .85 0.23
A.C. 27$ 1.23 0.16 247 1.14 0.22 270 1.60 0 . l 8 245 2.24 0.17 229 2.70 0.24 234 1.71 0.21 207 1.32 0.20 237 2.00 0.17 256 2.42 0.25
A.O. 233 215 1.65 0.22 177 1.77 0.12 174 2.08 0.27 165 1.72 0.15 172 187 1 ./5 0.13 186 2.10 0.26 19/ 1.63 0.21
AVEHAG *251.3 2.14 0.16 240.3 1.77 0.22 232.7 2.07 0.15 225.7 2.23 0.26 199.3 2.08 0.25 204.3 1.85 0.17 210.3 1.91 0.25 231.7 1.97 0.23
25Q.
CHOLESTEROL mg70
20Q.
DAY 123 6 9 12 15 22 29 I 23 6 9 12 15
25Q
/3  '.oc l ip o p r o te in
2 0 Q
1.75
22 29
ON ANTICOAGULANTS- 5  CASES NO ANTICOAGULANTS-3  CASES
Fig. 10. Serum lipids of 8 patients after acute myocardial infarction.
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thus carried out on a small group of patients to determine when, after a 
cardiac infarction, serum lipid levels became stable enough to be acceptable 
as baseline or control values. This study was carried out in two stages which 
are now reported.
STAGE I
8 patients were studied, 5 of them uncomplicated cases of acute myocardial 
infarction treated with anticoagulants (group A) and 3 treated without (group B)
- in each case because of a clear history of gastro-intestinal disease or opera­
tion. None was so shocked as to require noradrenaline but each conformed to the 
diagnostic criteria detailed earlier.
Blood was withdrawn for cholesterol and lipoprotein estimations on the day 
of admission (Day 1) and on the following days thereafter - 2, 3, 6, 9, 12, 15, 
22, 29. As far as could be assessed from the clinical history each patient had 
been admitted within a few hours of the onset of infarction. Uncomplicated cases 
were usually discharged about the 29th day of their illness and it seemed inad­
missible to delay this normal routine. In the event however the results obtained 
show that a more prolonged in-patient study would have made little or no differ­
ence to the value of the information obtained.
In Table XI the cholesterol and lipoprotein data are given in detail. The 
few blank spaces indicate technical or organisational errors. The average chol­
esterol and beta:alpha lipoprotein ratios are charted in Fig. 10. Obviously the 
serum cholesterol level does fall after a myocardial infarction, reaching its 
lowest levels about the 9th day in both groups, and returns towards the starting 
values thereafter. The maximum average fall is not great however, being 83.5 per
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cent and 79.5 per cent of the starting values in Groups A and B respectively, 
although individual cases show wide variation. In T.S. the fall from 210 to 
101 mg. per cent in 9 days with a return to 207 mg. by the 29th day shows con­
siderable cholesterol lability. The results for T.M. show no fall in choles­
terol levels after the infarction, but the slightly higher figures obtained 
at the 22nd and 29th days may indicate that a slight fall had occurred by the 
time the first blood sample was withdrawn.
In group A the average 22nd and 29th day cholesterol levels are slightly 
higher than the initial levels, but the differences are not significant. In 
group B the 22nd and 29th day levels have not quite returned to the starting 
levels. The numbers are too small to say whether this is a real difference 
between the two groups but it is conceivable that patients with an alimentary 
complaint and receiving aluminium hydroxide, as did two of the group B trio, 
might have a slightly different cholesterol response pattern.
The pattern of the beta;alpha lipoprotein ratio is interesting. Whether 
patients are receiving anticoagulants or not it falls abruptly on the 2nd day. 
In each group there is a rebound towards the day 1 level, and this may occur 
more rapidly in the anticoagulant group than in the other. In the individual 
case, however, the lipoprotein ratio is usually unpredictable and marked swings 
in value may occur, unrelated to changes in the serum cholesterol level.
Pre-beta lipoprotein was present in all subjects, in 6 cases on every 
occasion. In P.D. it was not detected in 2 samples and in S.S. it was absent 
from 1 sample. While the considerable alterations which occur in the pre-beta;
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beta lipoprotein ratio are probably to some extent real, technical causes 
play a part. This lipoprotein value also seems to bear no relationship to 
the serum cholesterol levels, a conclusion also reached by Besterman (1957).
The average ratio for a group of 73 'normal1 men, who had neither symptoms 
nor E.C.G. evidence of cardiac ischaemia, was 0.05 (See Chapter 13). The
corresponding figures for the subjects studied here are greatly in excess of
this, on average about four times as great.
Besterman (1958) encountered major variations in the fate of prebeta 
lipoprotein in the large series of infarction patients which he studied. In
15 cases whose sera were studied on the first day of infarction prebeta
lipoprotein was present in 8 and absent from 7. In 36 per cent of cases in 
which prebeta lipoprotein was present intravenous heparin caused it to disap­
pear; in the other 6J+ per cent it did not. In this study heparin was not 
being given intravenously apart from the first dose and blood was usually with­
drawn a few hours after its administration so that a heparin-lipoprotein effect 
is unlikely to have been encountered.
STAGE I CONCLUSIONS
1. The pattern of lipid change during the 29 days following a myocardial 
infarction seems to be roughly similar whether patients receive anticoagulants 
or not.
2. Serum cholesterol falls until about the 9th day, then begins to rise and 
reaches the starting levels about the 22nd to 29th days • The values on these 
days however may still underestimate the ’true' or pre-infarction levels.
3. There seems to be an abrupt fall in the beta: alpha lipoprotein ratio
on th e  2nd day i r r e s p e c t iv e  o f  w h e th e r a n t ic o a g u la n ts  a re  g iv e n  o r  n o t .
TABLE XII. Serum cholesterol levels of 6 male 
patients on the 22nd. and 29th. days following 
myocardial infarction and 4> 12 and 20 weeks 
after discharge from hospital.
Case lay 22 It>.y 29 '.Veek 4 7/eelc 12 .Veek 20
T.B. 195 162 217 199 181
J.C. 198 200 195 218 214
A.H. 221 228 272 184 224
K.H. 260 252 310 261 230
W.IicG. 311 313 309 316 296
A.G. 289 323 299 248 296
245.7 246.4 267.0 237-7 240.7
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A rebound to starting values occurs during the next few days, but thereafter 
individual trends are unpredictable,
4.. In any investigation on the long-term control of serum lipids, especially 
cholesterol* after a myocardial infarction,base line values should not be esti­
mated earlier than the 22nd day of the illness,
STAGE II
This small group study was undertaken to test the validity of the 22nd and 
29th day cholesterol levels as control values. Six patients admitted with myo­
cardial infarction had serum cholesterol readings on the 22nd and 29th days of 
their illness. They were discharged on no special treatment and seen again 4-*
12 and 20 weeks later, at the same time of the morning on the same day of the 
week. The cholesterol levels are shown in Table XII. There was a mean rise 
of 23 mg. per cent during the first 4- weeks out of hospital but this is clearly 
not significant (p > 0.10) since it incorporates a rise in 3 of the values and 
a fall in the others. At the 12th and 20th weeks the mean and individual fig­
ures are near the two control figures. During this test period 4- of the sub­
jects showed little variation in their cholesterol levels while 2 (A.H. and M.H) 
had values ranging from 184- to 272 and 230 to 310 mg. per cent respectively.
This small sample reflects the findings of Gordon and Brock (1958) and Thompson 
et al. (1959).
Without giving reasons Oliver and Boyd (1953) chose not to accept as repres­
entative of established infarction cholesterol levels estimated within 5 weeks 
of the acute attack. The extra week they allow may give a truer standard but 
from the results presented here the difference is probably no more than marginal.
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STAGE II CONCLUSIONS
Taking into account the considerable individual variations which can occur, 
serum cholesterol levels on the 22nd and 29th days after an acute myocardial 
infarction are suitable base line values for subsequent observations. In the 
tables which follow in this chapter the individual control cholesterol level 
recorded is the average of the 22nd and 29th day levels.
THE DEFINITIVE TRIAL
The 24. patients whose results are reported here fall naturally into 3 
groups because of the manner in which the trial evolved.
GROUP I
The therapeutic scheme for this group transpired as follows: -
Phase I for 3 months
Phase II for 3 months
Phase III for up to 10 months and still continuing.
For the nature of the different phases see the introductory pages of this
chapter.
This group consisted of 9 men, the first to be introduced to the trial, 
and in the light of experience with them the treatment plan was modified.
RESULTS
The group lipid and weight data are detailed in Table XIII. The average 
cholesterol levels and weights of 5 subjects, who have participated throughout 
the entire period of the trial hitherto, are shown in Fig. 11 along with the 
personal record of one of them (No. 3, J.D.).
Phase I
During this part of the trial 2 of the patients died, one (H.W.) of a
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11. Graph derived from Tahle XIII illustrating the
average cholesterol and weight trends of Group I*
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fresh infarction demonstrated at autopsy and the other (J.C.) probably from 
the same cause, for he died suddenly at home 5 weeks after discharge from 
hospital. A third patient (H.B.) had a fresh infarction and was readmitted 
to another medical unit. He was withdrawn from the trial. A fourth patient 
complained of troublesome dyspepsia not only during this phase of the investi­
gation when it proved to be a common symptom, but also during the second phase 
when the emulsion was withdrawn and plain oil substituted. Following a barium 
meal, which demonstrated a duodenal ulcer, this patient (J.K.) was withdrawn 
during phase II, but was later re-enrolled in the trial of trichiorothyronine 
reported in another chapter. The remaining 5 patients persisted with the corn 
oil emulsion, were transferred to the second phase therapy and then after 3 
months of this entered the third and extant phase and are still participating 
in it.
All complained of troublesome dyspepsia, which comprised flatulence, 
heartburn and a sense of epigastric distension, varying from mild to severe.
All 6 who completed phase I complained of dyspnoea, again varying in severity 
and 4 of them had slight effort angina, but in a fifth (R.R.) it was severe. 
None of the E.C.G.s showed deterioration however and in fact in 5 of the cases 
there was evidence of improvement • All gained weight, in 5 of the men the gain 
ranging from 11 to 14 lbs. and almost certainly this accounted in part if not 
wholly for their unsatisfactory clinical state.
Serum cholesterol rose in each individual and after 8 weeks the mean rise 
of 66.4 mg. per cent for the 8 subjects observed is significant (t = 3*58;
P <0.01). The average cholesterol level rose again in the third 4-week period.
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The mean beta: alpha lipoprotein ratio showed an upward trend during this phase, 
in keeping with the role of beta-lipoprotein as the main cholesterol receptor, 
but individual results were quite variable. No real change in the prebeta-lipid 
band seemed to occur.
It was soon obvious that this regime was a therapeutic failure and could 
not be persisted with. Although the deaths and reinfarction could not defin­
itely be attributed to the treatment schedule the possibility could not be ignored 
nor could the undesirable sequelae of indigestion, weight gain, dyspnoea and poss­
ibly angina. At this stage it was not clear if these undesired effects were due 
to the emulsifying agent or to the large dose of oil, which by supplying an 
exbra 1026 calories per day would certainly cause weight gain. This problem was 
investigated in an animal experiment which is reported in Chapter 8. Anticipa­
ting the results of this it is probably correct to infer that the emulsion base 
had no effect on the weight gain but was the main cause of the alimentary 
discomfort.
It was anticipated that the men would spontaneously adjust their diets to 
accommodate the increased caloric intake. Two of them however made no attempt 
to do this, while 4 did, 3 reducing the carbohydrate mainly and one curtailing 
the fat.
Phase II
The transfer from corn oil emulsion to plain corn oil in a smaller dose 
proved acceptable to all except J.K. who was shown to have a duodenal ulcer, 
as mentioned earlier. Patients no longer complained of dyspepsia. Weight 
began to fall and in 4 weeks the mean reduction was 4 lbs. In 4 cases dyspnoea
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disappeared or improved, in 1 it was unchanged and in 1 (R.R.) it worsened.
Of the 5 who had experienced angina 2 no longer did, 2 were unchanged and in 
1 (R.R.) it worsened. Four of the E.C. G.s showed continuing slight improve­
ment, usually manifest as lessening inversion of T waves, but in R.R. the 
E.G.G. was unchanged and showed evidence of moderately severe antero-lateral 
ischaemia.
During the first 4- weeks of Phase II the cholesterol levels fell and the 
mean reduction of 58.4 mg. per cent in 6 cases is significant (t = 3.07;
p <0.05). Thereafter although the mean weights fell from 176.8 to 170.6 lbs. 
the cholesterol levels began to rise again and the mean increase of 73.6 mg. 
per cent in the 5 men seen at the end of the 4-th and 12th weeks of this phase, 
is significant (t = 4-.13 p < 0.02). Again the betaialpha lipoprotein ratio 
tended to mirror the cholesterol trends but individual results varied.
It was by now clear that plain corn oil with an unmodified diet, even in 
the presence offalling weight (though not necessarily in the presence of 
genuine weight reduction) would not reduce serum cholesterol levels, an obser­
vation supported by the information from the 5 subjects in Group II. After 3 
months of Phase II therefore Phase III was introduced.
Phase III
As stated earlier one of two low animal fat diets was allocated to the 
subjects taking into account their height, actual weight relative to their ideal 
weight, and their occupation. The diets plus 2 ozs. of corn oil gave total daily 
caloric yields of 204.5 and 2595 calories respectively. In one or two cases the 
diets were changed from bigger to smaller when the patient was not losing weight
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satisfactorily, or in the other direction when he complained of hunger. The 
diet although rather monotonous was tolerated by all patients, both in this 
and in the other 2 groups.
On the new regime weights continued to fall, giving a mean reduction of 
about 7 lbs. during the first 16 weeks and running fairly steadily thereafter. 
Three of the men (Nos. 3, 6, and 7) ultimately achieved weights below their 
standard weight but R.R. (No. 8) changed not at all and remained about 4.0 lbs. 
above his standard weight throughout the trial. This man caused considerable 
anxiety. His angina responded only indifferently to glyceryl trinitrate. He 
complained occasionally of dyspeptic symptoms which suggested hiatus hernia, 
but after two negative barium meals at intervals of 9 months it was considered 
both safe and advisable to put him on anticoagulants and he has been so treated 
for 3 months. Three of the other 4 subjects eventually stopped having exer­
tional dyspnoea and the fourth had it on severe exertion only. Two became 
angina free and 2 occasionally had chest pain on severe exertion. Apart from 
R.R. the E.C.G.s continued to show minor improvements and in one (J.D.) it 
became completely normal. This man’s progress must represent the ideal result 
which can be achieved by this regime (See Fig. 11).
The mean cholesterol levels for the 5 men still left in Phase III fell
gradually but steadily, reaching a mean value of 226.8 mg. per cent after 24
weeks, and this is significantly less than the mean value of 344*4 mg- per cent
at the end of Phase II (t - 10.95; P < 0.01). It should be noted that the fall
was not sudden. By the32niweek of Phase III the mean cholesterol level of 
220.6 mg. per cent is significantly less than the mean control level of 251-6 mg.
per cent for the same 5 subjects, (t = 3 .2 6 ; p < 0.05).
Of these 5 men one (J.G.) is retired but does odd-jobbing at bricklaying 
and constructional work; 3 are working a full day and one of these, (A.L.
No. 6) the man who had ventricular tachycardia, has a heavy job in a tyre 
manufactory; the 5th (R.R.) although restricted and at times apparently 
crippled by severe angina maintains a supervisory interest in his own busi­
ness .
CONCLUSION FROM GROUP I
1. C o m  oil emulsion is unpleasant to take.
2. 4 ozs. of corn oil added to normal diet leads to a rise in weight and
serum cholesterol, with aggravation of symptoms such as angina and 
dyspnoea.
3. The transfer to 2 ozs. of plain oil with normal diet eliminates the
’emulsion dyspepsia", and gives a temporary fall in cholesterol, which
is soon reversed, however, in spite of continuing weight reduction.
4- A corn oil, low animal fat diet produced a gradual fall in cholesterol 
levels, which has been maintained hitherto, to a point significantly 
below the starting control values•
5. Although weight and cholesterol levels have both fallen in certain
instances there is no direct relationship between them and in Phase II 
of this Group study serum cholesterol levels were rising while weights 
were falling.
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GROUP II
The therapeutic scheme for this group of 5 patients worked out as follows:
Phase II for 3 months
Phase III for up to 10 months and still continuing.
This group of men entered the trial at the point when com oil emulsion
was being abandoned,
RESULTS
The lipid and weight data are detailed in Table XIV and the mean values 
charted in Fig. 12.
Phase II
No patient complained of dyspepsia. Four had slight exertional dyspnoea 
and of these 2 had angina of effort. One man (W. G.) had neither angina nor 
dyspnoea. Four showed T wave improvement in the electrocardiogram.
The important lipid change during this phase was a rise in serum choles­
terol from a mean of 267.2 to 350.0 mg. per cent after 12 weeks, but again the 
initial response to the corn oil was a slight fall in cholesterol after the 
first 4 weeks. The beta:alpha lipoprotein ratio rose from 2.00 to 2.42. The
mean difference of 0.42 is hardly significant (t = 2.17; 0.10> p >0.05).
There was no real change in weight during this phase.
Phase III
During this period all improved. Three were eventually symptom free.
One man, however, (F.McG.) though improved insofar as angina and dyspnoea 
were concerned, developed severe claudication of the left leg. Angiography 
revealed an early block of the distal third of the left femoral artery and he
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12. Graph derived from Table XIV illustrating the
average cholesterol and weight trends of Group II.
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was greatly helped by phenol block of the left lumbar sympathetic ganglia.
This man, a labourer, is one of the 2 not working. The other (J.H.) is a 
painter and lacks confidence for high work. The other 3 are working full 
time. All E.G.G.s have shown improvement and that of S.B. is now almost 
normal.
Cholesterol levels fell steadily and gradually reaching their lowest 
values at the 32nd and 4.0th weeks. The fall of 99.6 mg. from the highest 
mean figure of Phase II is significant (t = 14.00; p < 0.001) but the mean 
fall of 16.8 mg. from the initial control level is not significant (t = 2 .0 4 ; 
p > 0.1). It is clear from a study of Table XIV that with one exception (S.B.), 
in whom there seems to have been a real lowering of an initially elevated 
cholesterol, no definite reduction below the control level has been achieved 
in the individual case.
As a group this sample did not lose weight and were about 10 lbs. heavier 
than their mean ideal weight. Two men put on weight (J.B. 5 lbs. and F.McG.
7 lbs.) without their cholesterols rising while 2 lost weight (W.C. 8 lbs. 
and J.H. 13 lbs.) without their cholesterols falling. S.B. achieved his 96 mg. 
reduction in serum cholesterol although gaining 2 lbs.
The beta:alpha and pre-beta beta lipoprotein ratios showed considerable 
fluctuation, although the mean increase of 0.11 in the pre-beta:beta ratio at 
the 32nd and 4 0 th weeks, compared with the mean control of 0.09, is significant 
(t = 3.41; p < 0.05).
CONCLUSIONS FROM GROUP II
1. 2 ozs. of corn oil added to a normal diet may produce a slight fall in
serum cholesterol at first but this is quickly offset by a striking rise,
PABLE XV. Data for 10 male subjects given corn oil and a low animal fat diet.
a = beta:a'lpha lipoprotein ratio; b = pre-beta ratio? c * serum cholesterol in mg.? ; d * weight
in lbs.
Control 2 Ozs. Corn Oil + Low Animal Pat Die1
- Average of 
2 results Week 4 Week 8 Week 12 Week 16
Week 24 Week 32 Week 40
Case Age a b a b a b a b a b a b a b a b
15. A.A. 64 2.35 0.20 1-44 - 2.23 0.26 1.63 0.22 2.69 0.14 1.69 0.12 2.48 0.21
16. J.3. 43 3.44 - 2.39 0.19 3.23 0.33 3.64 0.20 "3.88 0.l8 3.02 0.19 3.20 0.32
17. A.G. 59 2.41 - 2-55 - 2.30 - 1.95 0.20 2.06 0.21 1.91 0.11 1.47 0.19
l8. K.G. 6l 2.87 0.11 1.06 0.12 1.91 0.2o 1.37 0.13 1.14 0.18
19. :.h. 55 1.51 0.14 I.84 - 1.50 0.19 1.64 O.lB 1.37 0.28 1.15 0.09 1.30 0.16
20. J.L. 49 3.22 0.25 2.48 0.18 1.57 0.11 1.58 0.27 2.10 0.2B
21. W.HcG. 60 2.02 0.15 4.91 0.23 2.76 0.19 1.50 0.19 DIED
22. J.H. 53 I.80 - 2.50 0.23 3.14 0.23 3.51 0.32 2.49 0.20 1.90 0.23
23. J.s. 51 2.14 C.15 4.35 - 3.33 0.0S 1.41 0.14 3.57 0.29 2.02 0.l6 1.23 0.27
24. J.H. 44 1.72 - 2.15 - 2.87 0.21 1.83 0.12 2.12 0.14 2.96 0.24 1.97" 0.27
Averages 53.9 2.35 0.10 2.57 C.10 2.52 0.13 1.97 0.19 2.67 0.22 2.05 0.16 1.94 0.24
. otandard 
Case . . i c weight
d 0 d c d c d c d c d 0 d
.
15. A.A. .155 239 154 250 154 266 156 214 155 222 158 196 152“ l80 161 lp7 158
16. J.D. 14^ 323 143 421 148 342 149 333 149 313 149 288 144 284 146 270 14o
17. A.G. 165 272 192 244 192 2°0 182 242 l8l 258 186 250 183 210 1-52 182 177
l3. H.G. 169 238 152 171 178 193 173 190 177 l3'l 174 170 173
19. 7.H. 147 229 134 262 127 242 127 200 127 174 125 206 129 179 131 129
20. J.L.
I 147
289 150 250 151 252 153 252 152 2o2 14«
21. W.HcG. 155 308 142 332 133 272 132 264 1'3'ff' 343 132 291 134 DIED
" W1 22. J.H. 147 23§ 126 266 133 233 127 220 l2'/ 192 124 207 126 lbo 12b 210
: 23. J.H. 147 31-8 141 335 140 332 142 334 141 “263 141 300 143 252 149 301 145
24. J.H. 174 271 154 284 154 318 154 256 155 239 156 23B 158 230 156 266 152
Averages 155.2 277.5 151.8 281.5 151.0 274-5 150.0 251.0 149.4 244.6 149.4 245.7 147.4 211.4 153.0 223.1 147.4
Averages 1>r a b a b a b a b a b a b a b a b
treated for 2.20 0.07 2.49 0.06 2.58 0.l8 2.18 0.19 2.74 0.22 2.18 0.14 1.94 0.25
40 weeks. c d c d 0 d c d c d 0 d c d c d
154.4 277.0 149.1 294.6 149.7 239.7 148.1 258.6 147.9 237.3 148.7 240.7 149.3 217.3 150.1 223.1 147.4
t-
4.83
P
< 0.01
t=
3.75
P
<0.01
t=
6.65
P
<0.0CL
t=
3.20
P
<0.02
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unaccompanied however by clinical or electrocardiographic deterioration.
2. The substitution of a low animal fat diet reverses the cholesterol 
rise but as far as this small group is concerned the ultimate serum 
cholesterol levels are not significantly less than the control values. 
Possible reasons for this are discussed later.
3. The pre-beta:beta ratio is significantly raised by the Phase III regime.
No definite pattern of response for the beta:alpha ratio is evident.
GROUP III
This group of 10 men was treated with the corn oil, low fat diet regime 
from the beginning, and 7 of them have been observed for 4-0 weeks.
RESULTS \
The lipid and weight data are detailed in Table XV. The mean cholesterol 
and weight values for the 7 subjects seen for the entire period of 4-0 weeks are 
charted in Fig. 13.
By the end of the study period 5 of the 10 men were working, 3 were enjoy­
ing a fairly active retirement, 1 was unemployed though employable if he could 
find light work and one had died presumably of a fresh infarction, during the 
23rd week of treatment. Seven are without angina or dyspnoea, one has no 
dyspnoea but trivial angina and one has a slight degree of each.
The man who died (W.McG.) was never really well. He had persistent angina 
and dyspnoea and developed claudication of the right leg which was shown to be 
due to a right femoral occlusion and was greatly improved by a phenol block.
He had been observed for 5 months before it was decided to include him in the 
therapeutic trial and his cholesterol levels during this time are shown in
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13. Graph derived from Table XV illustrating the average
cholesterol and weight trends of 7 subjects from Group III.
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Table XII. The control reading given for him in Table XU is the average of these 
5 readings. Clearly no useful reduction in cholesterol level was achieved in 
his case.
J.M. (No. 22) was very ill during the acute illness and was given intra­
venous noradrenaline, but not anticoagulants because of a history of radiologi- 
cally established duodenal ulcer. He developed a severe "frozen shoulder" on 
the right side which was not improved by intra and periarticular steroids, but 
did respond to short wave diathermy, massage and exercises.
Apart from T.H. whose E.C.G. is virtually unchanged all of the others have 
shown greater or lesser degrees of improvement in their electrocardiograms.
Definite evidence offalling cholesterol levels is delayed until the 12th 
week but by this time the mean fall of 26.5 mg. per cent in the whole group of 
10 subjects is significant (t = 3.05 p < 0.02). When the cholesterol levels 
for the 7 men seen up to the end of the 4,0 week period are compared with their 
control mean of 277.0 mg. per cent the average reductions of 39.7, 36.3, 59.7 
and 53.9 mg. at the 16th, 24-th, 32nd and 4-Oth weeks respectively are each sig­
nificant. The appropriate t and p values are given in Table XV.
A.A. (No. 15) and A.G. (No. 17) had particularly good reductions in their 
cholesterol levels. A.A. gained weight and A.G. lost weight. A.G. was another 
patient who was observed for 5 months before introducing him to the trial (see 
Table XII) and the cholesterol reduction achieved in his case is real and con­
siderable. Two of the men have not obtained cholesterol reduction (J.R. 23 and 
J.R. 24,).
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The beta:alpha lipoprotein ratio was again unpredictable but the pre-beta 
band increased in intensity and the average increase in the pre-beta:beta ratio 
of 0.17 for the 7 cases seen up to week 4.0 is significant, (t = 3.68; p < 0.02). 
CONCLUSIONS FROM GROUP III
1. A low animal fat diet augmented by 2 ozs. of corn oil will in certain cases 
produce and probably maintain lower blood cholesterol levels.
2. The nature of weight change bears no obvious relationship to the response.
3. The pre-beta lipoprotein band is increased in intensity but no definite 
alteration occurs in the beta:alpha ratio.
GENERAL DISCUSSION 
The first question which this study asked can, I think, be answered pos­
itively. A low animal fat diet supplemented by a relatively unsaturated vege­
table oil, such as corn oil, is acceptable to the average patient and can be 
persevered with. If this kind of diet is ultimately proven to make a positive 
contribution to health there is in fact no real difference between its status 
of acceptability and a diabetic routine. Corn oil although not a culinary 
treat is not unpleasant, indeed is almost tasteless and lacks the smell and 
cloying texture which contribute to the unpalatability of oils such as castor 
oiL There is certainly no need to garnish it and an attempt to do this here 
was singularly unrewarding. A daily dose of 2 ozs. (57 gms.-) would seem to be 
just about right. More would require further restriction of dietary fat with 
a corresponding increase in dietary monotony and less would perhaps be ineffec­
tive.
One cannot say with certainty that each man adhered to the regime with 
undeviating accuracy. What is important however is that this group of men
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adhered to it as well as any group of men can probably be expected to do in 
practice, and it is the actual achievement rather than the potential attain­
ment which will determine the limits of effectiveness. The spur to co-opera­
tion is no greater than the patient's own desire for good health. Undoubtedly 
this attitude can be greatly reinforced where there is a wife who also is 
anxious on this score.
There seems little doubt that the definitive dietary plan does lower the 
serum cholesterol, though not in all subjects. The easy answer to this diffi­
culty is that such patients were not taking the prescribed diet. I am not 
convinced that this explanation is the true one and will return to the matter
later. As far as permanence of effect is concerned there is no evidence that
this cannot be maintained. Two of the men in Group I (J.D. and A.I..) have
been taking corn oil for at least 15 months and have not yet developed "toler­
ance” to its effect. Their serum cholesterols, at the time of writing are 
respectively 28 and 18 per cent lower than the starting levels and there is no 
sign that they are about to rise, or that in the case of J.D. it has stopped 
falling. In Group II we have one man (S.B.) and in Group III four (A.A., J.D.,
A.G., and T.H.) who have achieved substantial reductions in serum cholesterol 
and show no sign of escaping from control after 10 months of treatment.
There is no a priori reason why individuals should develop tolerance to 
this regime. Whereas oestrogen and thyroid therapy for lipid reduction in 
otherwise normal people produce unphysiological sequelae, a dietary manipulation 
of this kind is physiological and there is nothing intrinsically unnatural for 
the body to adjust itself to or against. But we are still left with the problem
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that not all subjects have improved. This may of course be due to the degree 
of participation. But there may be other possibilities. In 1937 Sperry 
observed that each person has a "characteristic" serum cholesterol level. It 
is conceivable that after years of dietary adaptation this "characteristic level" 
becomes set at a higher level and is maintained, by homeostatic mechanisms, 
against dietary manipulations.
It is sometimes a condition for inclusion in a trial of hypercholesterolaemic 
substances.that initial cholesterol levels be above a certain selected minimum.
This was the case in Chapter 7 where the effects of the thyroid analogues are 
reported. But in this study every patient had had a myocardial infarction, and 
if the introductory chapter is to be interpreted in its widest sense, these sub­
jects had some lipid derangement. If this is related to the serum cholesterol 
in some way then one assumption must be that these individuals* serum cholesterols, 
whatever their level, were abnormal for them. In this respect it is of interest 
that certain patients with base-line cholesterol levels which would generally be 
regarded as within normal limits achieved considerable reduction in these levels; 
for example A.L. No. 6 (230 to 188), H. G. No. 18 (238 to 170), and T.H. No. 19 
(229 - 166 mg. per cent).
The fact that some men do better than others may be because of some personal 
factor or factors which go together to make a more responsive "type". The 
numbers of variables which could be investigated in this respect is vast and 
beyond the scope of this work as at present organised. But one clue at least 
Kay be contained in the figures of Table XVI, Here two selected groupings of the 
Ken are made with special reference to weight. We have seen already that inc­
rease or decrease in weight by itself is not the critical factor determining the
TABLE XVI, A comparison of weight change in 2 groups in whom the mean cholesterol response was
substantially different.
Weight in lbs.; cholesterol in mg. per cent.
Group Subject Standard
weight
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weight
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Difference
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3. J.D. 147 161 136 271 196 -21.1
6. A.L. 179 181 167 230 183 -18.3
10. S.B 155 159 161 341 245 -28.2
15. A.A. 155 154 153 289 157 -45-7
16. J.D. 146 143 146 323 270 -16.4
17. A.3. 165 192 177 272 162 -33.1
IB. H.G. 169 182 173 I 238 170 -29.6
19. T.H. 147 134 129 j 229 166 -21.5
Average 157-9 164.3 155-9 274.1 196.8 -28.2
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4. J.G. 135 140 154 214 239 +11.4
3. 3.H. 143 lo2 164 252 244 - 3.2
11. J.B. 155 160 165 287 270 - 5.9
12. W.C. 139 156 143 182 227 +24.7
13. J.H. 139 161 148 288 234 - 1.4
Average 142.2 159.8 159.8 244.6 252.6 + 5.2
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cholesterol response. The groupings made in Table TVI are, first, one in 
which each subject's cholesterol reduction was 16 per cent or more of the 
control level and, second, one in which the individual cholesterol levels 
either rose or fell by less than 6 per cent of the control reading. These 
groups are compared in respect of their standard weights, starting weights, 
final weights and final cholesterol levels. The good cholesterol response 
group with a mean reduction of 28.2 per cent in cholesterol levels is much 
better off regarding weight. Although a heavier group in terms of its mean 
standard weight it was within 6.4- lbs. of it at first and reduced to 2 lbs. 
below it latterly. Not so the poor response group which had a mean increase 
in cholesterol levels of 5*2 per cent. For though a lighter group assessed 
by its mean standard weight, it was 17.6 lbs. heavier than this at first and 
lost no weight in the course of the study.
The mean difference of 56.0 mg. per cent between the final cholesterol 
levels of these groups is significant (t = 2.75; p <0.02).
Here then is a possibility, supported by evidence in Chapter 13 that an 
individual's serum lipid levels depend to some extent on his "capacity" to 
remain within or return to the normal weight range for his height and age.
This "capacity"may be a complex property compounded of hormonal, enzymatic, 
intellectual and other functions. But it. is something which may be real and 
analyseable. However it is important not to overindulge in random speculations 
like this which can always be confronted with facts which do not fit, for both 
J.R.s (23 and 2U) in this study have weights lower than their standard weights 
and yet have shown virtually no reduction in their serum cholesterol levels.
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The sera of all subjects revealed a pre-beta-lipoprotein band at some 
stage of the study. The mean pre-beta:beta ratio was higher in all groups at 
the end of the study than the mean control value. When 17 subjects, for whom 
there is a record of this ratio both at the beginning and end of the study, are 
compared, the mean increase in the pre-beta:beta ratio of 0.13 or 186 per cent 
is significant (t = 5.19; p ^ 0.001). Whether this is attributable to the 
normal evolution of the pre-beta lipoprotein after infarction or the prolonged 
ingestion of c o m  oil cannot be said. Pre-beta lipoprotein contains fatty acids 
and whether or not these have been augmented or modified by the prolonged inges­
tion of linoleic acid must await an answer by advanced chromatographic or isoto­
pic techniques. In fact an assessment of the value of the unsaturated oils on 
the basis of their ability to lower the serum cholesterol level may be misleading. 
What may really matter is an advantageous change in the nature of cholesterol 
esterification with or without lowering of its total level.
CLINICAL ASPECTS
Finally, what can be said for the regime as a preserver of life and main- 
tainer of health? The 2 deaths and 1 reinfarction during Phase I were far from 
encouraging. But one must admit that this part of the trial was ill-conceived 
and may have been positively harmful. At first I contemplated a rough com­
parison with the reinfarction and mortality rates of the M.R.C. anticoagulant 
trial control group. But this would have been misleading for a number of reas­
ons and was not pursued. What is given then is a bare statement of the clinical 
status of the subjects at this point.
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Twenty men who have had a myocardial infarction have now taken a low 
animal fat diet supplemented with corn oil for 32 to 4.0 weeks. Some of these 
of course have sampled earlier experimental diets. Twelve are working (60%)
3 are unemployed (15/0 but could be working if appropriate jobs were available,
4. are retired (20%) and 1 is dead (5$) presumably from a fresh infarction. 
Otherwise there have been no reinfarctions. Fourteen are free of angina and 
15 have no dyspnoea. An assessment of these symptoms is always relative however 
and depends on the degree of effort expended. One is recovering from a "frozen 
shoulder" and 2 have suffered from intermittent claudication which was relieved 
by phenol block, one of these being the deceased patient.
The final treatment adopted is feasible, acceptable and physiological. Its 
fundamental value in reducing cardiac morbidity and mortality can only be assessed 
in a large and fully controlled trial, probably at the national level. The ulti­
mate aim may indeed be to persuade Western Civilisation to alter its dietary in 
a way which embodies the principles contained in a regime such as this.
GENERAL CONCLUSIONS
1. The addition of corn oil to the diet without some restriction of dietary 
fat will lead to an elevation of the serum cholesterol, and if enough is given 
also cause an increase in weight, which is undesirable and may actually be 
harmful in patients who have suffered a myocardial infarction.
2. A corn oil, low animal fat diet is feasible as a long term measure, and in 
certain individuals, but not necessarily all, it will lower and maintain at 
such lowered levels, the serum cholesterol, whether the initial value be high 
or "normal".
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3. This effect will perhaps be most readily achieved in patients whose weights 
are either near, or can be reduced to, their standard or ideal weight.
4. In the course of this treatment the pre-beta-lipoprotein band is greatly 
increased. This may reflect some fundamental change in the esterification of 
the cholesterol contained in this fraction.
A clinical impression that this regime contributes to the clinical better­
ment of patients after a myocardial infarction can only be confirmed by a 
study of larger and controlled series.
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C H A P T E R  7
THE EFFECT OF DEXTRO-DI-IODOTHYRONINE AND 
TRICHLORTHYRONINE ON THE SERUM LIPIDS OF 
PATIENTS WITH MYOCARDIAL ISCHAEMIA
It is well established that thyroid exbract lowers the serum lipids in 
hypothyroid and euthyroid subjects, and at the same time increases the basal 
metabolic rate (Levy and Levy, 1931; Turner and Steiner, 1939; Gildea et al., 
1939)• Serum cholesterol and beta-lipoprotein are usually high in myxoedema 
and low in thyrotoxicosis. In both conditions they alter towards normal when 
appropriate treatment is introduced. If only the lipid lowering and metabolism 
raising properties of thyroid hormone could be divorced this substance would 
achieve an important role in the control of blood lipids. Attempts to do this 
have already been made unsuccessfully.
Tri-iodothyroacetic acid (TRIAC), an acetic acid analogue of tri-iodothyro- 
nine first synthesised by Pitt-Rivers (1953), also lowers the serum cholesterol. 
Early work seemed to indicate that this could occur without a rise in the B.M.R. 
(Lerman and Pitt-Rivers, 1955; Trotter, 1956). But Oliver and Boyd (1957) 
could not maintain the cholesterol lowering effect even by increasing the dose 
of TRIAC. Three of the 12 subjects studied developed angina and their exercise 
tolerance was decreased. In one of these 3 the B.M.R. rose, but in the other 2 
it did not. They suggest, as do Barker and Lewis (1956), that TRIAC may increase 
the oxygen requirements of myocardium wihout causing an observable increase in 
the B.M.R. The latter authors have shown that TRIAC given to hypothyroid and 
euthyroid rats increases the oxygen uptake of heart tissue to a greater degree
than liver, skeletal muscle, and kidney. Oliver and Boyd concluded that TRIAC
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would probably not prove suitable for the long term control of hypercholesterol- 
aemia in patients with coronary disease and such a therapy has certainly not 
become established.
Nevertheless the search for ’’safe” lipid-lowering thyroid analogues has 
continued and in mid-1959 two new substances became available for testing.
Both were the result of research in the laboratories of Glaxo Ltd. and as a 
result of extensive laboratory testing both were believed to be effective 
lipid lowering substances and devoid of undesirable side effects. They were 
at this point untried in human subjects. The substances were the cbxbro isomer 
of di-iodothyronine (DT2) and a particularly interesting compound 3, 5-3* 
trichlor-D-thyronine (TCT), the chlorine equivalent of tri-iodo-thyronine.
In the light of previous experience with such substances it was decided to 
proceed with caution.
METHODS
Six patients, 3 men and 3 women, all with clinical and electrocardiographic 
evidence of myocardial ischaemia or infarction, have been studied. Two condi­
tions for inclusion were a serum cholesterol of not less than 2S0 mg. per cent
and no evidence of hyperthyroidism. In 3 cases this was determined by B.M.R.
131
estimations and/or I studies; clinical assessment of the other 3 was consi­
dered adequate. Base line cholesterol levels were determined during a control 
period in which dummy tablets were prescribed. The standard dose of DT2 was 
50 mg. three times a day, but the dose of TCT varied from 5 to 20 mg. three times 
a day.
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Patients were seen at fornightly intervals, weighed and interrogated, 
specific details being sought about angina, dyspnoea and palpitation. Blood 
was withdrawn for cholesterol and lipoprotein estimation and E.C.G.s were 
recorded on most but not all of these attendances. In some cases B.M.R. and/or 
•^1 studies were carried out during the trial.
RESULTS
Each subject is reported separately.
Case 1 Mrs. J. L. Aged 66 (Fig. 14.)
This patient had suffered recurrent effort angina for years. There was 
a history of rheumatic fever at 16 years, and she had aortic incompetence.
B.P. ^^/90. W.R. and Kahn negative. A slight hypochromic anaemia was present 
the haemoglobin being 76$. E.C.G. showed minimal changes of postero-lateral 
myocardial ischaemia, which improved while in hospital. She was an excitable 
woman and the lower of 2 "unsedated*1 B.M.R. readings was 28$ above standard.
But radioiodine studies on 5.5.59 were normal, the 24- hour gland uptake being 
J+0% and 4.8 hour protein bound iodine (PBl) being 0.04$ of the dose/litre.
DT2 was started on 13.5.59. Serum cholesterol levels fell thereafter, and 
the beta:alpha lipoprotein ratio responded likewise. The serum cholesterol 
fell from 4.98 mg. to 327 mg. per cent in 8 weeks, and then began to rise. Again 
it was followed by the lipoprotein ratio. About this point her angina became 
more troublesome, and by J+.8.59> that is after 12 weeks on DT2, the E.C.G. had 
worsened considerably. Treatment was stopped and the patient readmitted to 
hospital. B.M.R. was now 17$ above standard. The serum cholesterol and lipo­
protein ratio rose quickly to pretreatment levels, but the E.C.G. showed
!o don d:
■ od o-f:> J'Lfo ho.:;-:-;oo
IOO-
DT2 TCT
3 0 0
200.
\
o 4 8 12 16 20  WEEKS
'— ,— :------ l' rtr ~ ir  r.;
V4 i  ■  I
V6
CASE 2
27.10.59 8.12.59 5.1.60 19.1.60
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during treatment with LT2 and TCT.
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considerable improvement. She was discharged on 5.9.59 much improved and has 
remained in, for her, a reasonable condition until now.
Radioiodine studies were repeated in this patient on two further occasions. 
On 26.5.59, 6 weeks after starting on DT2, the gland uptake was 12% of the dose, 
and the 1+8 hour P.B.I. 0.02% of the dose per litre. These figures indicate 
impaired utilisation of iodine. On 10.8.59 the 21+ hours gland uptake was only 
4% of the dose and the J+B hour P.B.I. 0.01% of the dose per litre. These figures 
were interpreted as revealing considerable iodide block probably due to the 
daily intake of drug iodine.
The results in this patient show that DT2 does lower the serum cholesterol 
and betaSalpha lipoprotein ratio without apparently increasing the B.M.R. 
Nevertheless during its administration myocardial ischaemia may worsen, or sup­
ervene. All of these effects were reversed when the drug was withdrawn. It 
seems possible that on a constant dose spontaneous ‘’escape1' from the lipid low­
ering effect can occur.
Case 2 Mrs. J. G. Aged 63 (Fig. 15)
This woman, with a 5 year history of effort angina and dyspnoea, was 
admitted as a suspected acute myocardial infarction. This was not confirmed 
however and the final diagnosis was that of acute myocardial ischaemia. B.P. 
1S0/95. Poor heart sounds. Hb. 106%. After being discharged she was observed 
for 1+ weeks. She continued to have moderate effort angina readily relieved by 
glyceryl trinitrate. When DT2 was introduced the serum cholesterol fell rapidly 
from a mean control level of 29$ to 19$ mg* PeI* cent and the beta:alpha lipo­
protein ratio from 2.61+ to 1.03. But during this time her angina probably
Fig.
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worsened and she certainly had to take glyceryl trinitrate more frequently,
DT2 was stopped therefore after 10 weeks and the cholesterol and lipoprotein 
levels rose sharply and the angina lessened.
After 4- weeks T.C.T. 5 mg. t.i.d. was started and the cholesterol fell from
267 to 210 mg. per cent, but the lipoprotein ratio did not return to the pre­
vious very low levels. For the first 2 weeks of this regime she was moderately 
well, but by the J+th week she was complaining of severe angina and the E.C.G. 
showed increased T wave changes of lateral ischaemia. Treatment was again 
stopped and once more the angina and E.C.G. improved and the serum cholesterol 
rose.
The results in this subject again show that DT2 has a potent and rapid 
effect in lowering the serum cholesterol and beta:alpha lipoprotein ratio and that 
a low dose of TCT (15 mg./day) shows the cholesterol effect to some extent. How­
ever the patient’s angina was not improved and may have been aggravated. During
the administration of TCT the E.C.G. deteriorated.
Case 3 Miss M. B. Aged 4-9 (Fig. 16)
This patient was admitted with an acute posterior myocardial infarction 
and treated with anticoagulants. She made an uneventful recovery and was dis­
charged after 4- weeks in hospital. Hb. 86% B.M.R. 5% below standard. Radio­
iodine studies showed normal thyroid function with a 2 4 .-hour gland uptake of 
4-0% of the dose and negligible total plasma iodine blood levels after 4-6 hours.
DT2 was started after U weeks outpatient observation. There was a delay 
of 4- weeks before the serum cholesterol began to respond, but thereafter it 
fell steadily from a mean control level of 355 to 258 mg. per cent and main­
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tained this level without appearing to “escape” from it. The beta:alpha lipo­
protein ratio also showed a delayed fall. For 28 weeks she remained well and 
without angina, the E.C.G. improving gradually. But during the week ending 
26.1.60 she experienced moderately severe retrosternal pain. There was no 
deterioration of the E.C.G. Nevertheless DT2 was stopped at this point and TCT 
(45 mg./day) started without there being a break in therapy. There was a fur­
ther slight fall in cholesterol of 18 mg. per cent. But during the 5th week on 
TCT she was readmitted to hospital following the acute onset of crushing retro­
sternal pain which radiated to the arms and which she protested was worse than 
the pain of her original infarction. She was not unduly collapsed however, and 
the E.C.G. remained unchanged, but by the 7th day of admission the E.S.R. had 
risen from 10 to 28 mm. and the leucocyte count from 9.0 to 13*4 thousand per cm.
TCT was of course discontinued immediately and the serum cholesterol rose 
from 244 to 314 mg. per cent in a week. Radioiodine studies were carried out 
within a few days of readmission when it was clear that she had not suffered a 
definite reinfarction. The 24-hour gland uptake was now 24$ of the dose, the 
48-hour total plasma iodine level 0.0 4 $ of the dose per litre and the protein 
bound iodine negligible. These results show low normal uptake.
Again there was clear proof of the effectiveness of both DT2 and TCT as 
hypocholesterolaemic substances with no evidence of cholesterol escape from the 
former after 28 weeks of administration. But once more grave suspicion arose 
that both were responsible for the production of acute myocardial pain.
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Case L Mr. J. L. Aged 59 (Fig. 17)
This man may have had a myocardial infarction in 1955. He was treated 
at home then and there is no E.C.G. record of the illness. He was admitted to 
hospital on 3.11.58 as a suspected acute myocardial infarction but E.C.G. 
showed severe lateral ischaemia only and there were none of the clinical 
sequelae of infarction. He gave a history of dyspepsia and anticoagulants 
were not administered. Two days after admission he passed a tarry stool. The 
E.C.G. improved, blood disappeared from the stools and he was discharged on a 
bland diet. Barium meal examination showed scarring of duodenum without evi­
dence of active ulceration.
During some months of outpatient observation he complained of moderately 
severe effort angina which required the frequent use of glyceryl trinitrate. 
Eventually TCT was given in a dose of 15 mg./day. The serum cholesterol fell 
rapidly and steadily from a mean control level of 34-7 to 249 mg. per cent, after 
10 weeks. The betatalpha lipoprotein ratio followed suit, falling from 3.00 to
1.62. During this time his angina lessened considerably and only a sense of 
chest tightness remained. At the 12th week the cholesterol had risen to 300 
mg. per cent and the dose of TCT was increased to 30 mg./day. The cholesterol 
level fell steadily again, reaching a new low level of 236 mg. per cent, or 
111 mg. lower than the initial control level. However at his routine visit on 
the 6th week after the dose of TCT had been increased he complained that for 
3 days during the previous week he had suffered extreme chest pain, and dyspnoea 
and had to go home from work. The symptoms seemed to clear rapidly and spon­
taneously and he was much better at the time of his visit, but TCT was withdrawn
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and he was transferred to the low fat diet, corn oil regime. After 4 weeks of 
this his cholesterol had risen to 260 mg. per cent.
During the period of TCT administration the E.C.G. did not materially 
worsen. The slight alterations in T wave inversion in lead aVL (see Fig. 17) 
are probably postural. There is undoubtedly a degree of lateral myocardial 
ischaemia throughout, but the lateral leads of 12.1.60 taken a few days after 
his episode of severe pain show no significant deterioration.
The results in this patient suggest that TCT in as small a dose as 15 mg./ 
day will produce considerable lowering of the serum cholesterol level but that 
•‘escape1 seems likely to occur. A bigger dose will reverse this escape, but 
may precipitate angina.
Case 5 Mr. J. K. Aged 62 (Fig. 18)
This patient who had a posterior myocardial infarction in 1958 had previ­
ously participated in the corn oil trial, but had been withdrawn because of 
duodenal ulcer dyspepsia. After some months of occasional outpatient observa­
tion he was invited to take part in this study, and agreed.
At the time TCT was started he was feeling well and made no complaint
of angina, dyspnoea or dyspepsia. He was retired from work. The initial dose 
was 15 mg ./day. The serum cholesterol began to fall at once from a mean control 
level of 349 to 268 mg. per cent after 8 weeks. But it started to rise again 
and at the 10th and 12th weeks it was 298 and 307 mg. per cent respectively 
and once more it seemed that escape from the hypocholesterolaemic effect had 
occurred. No clear effect was produced on the beta: alpha lipoprotein ratio. 
During this period he remained in good health and the E .C .G. may have improved
slightly, the Q waves in lead III becoming smaller.
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After the 12th week the dose of TCT was increased to 60 mg ./day and the 
cholesterol level fell once more, reaching 225 mg. per cent after 10 weeks.
The patient was still symptom free at this point, but in view of the accumula­
ting experience of the drug it was discontinued. The cholesterol level promptly 
rose.
Radioiodine studies were performed during the 9th week of the 60 mg. dose 
period, or in the 21st week after the drug was first started. The 2X-hour gland 
uptake was 20$ of the dose and the 4-8-hour blood levels were a total plasma 
iodine of 0.07$ of dose/litre and protein bound iodine negligible. These results 
favour impaired thyroid function but their full significance will be discussed 
with the other results later.
Once more there is evidence of the profound hypocholesterolaemic effect of
TCT, though at lower dose levels escape again occurred. No cardiac pain had
been experienced by this patient up to the point at which the drug was withdrawn.
Case 6 Mr. tf. T. Aged 52 fFjg. 19)
This man was admitted as an acute myocardial infarction but the final 
diagnosis was acute lateral myocardial ischaemia only. The admission symptoms 
settled quickly but persistence of numbness and pain in the left arm, certain 
neurological signs and neck X-ray revealed extensive cervical arthritis which 
was probably the result of a severe neck injury in 19X2.
He was observed for two months after leaving hospital and then given TCT?
60 mg./day. The base line cholesterol level had been very constant about a mean 
of 325 mg* per cent. After 2 weeks of therapy it had fallen to 270 mg. per cent 
and remained near this level during the next 8 weeks showing no sign of a further
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Case
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before
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4 152 147
5 147 141
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fall. The beta:alpha lipoprotein ratio which had risen during the control 
period also fell. He remained symptom free throughout this time, but for the 
same reasons given in the previous case TCT was withdrawn and the cholesterol 
level rose.
Radioiodine studies were carried out during the 9th week of treatment.
The 24-hour gland uptake was 30$ of the dose and the 48-hour blood levels
were a total plasma iodine of 0.02$ of the dose/litre and the protein bound 
iodine was negligible. These results are within the normal range. The E.C.G. 
showed slight improvement in the course of therapy.
The fall in serum cholesterol was less marked in this patient than in 
the others but there seems little doubt that a real fall did occur.
The patients * weights before and at the end of treatment are given in Table
XVII. Four of them (cases 2, 3, 4 and 5) lost on average almost 7 lbs. Case 1 
gained 5 lbs, but most or all of this was probably due to oedema, and case 6 
gained 2 lbs. Pre-beta lipoprotein was present in the serum of each subject 
but the pre-betasbeta ratio was not significantly affected by the treatment.
DISCUSSION
The thyroid analogues D-diiodothyronine and trichlor-D-thyronine are 
patently effective hypocholesterolaemic agents. They cannot, however, be 
regarded as innocuous, for of 6 patients studied 4 had episodes of severe 
anginal pain. TCT was withdrawn from the other two lest angina supervene. It 
is admittedly difficult to attribute angina to iatrogenic causes when patients 
are already prone to it. But if it occurs at all one of the objects of the 
therapy has been frustrated, and when it occurs during the administration of
a type of drug which might cause it, the role of cause and effect cannot be
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easily ignored.
Although electrocardiographic worsening occurred in 2 of the patients 
with angina (Nos. 1 and 2) no pathognomonic alterations were observed in 2 
others (Nos. 3 and l±) seen shortly after the acute attack. Electrocardio­
graphic evidence of acute myocardial ischaemia need not persist for long 
after an attack, but one might have expected some changes in keeping with 
the severity of the pain, as described by these patients. Perhaps there 
was something in the nature of the incident compatible with greater subjec­
tive intensity of pain in the presence of minor ischaemia. But the rise in 
E.S.R. and leucocyte count which followed the pain in Case 3 may indicate 
organic myocardial damage.
On such clinical grounds one must suspect that these substances, like 
others before them, affect cardiac metabolism. But the metabolic effect may 
be more general than this • The considerable weight loss in U patients req­
uires comment, for all were taking their normal diet, none complained of an 
anorexia which might have impaired food intake, nor was their routine of 
physical activity altered in any way. Disregarding Case 1 in whom weight 
gain was probably due to oedema fluid, it is interesting that the least satis­
factory cholesterol response was in Case 6, where body weight was virtually 
unchanged. It almost seems as if the hypocholesterolaemic response and weight 
reduction are interrelated effects of some primary activity, and that this is 
likely to be within the fundamental metabolic function of thyroid hormones 
generally.
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The radioiodine studies are too few to permit generalisation. They 
suggest nevertheless that there is some impairment of thyroid function while 
TCT is being given. If TC? has thyroactivity, as seems likely, this effect 
may arise through depression of pituitary TSH. This may offer incidental scope 
for the substance in the treatment of exophthalmos. The low serum protein 
bound iodine levels are not necessarily abnormal, but equally they may indicate 
competition from TCT for a place in the plasma transport mechanism.
The phenomenon of cholesterol escape has been encountered with both anal­
ogues. This suggests that there is probably a critical minimum dose level. It 
is conceivable that this is the dose threshold above which thyroactivity effects 
begin to play their part.
In the main the beta:alpha lipoprotein ratio follows the pattern of choles­
terol response, probably due to the concomitant depletion of beta lipoprotein 
cholesterol •
CONCLUSION
D-diiodothyronine and trichlor-D-thyronine are effective hypocholesterol- 
aemic agents, but are not devoid of thyroactivity of a degree likely to increase 
the metabolic requirements of cardiac muscle and hence to produce ischaemic 
pain in patients with coronary artery disease.
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C H A P T E R  8
THE EFFECT OF CORN OIL. TRICHLOR THYRONINE AND AN EMULSION BASE ON THE SERUM 
CHOLESTEROL OF THE RAT. WITH A NOTE ON THE LIPOPROTEIN PATTERNS
Part I
In Chapter 6 it was shown that when adult males with coronary artery 
disease were given corn oil emulsified with acacia their serum cholesterol 
levels rose. It was of some interest and importance to discover whether this 
was due to the emulsifying agent and not solely a result of the rather large 
dose of oil given without dietary restriction of fat. But, in view of the 
poor clinical results which accompanied this part of the corn oil trial, it was 
obviously not ethical to undertake a human experiment in which serum choles­
terol levels might rise or troublesome alimentary symptoms ensue. A small 
experiment with rats was therefore devised and at the same time the opportu­
nity was taken to test the effectiveness of Trichlor thyronine (TCT) as a 
hypocholesterolaemic agent in the experimental animal. Although certain data 
from the manufacturer^ laboratory were available, an independent laboratory 
assessment of such a potentially important new compound was obviously desirable.
METHODS
Forty—five one year old male albino rats were divided into 5 groups of 9 
each. Unfortunately during the experiment 2 rats died from acute labyrinthitis 
and 2 of the groups were consequently one rat less. Weights were distributed 
comparably in each group. The animals were weighed at the start and again at 
the end of the experiment.
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The lipogenic diet used in this experiment was standard rat bran con­
taining 1 per cent cholesterol, 1 per cent sodium cholate, and 0.3 per cent 
methyl thiouracil. The smaller amounts of cholesterol and cholate, compared 
with the amounts used in the other experiments reported here, were used inten­
tionally in the belief that any disparity of serum cholesterol levels induced 
by the test substances would be more obvious if the "control hypercholesterol- 
aemia" was not excessively high. Nine rats from the same batch and of the same 
age were used as normal controls. This group of rats acted as a common control 
group for 3 separate experiments which were in progress at the same time and is 
referred to as Group P.
The diets were made up as follows:-
Group P - normal bran.
Group S - lipogenic diet.
Group T - lipogenic diet + 20% corn oil.
Group W - lipogenic diet + 4-0% com oil emulsion.
Group X - lipogenic diet + 20% emulsion base.
Group Z - lipogenic diet + 0.02% trichiorothyronine.
Since the corn oil emulsion contained 50 per cent com oil the amounts of 
oil given to groups T and W, and of emulsion given to groups W and X were iden­
tical. Each animal was given 20 gms. of diet per day and unlimited water.
After 2 4  days of experimental feeding each animal was anaesthetised with ether, 
and blood withdrawn by cardiac puncture for cholesterol and lipoprotein studies • 
The animals were allowed to recover, except those of Group P which were killed 
for dissection, as described elsewhere. Cholesterol estimations were carried out 
using Henly1s modification of the method of Zlatkis et al. (1953)•
TABT.B x v m .  Weights (in Gkn-) of rats of groups 3,T,W, X and Z 
before and after the experimental diets.
b - before a - after
S T W X Z
Bo. b a b a b a b a b a
1 265 240 285 280 305 315 325 340
2 315 310 300 315 295 295 290 280 320 295
3 300 325 270 285 300 310 275 255
4 280 275 325 380 300 300 345 335 280 270
5 325 315 285 290 350 350 285 275 300 270
6 320 310 325 325 360 355 350 380 310 275
7 340 330 345 340 280 285 310 310 290 285
8 300 290 330 320 285 290 295 295 345 320
9 280 275 275 280 345 345 350 360 330 310
Average 303 293 311 321 308 309 314 316 308 291
TABLE XIX. Cholesterol levels (mg.$) of 
rats in groups P, S,T,W,X and Z after 
24 days on the experimental diets.
No. P S T W X Z
1 78 244 566 208 233
2 76 250 564 316 345 196
3 76 474 276 225 140
4 82 170 542 572 202 192
5 63 256 350 564 148 164
6 97
ICO
i 0^ 
1
656 470 121 275
7 71 216 672 147 282 170
8 69 404 708 426 334 127
9 92 630 620
~573~
516 130 170
Average 78.2 322.3 417.0 221.7 185.2
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The composition of the ordinary bran for rat feeding as supplied to the 
laboratory in parts by weight is whole meal flour, 4-5$ Sussex ground oats, 4-0$ 
white fish meal, 8; dried yeast, 1; skim milk, 3$ cod liver oil, 1; sodium 
chloride, !•
RESULTS
The weights of the rats at the beginning and end of the experiment are 
shown in Table XVIII and the cholesterol levels in Table XIX. Under routine 
experimental conditions it is quite impossible to know accurately how much of 
the measured diet an animal consumes, chiefly because of spillage and admixture 
with excrement in the cage. But daily observation of the animal‘s cage and its 
dietary zest allows a useful assessment of the relative intakes. On this basis 
groups P, S, T and X had roughly equivalent intakes and groups W and Z ate a 
little less than the others, but as much as one another. Groups T, W, and X 
gained slightly in weight while groups S and Z lost an average of 10 and 17 gms. 
respectively.
Cholesterol Levels
The modified lipogenic diet used in this experiment still produced a stri­
king rise in the average rat serum cholesterol levels after 24- days of feeding 
(78.2 to 322.3 mg./lOO ml.). The addition of corn oil to the diet increases the 
serum cholesterol level still further (to a mean of 573*3 mg./lOO ml.) and the 
increase is significant, (t = 3.76; P < 0.01). But the addition of emulsified 
oil does not augment this increase and in fact the mean cholesterol level is 
considerably less than that achieved with the plain oil (417.0 compared with 
573.3 mg./lOO ml.) a difference which,however is only significant at the 2 per
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cent level (t = 2,82; 0.02 > P > 0.01). Nevertheless the figures show
convincingly that emulsification of the oil of itself is not a procedure likely 
to impart to it extra lipogenic properties.
The difference in the mean cholesterol levels of groups S and X (100.6 
mg./lOO ml.) although considerable is not significant (t = 1.74.; P>0.10).
The likely reason for this can be suspected from a study of the distribution 
of the individual cholesterol values of group S, where the range is 170 to 630 
mg./lOO ml. This wide dispersal of serum cholesterol levels tends to occur 
with an oil free lipogenic diet and was observed in other experiments. Closer 
grouping of individual cholesterol levels is more certainly achieved by incor­
porating a small amount of edible oil in the dietary mix. However to return 
to the main point of this paragraph, there is no proof that the emulsifying 
agent has intrinsic hypocholesterolaeroic properties.
Trichlorothyronine seems to have some hypocholesterolaemie potency in the 
rat although the mean difference of 137.1 mg. between groups S and Z is only 
significant at the 2 per cent level (t = 2.56; 0.02 >P >0.01) probably for
the reason suggested in the preceding paragraph. Each rat in group Z was 
receiving 4- mg* of trichlorothyronine per day. The equivalent dose for a 70 
Kg. human adult would be about 950 mg. per day, that is 20 to 60 times the dose 
tested in Chapter 7. However species susceptibility to drugs varies considerably 
and no conclusions should be drawn from this fact. Rats receiving the drug lost 
more weight than those in the control lipogenic group (S), they seemed to be 
more difficult to anaesthetise and to recover more rapidly from the anaesthetic.
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These observations, which might indicate increased metabolism have not been 
confirmed by the parent laboratory, even although they used larger doses of 
T.C.T. (25 to 100 mg ./Kg.) and more sensitive indices of thyroactivity such 
as antigoitre and oxygen consumption assays. (Dr. T. Binns. Personal communi­
cation) .
CONCLUSIONS
(1) Corn oil augments the cholesterolaemia produced by a standard type of 
lipogenic diet suitable for rats. Although the amount of com oil, namely 20 
per cent of the diet, is considerable a similar result has been observed in 
other rat dietary experiments in which amounts of 5 and 10 per cent have been 
used. The reason for this has not been established but may be due to improved 
alimentary absorption of cholesterol or to increased palatability of the diet 
with increased total calorie intake.
(2) Corn oil emulsified with acacia is not more, and probably is less prone to 
augment dietary cholesterolaemia in rats than the plain oil. The emulsifying 
base itself is inert, however, insofar as serum cholesterol effects are concerned.
(3) The rising serum cholesterol levels encountered during the first stage of 
the human corn oil trial were probably due to increased dietary intake of fat 
and not to any specific cholesterol raising property of the emulsion.
(4-) Trichlorothyronine (T.C.T.) is probably effective, in the dose employed, as 
a hypocholesterolaemic agent in rats. This study raises doubts that the effect 
is not entirely divorced from increased thyroactivity.
Part II
Not much has been written about serum lipoproteins in the rat. Filios et
RAT
gamma beta <x-2 albumin
HUMAN :
Fig. 20. Protein electrophoresis of normal rat serum. The
human pattern is shown alongside.
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al (1956) and Portman et al. (1956) mention that their experimental diets 
produced an increase in rat beta-lipoproteins but make no comment on the normal 
lipoprotein spectrum in this animal or whether the ’'beta-lipoproteins" of man 
and rat are structurally similar. Wilgram et al. (1957) observed an increase in 
the low density and alpha-lipoproteins of rats given choline supplemented choles­
terol rich diets but the average maximum serum cholesterol level achieved in 
their study was only 128.1 mg. per cent, a degree of cholesterolaemoa not usually 
accompanied by lipidosis or atherosclerosis in the rat.
In the course of the various rat experiments described in this thesis, 
lipoprotein electrophoresis was carried out systematically on all serum samples. 
An interesting and perhaps important phenomenon was observed during this routine 
work. This seems a suitable point at which to describe it and give a short 
account of normal and abnormal lipoproteins in the rat.
METHODS AND RESULTS 
So that a clear reference standard can be established for the nomenclature 
of the lipoproteins a typical example of rat serum protein electrophoresis is 
shown in Fig. 20 There are 5 main bands - gamma, beta, alpha-2, and alpha-1 
globulins and albumin. The relative amounts of each are slightly different 
from their percentage composition in human serum. Albumin and alpha-1 globulin 
run slightly behind the corresponding human bands but are denser. Beta-globu- 
lin lies in the same position as human beta-globulin, but gamma-globulin runs 
further than its human equivalent so that the gamma and beta-globulin bands in 
rat serum are not always clearly separate but frequently appear as differently
Lipoprotein
Protein
Fig. 21. Lipoprotein electrophoresis of normal rat serum.
Alpha-lipoprotein includes a pre-albumin component.
Cholesterol 
m9 %
Lipoprotein
Protein
Fig. 22. An alpha 2-lipoprotein emerges and increases in
amount as the serum cholesterol rises. There is little 
stainable protein associated with it.
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shaded components of one broad band. Rat alpha-2 globulin is a very faint 
band which is barely visible.
Fig. 21 shows the lipoprotein pattern of normal rat serum having a choles­
terol content of 72 mg. per cent. The characteristic features are the paucity 
of lipid staining material present, most of which occurs as alpha-lipoprotein, 
and two other faint lipoprotein bands, (difficult to demonstrate in a reproduc­
tion though clear enough on the original paper strip), one associated with the 
beta-globulin band (a beta-lipoprotein) and the other running ahead of alpha- 
lipoprotein and just beyond the albumin front (a pre-albumin component). The 
next illustration (Fig. 22) shows what happens as the serum cholesterol rises.
A new lipoprotein band emerges which increases in density with the increasing 
serum cholesterol concentration. This band is quite separate from beta-lipo­
protein. It lies between the beta-globulin and albumin bands and is perhaps 
associated with alpha-2 globulin. A remarkable feature however is how little 
protein there seems to be in relation to it. In this respect it is similar to 
human pre-beta-lipoprotein. In some of the sera slight increases in the alpha- 
lipoprotein and pre-albumin band were noted, but were trivial compared with the 
abnormal emergent lipoprotein band, called alpha-2 lipoprotein.
The distribution of cholesterol between the different lipoprotein bands was 
estimated by a simple elution procedure, which the cholesterol method used in 
this chapter makes possible. A marker strip is cut from the electrophoresis 
paper and stained with Sudan Black B. The pieces of unstained paper correspon­
ding to the lipoprotein bands thus identified are cut up with scissors and 
eluted overnight with the ferric chloride - acetic acid reagent. A portion of
Cholesterol Distribution %
Fig. 23. Marker strip showing the percentage distribution of
cholesterol among the lipoproteins in rat serum with a 
cholesterol level of 630 mg. per cent.
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serum-free paper is used as a blank. Thereafter sulphuric acid is added to 
aliquots of the eluate, the colour allowed to develop and read as in the standard 
method. This gives a measure of the percentage distribution of cholesterol 
between the various bands. In one serum so studied, in which the cholesterol 
level was 630 mg. per cent, 5 per cent of the cholesterol was in alpha-lipo­
protein, 82 per cent in the abnormal lipoprotein, 10 per cent in beta-lipopro­
tein and 3 per cent in the area between beta-lipoprotein and the starting line 
(Fig. 23). It is clear therefore that this new lipoprotein band contains all 
or most of the extra cholesterol held in the serum. In normal rat serum about 
80 per cent of the cholesterol is carried in alpha-lipoprotein.
In the discussion on lipoprotein composition in Chapter 2 the relative 
instability of lipoproteins having a small protein component was mentioned.
From the electrophoretic analysis described above it is clear that the new 
alpha-2 lipoprotein complex is deficient in protein and theoretically might be 
regarded as an ’’unstable lipoprotein”• Spontaneous confirmation of this suppo­
sition occurred as follows.
After serum lipid analysis all sera were stored in a J+°G refrigerator for 
2 or 3 weeks before discarding them. Not infrequently repeat lipoprotein elec­
trophoresis would be carried out, for various reasons, up to 3 weeks after the 
initial run and invariably the patterns were similar to the originals. But after 
the rat sera had been in the refrigerator for about 5 days those with high 
cholesterol levels became turbid to the point of milkiness. When some of these 
were electrophoresed for a second time a fundamentally different lipoprotein 
pattern was obtained, as shown in Fig. 24-. Alpha-2 lipoprotein had disappeared
Fresh
I alpha -2  I alpha |
Fig. 24. Lipoprotein pattern of fresh hypercholesterolaemic
rat serum and after 5 days refrigeration. The alpha 
2-lipoprotein has disappeared and a new lipid staining 
hand has appeared just ahead of the application line.
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and instead a dense lipid band was present in front of the starting line.
Elution analysis revealed that a radical redistribution of the cholesterol 
had taken place and that 85.5 per cent of it was now in the new lipid band,
11.5 per cent in beta-lipoprotein and 3 per cent in alpha-lipoprotein.
DISCUSSION
It seems reasonable to deduce from these experimental findings that when 
hypercholesterolaemia is produced in the rat an abnormal and highly unstable 
lipoprotein is formed which, on paper electrophoresis, runs to a position 
corresponding to alpha-2 globulin. After a few days storage at 4°0 some 
physico-chemical change occurs involving this lipoprotein. The increase in 
serum turbidity suggests that the lipid has split away from its protein with 
consequent loss of solubility. Although the new electrophoretic position of 
the lipid is in the normal chylomicron or neutral fat zone it is clear from 
the amount of cholesterol contained in the band that it is not composed of 
typical chylomicron particles (see Table III).
A lipoprotein which is so unstable in vitro may also be unusually unstable 
in vivo. This could explain the ease with which tissue and vascular lipidosis 
is produced in the rat once a state of hypercholesterolaemia has been achieved. 
Wissler et al. (1954) attributed intimal lipidosis to the high cholesterol: 
phospholipid ratio which occurred in their rats given a lipogenic diet. This 
relative insufficiency of phospholipid could be an important contributory cause 
of the general lipoprotein instability postulated here. For Oncley et al. (1950) 
state that lipoprotein stability partly depends on the mosaic interlacing of
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ionic phospholipid and protein molecules on the surface of the lipoprotein.
If both protein and phospholipid are inadequate for the amount of lipid to 
be carried,, the greatest possible degree of surface instability of the lipo­
protein must presumably exist.
The important and fascinating question to which I can give no answer is 
why the increasing cholesterol pool does not associate with the beta-globulin 
which is abundant. For some reason this protein is apparently not available 
to the lipid. The protein-deficient state of human prebeta-lipoprotein may 
be a similar problem, the answer to which may contribute significantly to 
our understanding of at least one of the biochemical issues which seems to be 
involved in the serum changes associated with vascular lesions.
-  102 -  
C H A P T E R  q 
MECHANISMS OF LIPID CONTROL 
It is still not certain, in spite of the volume of work on the control of 
blood lipids, what is the primary lipid abnormality requiring correction, for 
the fundamental lipid derangement underlying the initiation and development 
of atherosclerosis has not been determined. Various lipid parameters are 
abnormal in subjects with this disease, but many of these are probably obliga­
tory changes, developing because of change in one of the others. Thus if the 
primary fault is a rise in serum cholesterol this will imply a rise in the 
cholesterol/phospholipid ratio, an increase in the percentage of serum chol­
esterol in beta lipoprotein, (which seems to be the main carrier for cholesterol) 
and a rise in the ratio of free to esterified cholesterol (assuming there is some 
intrinsic limitation of esterification capacity). However, although these are 
secondary lipid derangements that is not to deny that they may he c f primary impor­
tance as far as the pathogenicity of hypercholesterolaemia is concerned.
On the other hand the primary defect may be a deficiency of ’’clearing 
factor” and through this a delay in the post-prandial clearing of lipaemia and 
an accumulation in the serum of lipomicrons and low density lipoproteins (Korn, 
1954)• The true state of affairs may again be the reverse of this, namely a 
deficiency of clearing factor caused by its functional exhaustion in the presence 
of hyperlipaemia. A situation theoretically akin to this is the further reduc­
tion in pancreatic insulin which occurs in the untreated diabetic with uncon­
trolled hyperglycaemia. Since heparin is so intimately involved in the release 
and production of clearing factor some defect in the endogenous stores of heparin
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might be suspected. The interesting, though inconclusive, observations of 
Cairns and Constantinides (1954) and Sundberg (1955) that tissue mast cells 
seem to be depleted in atherosclerotic vessels offer an attractive explanation 
for both the plasma and the tissue abnormality. But on the basis of work rep­
orted later one feels that this view cannot seriously be advocated. In any 
case although the intravenous administration of heparin undoubtedly leads to 
the appearance of a clearing factor in lipaemic plasma there is no proof that 
such a factor is evoked normally by lipaemia alone.
In the absence of precise knowledge about the aetiology of atherosclerosis, 
current therapy, despite the enormous amount of fundamental research which 
underlies it, is quite empirical. But this is no reason why therapeutic poli­
cies should be vague or irrational, and although our knowledge is limited it 
is important to appreciate what we are trying to do. Undoubtedly the commonest 
therapeutic aim is to reduce the serum cholesterol level. Hence the multipli­
city of hypocholesterolaemic agents which are in a sense a pharmacological 
convenience enabling us, if they are effective, both to eat our cake and have 
it. The author*s personal conviction is that the important evidence lies in 
those ethnic and epidemiological studies which seem to show that atherosclero­
sis is the end product of a dietary culture, and this is something which cannot 
readily be altered. For this reason it is probably essential that success in 
the pharmacological field be achieved if an acceptable method for lipid "norma­
lisation" is to emerge.
Serum cholesterol can be depressed either by limiting its absorption from 
the gut or promoting its excretion in the bile. These mechanisms can be, and
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in practice usually are, offset by the body's considerable capacity for chol­
esterol synthesis from non-lipid precursors. The biosynthesis of cholesterol 
is a complex process which requires an intimate knowledge of advanced bio­
chemistry for its understanding. Many of the intricate threads in this process 
have been unravelled using isotopically labelled tracer substances. According 
to a detailed consideration of the subject by Cornforth and Popjak (1958) the 
key stages in cholesterol synthesis are the creation of the "acetate pool" and 
from it the synthesis of squalene via the intermediate synthesis of mevalonic 
acid. The enzymes acetyl-coenzyme A and aceto-acetate-Go A play a vital part 
in the early stages of this transition. The next stage is the progressive and 
possibly single stepwise upgrading of squalene through lanosterol to desmosterol 
and finally to cholesterol. It is clear therefore that there are many points at 
which cholesterol synthesis might be interrupted, but how far this can be done 
without endangering vital enzymatic processes, devitalizing liver parenchyma, 
(where most of this synthesis occurs) or simply encouraging the accumulation of 
cholesterol precursors which may be as atherogenic as cholesterol itself (Nichols 
et al., 1955) is not clear.
Because the acetate pool can be derived from non-lipid sources such as 
carbohydrate and protein, the dietary restriction of cholesterol or sitosterol 
depression of cholesterol absorption has only a limited and usually evanescent 
effect on the level of circulating cholesterol. Sitosterol, of course, also 
inhibits the absorption of bile cholesterol. Thyroid hormone and certain thyroid 
analogues, including two of the most recent studied here, are powerful cholesterol
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lowering substances, but their site of action is uncertain. It is conceivable 
that they act directly on the liver cell, perhaps by increasing cellular 
oxygen consumption (Barker, 1956) and so affecting its capacity for cholesterol 
synthesis. There is a need for research into the nature of thyroid control of 
lipid metabolism. The serious problem with such substances, however, is whether 
their capacity for lowering cholesterol can be divorced from their effect on 
tissue metabolism. If the two effects are interdependent it must be considered 
unlikely that worthwhile progress can be made in this field.
The effect of oestrogens is complex. Oestrogens administered to human 
subjects cause a lowering of the serum cholesterol, and a similar effect is 
observed in rats, probably due to depression of hepatic synthesis (Boyd and 
McGuire, 1956). The effect in chickens and rabbits is the converse of this, and 
the serum cholesterol rises in pregnancy at a time when there is gross endoge­
nous oestrogenisation, although admittedly there is a concomitant alteration 
in other hormones. From experience with one thyrotoxic primigravid woman in 
Chapter 3 it seems possible that the normal hypercholesterolaemia of pregnancy 
can be prevented by thyroid hormone. This suggests a strategic site for its 
hypocholesterolaemic effect. The long term administration of oestrogens to 
human subjects has certainly produced and maintained lowering of serum choles­
terol levels, but there is no evidence that this has been accompanied by clini­
cal betterment (Oliver and Boyd, 1959).
Various substances have been used for their effect on the hepatic biosyn­
thesis of cholesterol, but all have caused serious toxic effects either in man
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or in the experimental animals Examples of some of these substances are 
phenyl- oC -butyric acid which blocks the formation of acetyl - Co A from 
acetate (Steinberg and Fredrickson, 1955) and nicotinic acid which may compete 
for Co A in its detoxication to nicotinuric acid (Reddi and Kodicek, 1953).
The ability of the vegetable oils to depress serum cholesterol levels 
seems to depend on their degree of unsaturation, and hydrogenation abolishes iheir 
effectiveness. It has not been possible to identify the cholesterol lowering 
activity of an oil with specific fatty acids and some workers believe that the 
hypocholesterolaemic principle resides in the non-saponifiable fraction of the 
oil. Nath (1959), for example, attributes the effect to 1:2 - dienolglucose.
The fact remains however that the effectiveness of an oil is to some extent 
related to its degree of unsaturation.
Whatever the active principle in the various oils the mode of action seems 
to be through the increased catabolic conversion of cholesterol to bile acids 
and hence to its excretion (Lewis, 1958)• Saturated fats increase the serum 
cholesterol not by reducing biliary excretion, but by promoting the biosynthe­
sis of cholesterol. A different mode of action and one perhaps more pertinent 
to the process of cholesterol deposition in arterial tissue is suggested by the 
work of Rutstein et al. (1958). They have shown that the in vitro deposition 
of cholesterol in human aorta is inhibited by linoleic acid and promoted by 
stearic acid.
The clearing action of heparin suggests that heparin or heparin-like 
substances might be of value in the control of blood lipids. But heparin to be 
effective has to be injected intravenously and of course it has anticoagulant
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properties. Many synthetic sulphated polysaccharides originally produced as 
anticoagulants have antilipaemic activity, but all have proved to be toxic. 
(Astrup, 1953). Examples of such substances are dextran sulphate and 
"Manuronate", a sulphated alginic acid.
It has not been the aim of this Chapter to give an exhaustive account of 
factors which control blood lipids. Symposia have been held to consider 
isolated aspects of the problem. The object has been to crystallize the 
therapeutic intention and indicate in what regions it might expect to achieve 
success. The author, although admitting gaps in the evidence, is persuaded 
that dietary methods such as that tested here and advocated by other writers 
offer the safest, most rational and most fundamental means of controlling the 
blood lipids. Whether this will control atherosclerosis and thrombotic vascu 
lar disease is another matter.
P A R T  II
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C H A P T E R  1 0  
LIPAEMIA. HEPARIN AND BLOOD VISCOSITY 
Mention was made in Chapter 4 of the gross milkiness of the serum of the 
group of chickens on cholesterol diet and receiving 5 mg. epi-oestradiol ben­
zoate per day. This serum appeared to be more viscous than that of the normal 
chickens and on testing with a Hess viscometer this was confirmed. But in 
view of the grossly abnormal state of the serum lipids in these birds it seemed 
that the physico-chemical conditions were too artificially distorted to have 
real clinical importance.
The viscosity of a liquidmay be increased by the addition of particulate 
matter. After a fatty meal particulate fat, in the form of chylomicrons, is 
added to the blood. It is important to know whether this post-praridial-lipaemia 
increases blood viscosity or not; for an increase in the viscosity of a liquid, 
other conditions being unchanged, diminishes its rate of flow (Poiseuille*s Law). 
The implications of this is terms of in vivo tendency to coagulation and tissue 
ischaemia are obvious.
I. LIPAEMIA AND VISCOSITY OF SERUM AND PLASMA 
For the purpose of this study the measurement of relative viscosity is 
adequate. A Hess's viscometer was used. After practice with the instrument 
and standardisation of technique, which included scrupluous care in cleaning, 
individual results rarely varied more than + 0.05 units. The reading taken 
was the wet glass viscosity, that is the reading obtained after a preliminary
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vetting of the viscometer capillaries by the water standard and the material 
under test (serum, plasma or blood). It was appreciated that the cleaning 
process between readings, since it involved the cooling effect of evaporating 
ether, might alter the viscosity values. However this effect must have been 
negligible, because the variation of + 0 . 0 5  for identical samples included the 
cleaning manoeuvre. At first the mean of 10 readings was taken but this was 
extremely tedious and when it was seen to be unnecessarily repetitive only 
two or three readings were recorded. Lipaemia was measured in an ’Eel” photo­
meter using a red filter and water as blank. The optical density was taken as 
a measure of ’units of turbidity”.
The subjects were convalescent patients of both sexes. Their ages ranged 
from 15 years to 78. Blood was withdrawn from an arm vein, by a short wide 
bore needle, into a dry syringe. Samples were taken while the subjects were 
fasting and three hours after the ingestion of 5 0  g. cream fat ( 2 5 0  ml. of 
dairy cream of tested fat content 1 9 - 2 1  per cent supplied by the hospital milk 
contractor). To obtain plasma samples, 8  ml. of blood was added to a small 
quantity of potassium oxalate (about 3  nig.), inverted gently 5 or 6  times, and 
spun at 3000 r.p.m. for 10 minutes. Oxalate in this quantity has no effect on 
blood plasma viscosity (Langstroth, 1919). Serum samples were obtained by 
allowing the blood to clot and then centrifuging as for plasma. Haemolysed 
samples were discarded.
Although the laboratory temperature varied between 14-°C and 22°C during 
the period of the study, there was no significant variation in temperature while 
any group of comparative readings was being taken.
TABLE XX. Serum turbidity and viscosity 
measurements in fasting subjects (P) and 3 hours after 
ingesting 50 G of cream fat. (25 subjects; 29 tests)
Serum Turbidity Serum Viscosity
P. 3 hr. P. 3 hr.
1 8 22 1.60 1.60
2 6 56 1.70 1.70
3 6 37 1.80 1.80
4 7 57 1.80 1.80
5 9 57 1.90 1.90
7a 6 22 2.30 2.40
7h 5 26 2.00 2.00
8a 6 15 2.10 2.10
8b 5 32 1.90 2.00
9 3 15 1.90 1.90
10 11 23 2.10 2.00
11 7 15 1.90 1.90
12 7 20 1.80 1.80
13 7 28 1.90 1.90
14 6 44 1.70 1.70
16 6 39 1.90 1.90
17 4 4 1.80 1.80
19a 5 23 1.70 1.70
19b 5 25 1.80 1.80
20 8 42 1.90 1.90
21 5 14 1.80 1.80
24 4 14 1.80 1.80
25a 5 21 2.00 2.10 ]
25b 5 22 2.00 1.80
26 3 27 1.80 1.80
27 3 14 1.70 1.70
28 5 19 2.40 2.30
29 5 16 1.70 1.60
30 4 12 1.90 1.90
Kean 5.7 26.2 1.88 1.88
TABLE XXI. Plasma turbidity and viscosity 
measurements in fasting subjects (F) and 3 hours 
after ingesting 50 0 of cream fat. (21 subjects; 
23 tests).
Plasma Turbidity Plasma Viscosity
P. 3 hr. P. 3 hr.
23 6 26 2.10 2.10
28a 6 28 2.20 2.10
28b 6 42 2.20 2.20
31 6 30 2.15 2.20
32 6 53 1.95 2.00
33 7 26 2.25 2.25
38 7 44 2.00 2.10
41 7 21 2.30 2.35
42 6 35 2.00 2.00
43 6 48 1.85 1.85
44a 7 40 2.20 2.25
44b 7 34 2.05 2.05
45 6 37 1.95 2.00
46 7 39 2.00 2.05
48 4 54 2.00 1.95
49 6 31 2.00 2.00
50 4 35 1.75 1.85
51 6 78 1.90 1.95
52 4 33 1.80 1.85
55 4 46 2.05 2.06
56 3 19 1.75 1.75
57 4 15 2.00 2.00
66 7 62 2.00 2.00
Kean 5.7 38.5 2.01 2.04
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The results are shown in Tables XX and XXI.
The turbidity readings cover a clinically representative range of lipaemia. 
It is clear that serum and plasma viscosities were not affected by the presence 
of particulate fat in the concentrations encountered clinically. The higher 
value of the mean plasma viscosity as compared with serum viscosity is in con­
formity with established knowledge (Wintrobe, 1 9 5 6 ) and is due to the presence 
of fibrinogen.
Conclusion
Lipaemia of clinical degree has no effect on serum or plasma viscosity.
II LIPAEMIA AND VISCOSITY OF WHOLE BLOOD
Although lipaemia has no effect on serum or plasma viscosity, it cannot 
be assumed that it will have no effect on whole blood. Nygaard et al. (1935)
have shown that there is a linear relationship between blood viscosity and the
haematocrit, for the haematocrit range 1 5 - 5 0  per cent. That is, blood viscosity 
varies depending on the number of red blood corpuscles present. The effect of 
chylomicra intermingled with red corpuscles could have quite a different effect 
from that of small fat particles suspended in plasma by themselves. The aim of 
this part of the study was to examine this possibility and also to investigate 
the effect of heparin on blood viscosity in fasting and lipaemic subjects.
Method:
The method and subject sample were as before except that: -
(l) Viscosity readings were made at the bedside immediately after the
blood was withdrawn. The four samples from each patient (see later) were allowed
TABLE XXII. Plasma turbidity and blood viscosity reading in 
21 subjects to show the effect of lipaemia, clearin'; action of 
heparin and standing at room temperature for 1 - 2  hours.
Case
Plasma Turbidity Blood Viscosity
Bedside Readings Delayed readi IRS1.0.
A B c D A B C
D
al bl CL "l
43 6 48 19 4 5-70 5-35 5.25 5.20 5.45 5.50 6.20 5.25
44 7 34 33 7 4.45 4.25 3.95 4.05 4.40 4 .40 4.20 4 .15
45 6 37 15 7 4.65 4-40 4-25 4.20 4.60 4.60 4.90 4 .40
46 7 39 15 4 4.55 4.30 4.20 4.15 4.35 4.20 4.85 4 .1 5
48 4 54 23 - 5.00 4.80 5.00 4-60 4.85 4 .80 5-70 -
49 6 31 19 7 5-io 4.70 4.75 4.70 5.10 4.75 6.00 4 .75
50 4 35 12 - 4.90 5.00 5.00 - 4.90 5.10 5.10 -
51 6 78 60 11 5 .65 5-35 5.50 5.50 5.70 5.65 8.00 5.70
52 4 32 10 5 4 .85 4.35 4-35 4.30 4.45 4.45 4.80 4.45
55 4 46 36 5 5.20 5.00 4.90 5.05 5.00 4.90 6.00 5 .05
56 3 19 7 3 3.80 4-00 3.90 3.95 3.80 4.00 4.00 3.80
57 4 15 8 4 4.60 4.40 4.40 4-30 4.70 4.45 4.45 4.40
58 5 26 12 10 5.50 5.15 5.00 5.10 5.30 5.20 5.20 5.10
59 4 50 10 7 5.70 5.80 5.60 5.50 5.70 5.80 5.80 5.70
61 4 45 15 7 4.50 4-40 4.20 4.35 4.30 4.20 5.10 4.35
62 4 25 9 4 4.15 4.35 4.25 4.30 4.30 4.35 4.25 4.25
63 4 34 19 5 4 .00 4.30 4.20 4.30 3.95 4.25 4.60 4.35
65 5 8 6 5 4.10 3.80 3-75 3.60 - 3.55 3.80 3.65
66 7 62 59 7 4 .65 4.65 4.65 4.50 4.50 4.45 5.50 4.50
67 6 26 15 6 4.65 4.60 4.60 4.60 4.50 4.50 5.00 4.60
69 4 34 19 5 4 .00 4.30 4.20 4.30 3.95 4.25 4.60 4.30
Mean 5 38 20 6 4.75 4.63 4.54 4.53 4.69 4.63 5.15 4.57
TABLE XXIII. Blood viscosity in 10 fasting subjects before 
and 15 minutes after 5)000 units of intravenous heparin.
Case
Ho.
Plasma Turbidity
Blood Viscosity
Imnediate Readings 2 Hours Later
Fhsting 15 mins. Pasting 15 mins. Pasting 15 mins.
47 4 4 3.80 d.70 3.70 3.60
48 5 5 5.40 5.40 5.20 5.15
53 4 4 3.65 3.75 3.60 3.70
54 5 5 5.20 5.10 5.00 4.90
59 4 4 5.30 5.20 5.20 5-25
61 3 3 4.40 4.40 4.25 4.35
63 4 4 4.15 4.05 4.05 4.00
64 4 4 4.45 4-.3C 4.25 4.1C
65 6 6 4.70 4.70 4.50 4.50
68 5 5 5.20 5.20 5.2C 5.20
Vean 4.4 4.4 4.62 4.58 4.50 4.48
- i n ­
to stand at room temperature until about 1 - 2  hours after the last one had been 
withdrawn, and their viscosities again measured in a group. It was not at 
first appreciated that this time interval was critical. The specimens were 
next centrifuged and plasma viscosities estimated.
(2) After withdrawing the 3-hour sample the needle was left in situ and
5000 units of heparin injected. Further samples were taken from the opposite
arm 15 and 75 minutes later. For simplicity of reference, the fasting, 3-hour 
and first and second post-heparin samples are called A, B Cand D respectively. 
Readings taken after the samples had stood in vitro are indicated by the suffix 
L. V = viscosity and T = turbidity.
e.g. VAL = viscosity of fasting sample after standing at room temperature.
The results of 21 experiments are shown in Table XXII.
(3) Two samples of C were taken. One was centrifuged immediately for the 
estimation of plasma turbidity before further clearing occurred due to the 
continuing in vitro action of the heparin-lipoprotein lipase complex. The 
other was used for viscosity measurements. In this way possible alterations
in viscosity produced by packing of the red cells in the centrifuge was avoided.
(4.) In 10 fasting subjects blood viscosity was measured before and 15 
minutes after the intravenous injection of 5 0 0 0  units of heparin, and the 
readings repeated about 2 hours later (Table XXIII)•
Results
The statistical method used for analysis of the figures was Student's "t" 
test for paired results.
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The bedside readings will reflect more closely the circulating viscosity 
and are considered first. There is a slight fall in the mean blood viscosity 
of the lipaemic samples (t = 2.3; 0.05 > P > 0.02). A further slight fall
is found 15 minutes after the intravenous injection of heparin (t = 3.5; P<0.01). 
However the fall in viscosity from the mean level of 4.75 in the fasting sample 
to the mean of 4*54 fifteen minutes after the intravenous administration of 
heparin, though not great, is highly significant (t = 3.97; P < 0.001). There 
is no simple or obvious relationship however between the nature of the viscosity 
change and the degree of the lipaemia.
Heparin had no effect on the blood viscosity of the fasting subjects and, 
as one would expect, there was no change in the turbidity of fasting plasma 
after the intravenous injection of heparin.
When the immediate and delayed readings are compared there is an obvious 
increase in the viscosity of CL (4-.54 "to 5.15). This increase must be due to 
some change associated with the red cells, for no increase was found in the 
plasma viscosity of these samples. It also seems to require the presence of 
lipid and heparin together, for it is not caused by lipaemia in the unheparin- 
ised samples (compare VB and VBL) nor by heparin in a lipid free sample (compare 
the immediate and delayed post-heparin viscosities of the fasting subjects)
(Table XXIII). It seems therefore that a heparin-lipid complex is formed or that 
heparin mediates some change in the lipids which is followed by adhesion of the 
complex or the altered lipids to the red cell. The strongly electro-negative 
nature of the heparin molecule may be the binding force.
If this hypothesis is correct, and the administered dose of heparin is
10 2 0  3 0  4 0  SO 60
TURBIDITY 
( first post-heparin sample)
Fig. 25. Relation between the turbidity and in vitro increase
in viscosity of sample C.
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x°o'
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5  52 2 0kj ^
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Fig. 26. In vitro increase in viscosity of sample C plotted
against time. (Subject 6 7 )
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constant (as in this study) there should be some relation between the per­
centage increase in VC on standing, and its turbidity (i.e. between
VCL - VC x 100 and TC); for the increase in viscosity should depend to 
VC
some extent, although not altogether, on the amount of heparin-lipid complex 
formed. This relationship is plotted in Fig. 25. It was realised at this 
point that there might have been closer correlation if the time interval bet­
ween VC and VCL had been constant. Therefore in subject 67, one of the last 
to be studied, the viscosity of the first post-heparin sample was measured at 
intervals, and in Fig. 26 the percentage increase in viscosity is plotted 
against time. The graph indicates that the viscosity of this sample increased 
at a constant rate until some point just short of its maximum. Thus the degree 
of increase in VC seems to depend not only on the amount of heparin-lipid com­
plex formed but on the time allowed for it to adhere to the red cells.
There is no increase in VDL, presumably because the heparin-lipid complex 
has been cleared from the circulating blood during the intervening hour.
DISCUSSION
It seems clear that post-prandial lipaemia, of the degree encountered in 
this study, tends on the whole to diminish rather than increase blood viscosity.
The difference is not gross however and is unlikely to have a significant effect
on blood flow. But it is a reduction and this is at least reassuring in so far 
as any increase in post-prandial viscosity could theoretically increase the 
tendency to coagulation.
It must be emphasised however that these findings apply, in a strict sense, 
only to the fixed and rigid physical conditions of the instrument used, and
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cannot be applied without reservations to the more complex problems of blood 
flow in a system of tubes of varying calibre and elasticity (Fahraeus and 
Lindqvist, 1931). Therefore one cannot deduce that lipaemia has no effect on 
blood flow in very narrow tubes such as capillaries and arterioles. Landis 
(1 9 33) has shown in fact that blood viscosity in frog capillaries is much 
higher than in small bore arterioles.
It must also be mentioned that the findings of this study are to some 
extent at variance with those of R.L. Swank who has made a number of contri­
butions to the problem. But the differences are not irreconcilable nor are 
they in fact strictly comparable. For most of his work has been done on ham­
sters fed unnaturally high fat diets for two or three weeks with a final load­
ing dose of milk cream 1 0 - 1 5  times as large as the comparable adult dose given 
in this study (Swank, 1954-) • It is possible that such regimes produce a degree 
of lipaemia equivalent to those of the group D chickens of Chapter U and it is 
therefore not surprising that increased viscosities are measured. This is alto­
gether a different experimental dietary scheme from mine, in which an amount 
of fat not unrepresentative of the normal dietary intake was used. Similarly 
the dose of heparin he used, and which produced a pronounced fall in the raised 
viscosity levels, was, at 4 . 0 0 units for a 1 0 0  g. hamster approximately 5 0  times 
the comparable dose used in this experiment, which again was based on the custo­
mary anticoagulant dose requirement.
It is also the case that whereas Swank’s measurements continued for 72 
hours and showed the peak increase in viscosity to occur between 6  and 9 hours 
after the final loading diet, and at a time when the lipaemia was beginning to
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o2.QQ.Yf my readings m  effect come to an end with, the administration of heparin 
3  hours after giving the cream, and at the approximate time of peak lipaemia.
In other words the increase in viscosity noted by Swank in his hamsters was 
occurring at a time when the dietary lipid intake was being assimilated into 
the general cholesterol-phospholipid-fatty acid pool. But Brundage et al.
(1 9 3 6 ) detected no relationship between blood viscosity and plasma lipids in 
a study which took no account of the post-prandial chylomicron lipaemia but 
dealt specifically with the plasma cholesterol, phospholipid and fatty acid 
levels •
It might also be argued that the Hess viscometer is hardly a sensitive 
enough instrument for this work. But it proved sensitive enough to demonstrate 
the slight but consistent difference between the viscosity of plasma and serum 
and differences in viscosity of a lesser order than this can hardly be consid­
ered clinically important. Holbrook and Watson (1939) have made a good defence 
of the Hess Viscometer and the ideal conditions for viscosity determinations on 
whole blood as described by Trevan (1918) were followed by me as closely as 
possible. And Eckstein et al. (1942) argue that the type of apparatus is not 
critical where only relative viscosities are being determined. Swank (1954-) 
measured relative viscosity by timing the flow of blood from a needle intro­
duced into the inferior vena cava of the hamster but as Pirofsky (1953) points 
out a possible major inaccuracy in this method is the effect of changing venous 
pressure.
The increase in viscosity, on standing at room temperature, of the blood 
sample taken 1 5  minutes after the giving of heparin to the lipaemic patient
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seems to be an in vitro effect only. It is probably caused by the adhesion of 
chylomicron aggregates to red blood corpuscles or increased adhesiveness of the 
red cells to one another (Swank, 1951; Swank and Cullen, 1953). Swank and Levy 
(1 9 5 2 ) suggest that heparin facilitates the transport of neutral fat through 
the capillary wall. Whatever the mechanism, this heparin-lipid complex is 
•’cleared” in vivo without changes in blood viscosity.
It also seems clear that heparin has no clinically important viscosity 
effect in either the fasting or lipaemic patient. For although its administra­
tion to the latter group does produce a significantly detectable fall in blood 
viscosity it is of a very small degree. If heparin increases coronary flow 
volume as reported by Gilbert and Nalefski (1949) and relieves effort angina as 
reported by Graham et al. (1951) these effects probably depend on mechanisms 
other than lowering of blood viscosity. Certainly Copley et al. (1942) reported 
a fall in the ”apparent viscosity” of blood after the in vitro addition of 
heparin, but they used about 2 0 0  times the amount of heparin given here.
Finally let me consider briefly two theoretical points. Firstly, if a 
moderate degree of alimentary lipaemia reduces the blood viscosity, as in fact 
it seems to do, is there any simple explanation for such an action? Apparently, 
there may be. It is possible that the small chylomicron particles have a lubri­
cant or ball-bearing effect on the much larger red blood corpuscles. And secondly 
while this study has assumed the main problem to be one of variations in laminar 
flow in smooth tubes what might be the effect of atheromatous plaques or vessel 
constrictions? These physical barriers within the flow system introduce the 
possibility of turbulence and eddying with perhaps minute backwaters of stagnant
- 115a-
blood in which blood clotting could begin. The last word has almost certainly 
not been written on the importance of blood viscosity changes as a factor in 
vascular disease.
Footnote
Following the publication of this work (Watson, 1957) Ahrens (1957) in a 
review article discussed the divergent results obtained by Swank and myself.
He was inclined to accept Swank’s work on the grounds that his method was 
probably more sensitive, one reason why this chapter contains a defence of the 
Hess technique. However Gousios and Sheam (December 1959) have published 
an article in which they find no significant reduction in blood viscosity in 
human subjects following the intravenous injection of heparin. They used a 
method similar to that employed by Swank in his work on dogs. Further, Sheam 
and his colleagues (i960, Personal communication) have studied the effect of 
intravenous fat emulsions on human whole blood viscosity and have been unable 
to demonstrate an increase.
-  116 -  
C H A P T E R  1 1
THE ROLE OF THE TISSUE MAST CELL IN EXPERIMENTAL ATHEROSCLEROSIS
There is evidence which suggests that the presence of mast cells may 
protect from the occurrence of atherosclerosis, while on the contrary their 
absence predisposes to it. Atherosclerosis is easily induced in the rabbit 
and chicken. The rabbit is almost devoid of mast cells (Westphal., 1891; 
Holmgren and Wilander, 1937) and they are absent from the myocardium of the 
chicken (Watson and Campbell 1957). On the other hand the rat, which has an 
abundance of mast cells, particularly in connective tissue and peritoneum, 
(though not too numerous in the parenchymatous tissues such as lungs, spleen, 
liver and kidney), (Laguesse, 1919; Arvy, 1956), is notoriously resistant to 
the production of atherosclerosis. Atheromatous lesions can be induced in the 
rabbit and chicken by supplementing their normal diet with cholesterol but 
rigorous experimental regimes have been necessary in the rat and sometimes 
even these have failed (Page and Brown, 1952). Such regimes have included 
cholesterol feeding augmented by sodium cholate or cholic acid, and thiouracil 
or 1311  induced hypothyroidism (Page and Brown, 1952; Filios et al., 1956) 
hypertension (Wissler et al., 1954), steroid administration (Selye, 1958) and 
choline deficiency (Wilgram et al., 1954)* Sundberg (1955) and Cairns and 
Constantinides (1 9 5 4 ) have demonstrated a lower concentration of tissue mast 
cells in human adults with atherosclerosis compared with those having a heal­
thy vascular tree.
The aim of this study was to observe whether the depletion of mast cells 
in the rat impaired its relative immunity to experimental atherosclerosis.
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METHODS
Twenty-two double-hooded Norwegian rats were divided into 3 groups (A, B 
and G) of 6 , and a group of 4 , which were used for intermediate observations.
Each rat was housed separately. Group A was fed a standard rat bran throughout 
group B was fed bran supplemented with 5% cottonseed oil and 2% cholesterol; 
group C was given the same diet as group B and in addition submitted to the 
injection regime to be described. Water intake was unlimited but the bran 
ration was maintained at 20 gms. per day. All animals were weighed weekly.
After 2 weeks of this diet group C began to receive intraperitoneal injec­
tions of compound 4 8 / 8 0  in increasing doses, up to 800 fx g. to 1 0 0 0  yu,g. per 
day. Compound 48/80 (generously supplied by Burroughs Wellcome) is a relatively 
specific histamine liberator of low toxicity. It is a condensation product of 
p-meth o xyphenethylmethylamine and formaldehyde. Full accounts of its pharmaco­
logy and its effect on the tissue mast cell have been given by Paton (1951), 
Feldberg and Miles (1953), Feldberg and Talesnik (1953) and Riley and West (1955). 
The 4 reserve rats were included in this schedule and killed singly on the 4 th, 
5th, 6 th and 7 th days of the injection course to verify that mast cell destruc­
tion was taking place.
Seven weeks from the start of the experiment, that is 5 weeks after the 
injections had begun, 3  rats from each group were killed by ether anaesthesia 
and the remaining rats 3 weeks later. Injection of compound 48/80 was withheld 
for the 24 hour period preceding the death of the animal. Blood for cholesterol 
and lipoprotein analysis was obtained by cardiac puncture. Mesenteric spreads
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were prepared as described by Riley (1953) and stained without fixation. The 
aorta and its main branches were dissected and examined in situ, in some cases 
before and after infiltration with Sudan Black B as described by Filios et al. 
(1956). Heart and aorta were then fixed in a 10% formalin, 1% calcium chloride 
solution, and mounted in gelatin. Frozen sections were cut through the middle 
and base of the heart and the first part of thoracic aorta. All specimens were 
stained for mast cells with 0.1% aqueous toluidine blue for 20 secs. Heart 
and aortic sections were stained for fat with Sudan IV and counter stained with 
haemalum. Aortic sections were also treated with Weigert’s elastic stain.
Serum cholesterol was estimated by the micromethod of King (1951) and the lipo­
protein pattern demonstrated hy paper electrophoresis and staining with Sudan 
Black B (Chapter 2).
The heart and aortic sections were examined as follows:(a) mast cells were 
examined and counted in each toluidine stained section; (b) vessels in the 
corresponding Sudan stained sections were examined for atheromatous change or 
fatty infiltration; (c) aortic sections were examined with special reference to 
elastic tissue.
RESULTS
The systemic effect of the intraperitoneal injections of compound 48/80 
were in general as described by Feldberg and Talesnik (1953). The animals were 
severely collapsed following the initial injections, but later in the experiment 
showed only slight and transient weakness with mild erythema and puffiness of 
snout, ears and paws•
TABLE XXIV. Summary of experimental data for Chapter 11. 
B = Bran; C.O. - 5$ Cottonseed Oil; C - 2$ Cholesterol.
Average Heart
IXiration Weight Wei fit weekly Serum Ma3t Cell Count Lesions
Bat No. Diet 48/80 of expt. before after wt.gain cholest.
(wks.) (®») (gm) (mg.5) Mid. Base Total
A4 B 0 7 265 305 5.7 83 135 83 218 0
A5 B 0 7 285 310 3.6 90 87 115 202 0
A6 B 0 7 295 300 0.7 92 108 225 333 0
Al B 0 10 235 255 2.0 91 63 91 154 0
A2 B 0 10 235 305 7.0 101 38 76 114 0
A3 B 0 10 265 320 5-5 70 75 102 177 0
Mean 263 299 4.1 88 84 115 199 0
B1 B + C.O. + C 0 7 305 325 2.9 54 27 114 141 0
B4 B + C.O. + C 0 7 270 315 6.4 104 121 56 177 0
B5 B + C.O. + C 0 7 315 330 2.1 122 82 78 160 0
B2 B + C.O. + C 0 10 240 275 3.5 71 128 137 265 0
B3 3 + C.O. + C 0 10 250 250 0 70 44 51 95 0
B6 B + C.O. + C 0 10 295 350 5-5 68 77 104 181 0
Mean 279 308 3.4 82 80 90 170 0
C3 B + C.O. + C -> 0 .8 rag./day 7 315 290 -3.6 133 7 7 14 0
C4 B + C.O. + C -> 0.8 ir.g./day 7 270 315 6.4 78 3 7 10 0
C6 B + C.O. + C -> 0.8 rag./day 7 300 300 0 79 0 0 0 0
Cl B + C.O. + C -> 1 mg./day 10 230 235 0.5 64 6 5 11 0
C2 B + C.O. + C -> 1 mg./day 10 245 250 0.5 56 0 1 l 0
C5 B + C.O. + C -> 1 mg./day 10 285 275 -1.0 70 4 1 5 0
Mean 274 278 0 .5 83 3 4 7 0
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The results are presented in Table XXIV. No mast cells were seen in the 
aortic sections of any group. Figs. 27 and 28 give examples of intact and 
disintegrated mast cells respectively, as seen in the mesenteric spreads.
The heart mast cell counts of those animals killed on the 3rd, 4th, 5th and 
6 th days were 176 , 50 , 54 and 44 respectively. While most of the heart mast 
cells in the first animal were still intact the majority of mast cells in the 
other 3 were disintegrating. It seems a reasonable assumption therefore that 
the 3 rats killed in the 7th week of the experiment had been in a state of 
mast cell depletion for 4  weeks, and those killed 3  weeks later for 7  weeks.
There was no significant difference in the cholesterol levels of the 
three groups and the lipoprotein patterns were unaltered. Details of normal 
and abnormal lipoprotein patterns in rat serum are given in Chapter 8 . There 
was considerable matting of bowel in each of the 3  rats killed after 8  weeks 
of compound 4 8 / 8 0  injections. Although the loops were teased apart without 
difficulty a longer course of injections might produce firm adhesions with 
intestinal obstruction.
No macroscopic aortic lesions were seen in any animal. There was no 
naked eye evidence of infiltrations of either liver, kidney or myocardium and 
histologically no myocardial tissue or vascular lipidosis was seen.
DISCUSSION
Within the limits of this experiment there is no evidence that the eradi­
cation of tissue mast cells in the rat diminishes its resistance to the produc­
tion of atherosclerosis. However these limits are considerable and while the
P ig .  2 7 . N orm al in t a c t  m ast c e l l s  i n  r a t  m e s e n te r ic  s p re a d .
T o lu id in e  "blue. x 6 0 0 .
• V .
1 **■ I)
P ig .  2 8 .  M e s e n te r ic  spread  fro m  r a t  a f t e r  5 days o f  48/80
i n j e c t io n s .  N o te  s c a n ty  m ast g ra n u le s  and c e l l u l a r  
d is in t e g r a t io n .  T o lu id in e  N iu e . x 60 0 .
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ensuing discussion does not explain them away or create significance out of 
negative results it enlarges the background of this particular experimental 
approach which at first sight seemed to have something to commend it.
To begin with it may be argued that the experiment was too brief. But 
arterial lesions can be produced in the rat quite rapidly, for Filios and his 
co-workers (1 9 5 6 ) have produced definite atheromatous changes after only 3 1  
days, others in chickens after a similar period (Rodbard et al., 1 9 5 0 ) and 
Thomas and Hartroft (1959) have produced actual myocardial infarcts in rats 
in 4  weeks •
A more trenchant objection lies in the absence of proof that the short 
or long term administration of compound 4 8 / 8 0  eradicates tissue mast cells.
It has been too readily assumed that the discharge of granules from the mast 
cell and the concomitant depletion of tissue histamine following the adminis­
tration of compound 4 8 / 8 0  means the elimination of the mast cell as a function­
ing unit. In one of his less well known communications Riley (Riley et al., 
1 9 5 5 ) shows that whereas almost the entire histamine content of rat skin is 
lost following mast cell disruption by 4 8 / 8 0  only 5 3  per cent of the heparin 
disappears. Heparin and histamine coexist in the mast cell and until recently 
it was felt that the discharge of histamine from the cell must entail the loss 
of heparin also. But Riley’s observation and the work of Uvnas (Hogberg and 
Uvnas, 1957; Uvnas, 1958 a and b) seems to indicate that histamine msy be 
released from the mast cell without total loss of heparin.
And it is certainly not the case that prolonged administration of 48/80 
to the rat destroys or inactivates the mast cell, for in recent work (Watson
and Kennedy, I960) it was found that after 14 days of 48/80 injections
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considerable sulphate uptake could be demonstrated within 2 4  hours not only 
in the remaining intact or partially degranulated cells but in cells which 
were almost impossible to detect and identify as mast cells so complete was 
the degranulation and loss of normal morphological characteristics.
It is also possible that the experimental regime employed here could 
protect the animals, for although the heparin discharge of the degranulated 
mast cells is not comparable in degree to the histamine release as reported 
by Riley (Riley et al., 1955) it does occur to some extent, and heparin 
through its effect on blood lipids may have a role in the prevention of 
atherosclerosis (Boyle, Bragdon and Brown, 1952), the main inference in fact 
supporting the experimental principle of this study. But the appearance of 
heparin in the blood as revealed by increased clotting time, following the 
injection of 4 8 /8 0 , is transitory (Paton, 1 9 5 1 ) and unlikely to influence 
the result.
In this experiment the failure to induce atherosclerosis can almost cer­
tainly be attributed to the failure to produce hypercholesterolaemia. A detary 
regime such as that employed by Filios et al., (1956) could have been used to 
produce an increase in the circulating lipids, but was deliberately avoided.
A diet similar to that used here produced marked lipaemia in chickens. It was 
considered that its failure to do so in the rat might be due to mast cell 
activity, and one expected that if mast cell depletion did induce atherosclero­
sis the corollary to this would be a rise in serum lipids.
The uninjected rats on the cholesterol enriched diet (group B) showed no 
qualitative or quantitative change in their mast cells. Since hypercholesterol­
aemia was not achieved one cannot discount the possibility that such a state
Fig, 29. Mast cells near a coronary arteriole. Toluidine
blue. x600
F ig ,  3 0 . M ast c e l l s  i n  r a t  m yocard ium . These a r e  s m a lle r ,
m ore e lo n g a te  and more d e n s e ly  g r a n u la r  th a n  th e  
m e s e n te r ic  mast c e l l s .  T o lu id in e  b lu e .  x600
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may affect the mast cells.
Although mast cells are seen near or around vessels in heart sections 
(Fig. 2 9 ) they also lie in the myocardium (Fig. 3 0 ) while a number are seen 
immediately under the pericardium. The majority of the vessels seen in 
section had no adjacent mast cells. It seems unlikely therefore, on a 
purely teleological basis, that the cardiac mast cell has a specific function 
to protect arteries. The absence of mast cells may contribute in some secon­
dary way to atherogenesis in certain species, but is unlikely to be a primary 
factor. Alternatively atherogenetic regimes may induce depletion of mast 
cells. It was the need to test this possibility which led to the work repor­
ted in the next chapter.
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C H A P T E R  12
HYPERCHOLESTEROLAEMIA. CORONARY LIPIDOSIS AND THE TISSUE MAST CELL
The work described in the previous chapter (Watson, 1958) did not support 
the idea that tissue mast cell depletion promotes hyperlipaemia or atherosclero­
sis. But it did not examine the possibility that if mast cell deficiency really 
occurs in association with these states it might be secondary to them and not 
their cause. Grunbaum et al. (1957) found no difference in the mast cell count 
of the rat ear when hyperlipaemia had been produced by a diet of butter fat, 
cholesterol and thiouracil. But they did not achieve particularly high serum 
cholesterol levels nor, it seems, did they produce vascular lipid infiltration. 
Shoulders and Meng (1957) on the other hand claimed that the intra-peritoneal 
injection of fat emulsions caused disruption of mesenteric mast cells. However 
this was probably due to the non-ionic detergents present in the emulsifying 
medium and not to the fat.
This study had two main aims, firstly to determine to what extent hyper- 
cholesterolaemia.and coronary lipidosis affected the myocardial mast cell count, 
and secondly to investigate the effect of total body depletion of mast cells on 
the ability of the rat to correct an experimentally produced hyperlipaemia.
Three separate experiments were carried out and these are now described. 
EXPERIMENT I 
METHODS
Forty, 3 month, male albino rats were divided into 5 groups (K, L, M, N 
and 0) of 8 . Weight was distributed comparably in each group. The rats were 
housed separately and fed as follows.
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.ft Normal bran. Rats 1, 3 5 and 7 were killed after 8  weeks and the 
others after 1 6 .
Group L Bran, 10$ corn oil, 2% cholesterol, 2% sodium cholate, and 0.3% 
methylthiouracil for 8  weeks.
Group M Bran, 2% cholesterol, 2% sodium cholate and 0.3% methylthiouracil 
for 8  weeks.
Group N Same diet as group M, for 16 weeks.
Group 0 Same diet as group M for 8  weeks and then normal bran for a fur­
ther 8  weeks •
Water intake was unlimited, but food was restricted to 20 gms. per day.
The animals were weighed at the start and finish of the experiment. At the 
end of each dietary programme blood for cholesterol estimation was obtained by 
cardiac puncture and the animals killed with ether. The liver and kidneys were
inspected and segments taken for section. The aorta and its main branches were
dissected in situ and examined for lesions. The external surface of the heart 
was inspected for macroscopic lipid infiltration. It was then divided trans­
versely and fixed with the liver and kidney slices in 1 0  per cent formalin, 1  
per cent calcium chloride. Frozen sections of all hearts and 2 liver and kidney 
specimens from each group were stained for fat with Sudan IF. Paraffin sections 
of the other half hearts were cut at 5 /*• and stained with toluidine blue, as 
described previously. Preliminary examination of normal rat liver and kidney 
revealed that these organs were devoid of mast cells, so a systematic study for 
rat liver and kidney mast cell changes was not included.
This study required a quantitative estimate of mast cell density in myo­
cardial sections. The total mast cell count for a complete cardiac section is
Fig. 31. Intimal and medial lipid infiltration of a coronary
artery in a rat from group L. Frozen section: Sudan IV
and haemalum. x310
Fig. 32. Mast cells near a coronary artery in rat heart.
Toluidine blue. x600
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unsuitable for numerical comparison since sections from different hearts vary 
in area. The method adopted therefore was to count the number of mast cells 
in an entire transverse section of myocardium, measure the area of the section 
using a square-lined microscope graticule (Watsons Ltd.), and then calculate the 
mast cell density of the section as the number of cells per 100 squares. It 
is of course essential that the sections be of even thickness otherwise a
serious fallacy creeps into the method.
RESULTS
Wo naked eye aortic lesions were seen in any group.
All animals in group L had severe macroscopic fatty infiltration of the 
liver, mottled infiltrations of the kidneys and a small white plaque of vary­
ing size, though averaging about 2 x 2 mm., at the apex of the heart. Frozen
sections of the liver and kidney segments showed gross fatty infiltration and 
in U of the 8 hearts intimal and medial lipidosis of coronary vessels was pre­
sent (Fig. 31). No systematic serial section cutting of hearts was undertaken. 
There is a reasonable probability that coronary lipidosis was present in all 
8 hearts. Coronary lipidosis is the usual arterial lesion produced in rats by 
the short term experimental diet (Wilgram et al., 1954-)* This is no more than 
an infiltration of fat-staining material into the intima, often into the media, 
and sometimes through to the adventitia and periadventitious tissues. The 
fibrosis, ulceration and calcification of adult human atherosclerosis are not 
seen in this particular kind of experimental lesion. Figure 32 shows a cluster 
of mast cells close to a coronary artery in the heart from L 8.
Similar, but less severe degrees of fatty change were present in the rats 
of group M, and of a degree intermediate between L and M in group N. These
TABLE XXV. lata for 5 groups of rats on different dietary schedules showing (a) initial weight (Gkns)t (b) final 
weight, (o) serum eholesterol when killed (mgms and (d) mast oells per unit of area. The naat oell oount for 
each group is compared with group K and the significance values are shown alongside. C.O.. • oora oill 
C. - oholesterol; S.C. - sodium cholate; M.T. - methyl thiouracil.
Group Diet Reading 1 2 3 4 5 6 7 8 Kean
K
Bran
1>3,5»7 for 8 weeks 
2,4,6,8 for 16 weeks
a
b
c
d
275
280
95
23.7
285
310
70
25.3
280
310
61
22.0
295
350
89
20.2
295
315
91
25.2
310
335
88
27.0
275
290
74
25.9
320
360
73
17.9
292
319
80
23.4
L
Bran + 1C$ C.O. + 
2^ C + 25? S.C. + 
0.3^ k.T. for 
8 weeks
b
c
d
290
235
2340
23.4
285
240
1330
27.8
290
210
1140
15.3
300
215
1440
10.5
295
240
1200
22.7
310
275
1406
11.1
290
245
2030
26.4
320
265
1680
21.9
298
241
1571
19.9
t - 1.33
p > 0.10
M
Bran + 2$ C +
2$ S.C. + 0.3^ K.T. 
for 8 weeks
a
b
c
d
285
240
676
8.7
285
240
1080
23.9
290
240
1720
23.8
295
230
1210
26.9
290
250
773
14.9
325
265
528
27.8
315
220
176
18.7
315
250
680
23.8
300
242
855
21.1
t > 0.90 
p * 0.25
11
As H for 16 weeks a
b
c
d
280
230
811
16.9
290
245
295
230
604
11.3
295
240
1109
13.1
305
250
1006
30.6
305
250
974
21.2
310
260
978
27.3
330
270
900
15.9
301
247
912
19.5
t - 1.36 
p > 0.10
0
As K for 8 weeks 
then bran for 
8 weeks
a
b
c
d
280
300
89
22.4
285
305
59
21.6
295
300
73
28.2
295
300
95
22.4
295
300
75
21.4
305
330
61
23.0
305
310
85
22.4
320
345
46
23.7
298
311
73
23.1
t • 0.24
p * 0.25
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gradations can be explained by the different degrees and durations of hyper- 
cholesterolaemia in the 3 groups of animals.
In group 0 considerable regression of tissue changes had occurred. The 
livers were only slightly paler than normal and no lipid infiltrations were 
seen in hearts or kidneys. The liver sections showed only traces of lipid 
staining and the hearts none.
The animals1 weights, cholesterol levels and myocardial mast cell counts 
are given in Table XXV. Rat N2 died 3 days before its due time. No blood was 
obtained for cholesterol estimation and although the heart was sectioned and 
stained for mast cells, post-mortem changes had occurred and only faintly siaimng 
granular remnants were visible.
The myocardial mast cell counts for the groups L, M, N and 0 are each 
compared with group K and the significance values shown in Table XXV. The 
slight variations in the average mast cell counts for each group are ohviously 
not significantly different from group K or from one another. But it can be 
seen from a study of Table XXV that there is a bigger range between the mast 
cell counts of individual animals in groups L, M and N. The differences are 
not related to cholesterol levels or degree of weight loss (all of the animals 
on the lipogenic diet lost weight). Individual myocardial mast cell counts 
might have varied according to the extent of the conxary lipid infiltrations. 
Therefore the 23 animals in these 3 groups were divided into 2 categories, 16 
in which the coronary artery changes were slight or absent, and 7 in which they 
were severe. The mean mast cell counts for these groups are 19.0 and 22.9 
respectively (t = 1.50; p > 0.10). The difference is not significant.
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The conclusions which can be drawn from this experiment are:- 
From Groups L. M and N
1 Acute * hypercholesterolaemia and coronary lipidosis of short duration 
and of a moderate or severe degree neither increase nor decrease the con­
centration of mast cells in the myocardium. The slight difference in the mean 
count of groups M and N is not significant (p > 0.25) and provides no evidence 
that prolongation of a lipogenic regime might lower the count. No morphological 
changes were observed in the mast cells.
From Group 0
Recovery from moderately severe hyperlipaemia and minor degrees of coronary 
lipidosis, (the results of group M represent this) allowed to continue for 8 
weeks after the withdrawal of a lipogenic diet, is accompanied neither by an 
increase nor a decrease in the myocardial mast cell count. An increase might 
have occurred as part of some ’’normalising” mechanism, in which a mast cell 
lipid scavenger effect came into play; a decrease might have followed, for 
example, exhaustion of the cells through utilisation of their heparin.
EXPERIMENT II
The last experiment left a doubt as to whether a possible normalising or 
scavenger role of the mast cells had been adequately tested, or the effect 
looked for at the optimum time. The coronary lipidosis in Group M (the group 
whose serum and tissue changes probably corresponded with those of group 0 at 
the point of withdrawal of the lipogenic diet) was not gross. Again the recovery 
period of 2 months which elapsed might have been long enough to permit a transient
TABLE XXVI. Serum cholesterol and myooardial 
mast cell count of normal rats (Group P) and of 
rats at the 24th. day of spontaneous recovery 
from severe hypercholesterolaemia and coronary 
lipidosis. a = serum cholesterol after 
2 months of lipogenic diet} b ■ serum 
cholesterol when killed; c = myocardial mast 
cell count per unit of area.
Group P Group V
No. b c a b 0
1 78 20.0 1280 82 12.0
2 76 23.6 1280 95 16.4
3 76 28.3 1570 80 16.2
4 82 29.5 1310 80 28.8
5 63 21.2 2340 92 14-3
6 97 19.6 1320 80 25.4
7 71 27-4 1390 90 12.4
8 69 27-5 1710 61 16.5
9 92 17.8 1600 73 10.6
11 2270 84 25-1
Kean 78.2 23.9 1617.0 81.7 17.8
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change in the mast cells and their subsequent return to normal, A second 
experiment was therefore devised and carried out as follows,
METHODS
Twenty-two, 1 year old, male albino rats were divided into 2 groups (P 
and V) of 10 and 12. P is the control group referred to in Chapter 8 and in 
the experiment described after this • One of the rats in group P died during 
the experiment. Group P was given normal bran throughout. Group V was given 
bran supplemented with 10% corn oil, 2% cholesterol, 2% sodium cholate and 
0*3% methyl thiouracil, for 8 weeks. At the end of this time blood was with­
drawn by cardiac puncture, under ether anaesthesia, for serum cholesterol 
estimations, and all animals allowed to recover. The 2 rats with the lowest 
cholesterol levels (910 and 1030 per cent) were killed and their hearts, livers 
and kidneys examined macroscopically and microscopically as described in Experi­
ment I. Both had gross lipid infiltrations of these organs. Fig. 33 shows 
sections stained for fat from heart, liver and kidney of one of them.
The remaining 10 rats, whose average serum cholesterol level at this point 
was 1617.0 mg. per cent, were returned to normal feeding for a further 2U days 
at which time blood was again withdrawn and the animals killed while still 
anaesthetised. The organs were inspected and sectioned as already described.
RESULTS
The serum cholesterol and myocardial mast cell counts for the two groups 
are given in Table XXVI. It can be seen that a remarkable drop in the choles­
terol levels of group V has occurred in this short time (from 1617.0 to 81.7 mg^: 
normal average 78*2 mg ../&)• However although the serum lipids had returned to
Fig. 33. Frozen sections of (a) heart, (b) liver and (c) kidney
from rat VI2 to show the degree of fatty infiltration after 
8 weeks on a lipogenic diet. Serum cholesterol 1030 mg. 
per cent. Fat is present in coronary intima and media, in 
liver cells and renal glomerular tufts and arterioles.
Sudan IV and haemalum. (Heart and kidney x220; liver x600)
normal levels the tissue lipids had not. (Fig. 3 4 ). The liver was still 
pale, but showing the red mottling of lipid losing areas, and in hearts and 
kidneys microscopic lipid deposits were present to a considerable degree.
The animal at the time of death was thus still in the phase of recoveiy from 
the dietetically induced organ lipidosis.
The average myocardial mast cell concentration at this point of recovery 
was 17.8 cells/unit area. This may be significantly less than the average mast 
cell concentration of the control group which was 23.9/unit area, (t = 2.32; 
0.05>P>0.02) but is not a convincing reduction. Nevertheless when one 
examines the mast cell figures for all groups of this and the previous experi­
ment the mean figures for the two normal groups (K and P) come very close to 
each other, (23.4- and 23.9, respectively) while the mean figures for the 5 
groups which have been exposed to some degree of tissue lipid infiltration are 
to a greater or lesser degree below these values. If the figures for the two 
experiments are considered together the mean mast cell tissue concentration 
for the 17 animals of the 2 normal groups K and P is 23.7 per unit area and that 
for the 41 animals of groups L, M, N, and 0 and V is 20.1 per unit area. Their 
mean difference of 3.6 is again in the marginal area of significance (t = 2.36 
0.05 >p >0.02). The balance of probability, however, considering the indiv­
idual group statistics of Experiment I and the apparent lack of correlation 
between mast cell counts and degree of vascular change in individual animals 
seems to be against any significant involvement of the tissue mast cell in the 
deposition or clearing of tissue lipid. Any claim that the greater lipid infil­
tration of liver and kidney reflects a vulnerability to lipid, due to the absence
m *.
+ * L  »*
Fig. 34. Frozen sections of (a) heart, (b) liver and (c) kidney
from rat Vll showing persistence of lipid in these tissues 
24 days after the lipogenic diet had been withdrawn. The 
lipidosis in liver and kidney is much less than in V12.
Sudan IV and haemalum. (Heart and kidney x220; liver x600)
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of mast cells, would be a superficial interpretation of the facts. For these 
organs by virtue of their stucture, vascularity and functions are at greater 
risk than the myocardium.
The third and final experiment now described seems to show clearly that, 
so far as relatively acute changes in the rat are concerned, the tissue mast 
cell is not involved in tissue and blood lipid derangements*
EXPERIMENT III
Recovery from a hyperlipaemic state might occur without a demonstrable 
change in the number of mast cells, the cells participating in this recovery 
as a normal function and without such a degree of functional stress as would 
affect their concentration in the tissues. On the other hand if the mast cell 
does assist in the recovery their absence might retard it, because of impaired 
mobilisation of tissue lipid and perhaps also because of impaired transport 
for excretion.
METHODS
The rats of Group P, as mentioned previously, acted as the control group 
for this experiment. Another 20 animals from the same batch, of the same age 
and of comparable weight, were divided into 2 groups (Q and R) of 10 each.
One animal in group R died before the experiment was completed. Both groups 
were given a diet consisting of normal bran containing 2% cholesterol, 2% 
sodium cholate and 0.3$ methylthiouracil for 8 weeks. The ration was 20 gms. 
per day and water intake was unlimited* A similar diet for a similar period 
had produced a mean cholesterol level of 855 mg.$ in a younger group of rats 
(group M, Experiment I) and it seemed reasonable to expect a comparable increase.
TABLE XXVII. Serum cholesterol levels of 
normal rats (Group P), lipaemic rats after 
spontaneous recovery (Group Q) and lipaemic rats 
after 24 days of compound 48/80.
Cholesterol (mg £)
Bo. P Q . R
1 78 74 65
2 76 71 87
3 76 93 76
4 82 83 77
5 63 66 94
6 97 64 73.
7 71 55 79
8 69 78 79
9 92 57 60
10 - 80 -
Mean 78.2 72.1 78.9
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This expectation is largely confirmed by the rise to a mean level of 1501 mg.$ 
for the 12 animals in group V whose diets contained 10$ corn oil in addition.
After 8 weeks of special diet both groups (Q and R) were returned to 
normal feeding. At this point of transition intraperitoneal injections of com­
pound 48/80 were started in group R, the dose increasing from an initial dose of 
0.1 mg. to 1 mg. over a period of 8 days. The animals showed the usual effects, 
(see previous chapter) but none succumbed. No intermediate histological studies 
were carried out to observe the progress of mast cell disruption. By this time 
sufficient experience of the method had been obtained to permit confidence in 
its effects. The injections were given on 6 days of each week.
Twenty eight days after the return to normal diet both groups of animals 
were bled and killed, the main organs inspected and sectioned as described 
earlier, and mesenteric spreads prepared from some of the animals in group R 
to confirm that the expected mast cell change had occurred.
RESULTS
It can be seen from Table XXVII that there is no significant difference 
between the cholesterol levels of the 3 groups of rats. Total tissue mast cell 
depletion has not prevented, although of course it may have delayed by a few 
days, the return to normal from high cholesterol levels. There was no differ­
ence in the degree of coronary lipidosis in the hearts of the group Q and R 
animals. In both groups it was either negligible or absent. The naked eye 
appearance of liver in both groups was comparable and microscopically there 
were equivalent degrees of fatty cellular infiltration.
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It does not seem that the tissue mast cell is essential either for the 
mobilisation of tissue lipids or their excretion from the blood.
GENERAL DISCUSSION
This work does not advance the idea that the tissue mast cell may be invol­
ved in atherosclerosis. It does not completely rebut it, for the lipid changes 
produced in the foregoing experiments come critically short of atherosclerosis 
as opposed to the mere infiltration of fat into vascular tissue, the earliest 
stage in the development of the atheromatous plaque. It seems clear nevertheless 
that this initial stage can occur in the presence of normal concentrations of 
mast cells and without causing their disappearance, depletion or morphological 
derangement. Any mast cell disturbance which occurs later than this may be no 
more than the normal response to tissue reaction.
Poliak, (1957) in a careful and detailed study of mast cell incidence and 
distribution in the normal and diseased human vascular tree, was unable to 
correlate clinical and autopsy data with aortic mast cell counts• Without quo­
ting figures, however, he gives it as his impression that the incidence of peri- 
adventitial mast cells around atheromatous coronary arteries is higher than 
around normal vessels. The closing sentence of his account comes as a surpris­
ing non-sequitur in an otherwise conservative and balanced discussion. He 
writes ,fThe presence of mast cells in oedematous tissues and their absence in 
atheromatous plaques possibly implicate these cells as participants in atheroge- 
nesis’*.
The ultimate experimental answer to this problem may be found in a long 
termsbudy where there is time for coronary atherosclerosis, with fibrosis or 
calcification, to develop. But there are some drawbacks to this, for on diets
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like that used here, the animals go out of condition, lose weight and have 
chronic diarrhoea. In addition the thiouracil in the diet must cause profound 
changes in the animal’s normal metabolism. After only 2 months of the diet 
the rat thyroid is greatly hypertrophied.
Because mast cells contain heparin and because in unphysiological doses 
heparin modifies lipoprotein structure there is the temptation to incriminate 
them in a tissue lipid defect. The mast cell presumably has some role in 
tissue metabolism and this, among other things, may include lipid regulation 
or utilisation, but on the basis of the experimental evidence produced here, the 
verdict for or against such a function seems to be not proven.
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C H A P T E R  13
SERUM LIPOPROTEINS AND ELECTROCARDIOGRAPHIC CHANGES AFTER PARTIAL GASTRECTOMY'
Following partial gastrectomy of the Polya type many patients lose weight 
and most are below their expected weight (Anderson et al. 1955). This is 
probably due to a low caloric intake and post-gastrectomy symptoms, but imp­
aired digestion and absorption of fat may be a contributory factor. Recent 
work in gastrectomy patients using I31i labelled fats has shown increased fat 
excretion and diminished absorption after fatty meals, and that fat loss is 
greater after the Polya operation than after the Billroth I (Everson, 1954; 
Shingleton et al., 1957). Bearing in mind the possible relationship between 
dietary fat, serum lipids and myocardial ischaemia which was discussed in the 
introductory chapter, this impaired fat absorption might be reflected in a 
lower incidence of coronary artery disease and a corresponding alteration in 
the serum lipoproteins of gastrectomy patients.
This study was carried out in association with Mr. J. K. Watt and Dr.
R. S. Walker who together were responsible for the organisation of the experi­
mental routine and selection of patients.
MATERIAL
Of 53 patients who had undergone the Polya type of partial gastrectomy 
40 were traced and examined. All were males between 45 and 65 years who had 
been operated on because of severe duodenal ulcer symptoms. The mean lapse 
of time from operation to interview was 9 years 10 months (range: 7 years 1 
month to 13 years 4 months). At the same time 40 men in the same age group
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with long-standing symptoms of duodenal ulcer (mean duration 17 years) were 
studied; 15 of these patients had suffered major complications such as per­
foration and haemorrhage. As a "normal’' control group 4 0  males, admitted for 
operative treatment of minor surgical conditions and without ulcer or cardiac 
symptoms were examined. In the latter two groups the last 5 or 6 patients were 
selected on an age basis to ensure that the mean ages of each group were closely 
related (Table XXVIII).
METHODS
A clinical history and examination of each patient were undertaken; 
height, weight, pulse rate and blood pressure were recorded and a sample of 
venous blood withdrawn for haemoglobin and lipoprotein estimations. Electro­
cardiography was performed using a direct writer (Mingograph) before and after 
Master's double two step test (Master, 1950). The amount of exercise in this 
test is graduated according to the patient’s weight and age. One man with a 
previous myocardial infarction was not exercised, in two others the exercise 
was discontinued because of angina and in a third because of dyspnoea; all 
others completed the test. To facilitate rapid recording after exercise only 
nine leads were used; the 3 standard leads, aVR, aVL, aVF, V2, V4 and V6. The 
records were studied independently by two of us without reference to the pati­
ent's group, and the findings compared. A further independent opinion was 
obtained where a difference in interpretation occurred.
It is difficult to apply rigid standards to the interpretation of electro­
cardiograms but the following criteria of ischaemia were adopted as a guide: ST
TABLE XXVIII. Gunjnary of clinical, E.C.G. and biochemical data contained in Appendix III. 
There are 40 subjects in each sroup.
Group
Kean
age
(Yrs.)
Kean 
Hb 0
Kean
weight
(lbs.)
Ho. with E.C.G. 
or clinical 
ischaemia
Kean
beta:alpha
ratio
Ko. with
prebeta
Lipoprotein
Polya 53.2 88.2 132 11 1.59 14
Gastreotomy
Range 45 - 65 59-103 103-183 0.56-3.95
Control 53.6 96.7 154 15 1.70 19
Range 46- 64 77-118 114-208 0.82-2.83
Uloer 53.5 97.7 147 21 1-73 24
Range 47- 64 80-112 110-202 0.59-5.02
o-:.''-' . zooi.dzzdd^e rod:odoz-' d : d ^ : - .7 ; (dzdro/zor. ■ -lod r r z " jd rd ; ) n o . rr' -
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depression of 1 mm. or more where the increase in pulse rate did not exceed 
20/min. and of 1*5 mm. or more where it didj flat or inverted T waves in 
appropriate leads j and multiple extrasystoles. All other abnormalities were 
noted and care was taken to distinguish changes due to tachycardia alone, 
namely a low RS-T junction with upward sloping ST segment. The distinction 
between the lateral ischaemia of coronary artery disease and that of left 
ventricular strain is taken into account in the analysis of the results.
The betaialpha and pre-beta:beta lipoprotein ratios were estimated as 
described in Chapter 2.
RESULTS
The individual results are listed in Appendix III and a summary of the 
principal findings is presented in Table XXVIII. Only blood pressures greater 
than 139/89 are recorded.
The present account of this study differs from the published version 
(Walker et al., 1958) in 2 respects. Firstly a different convention was used 
for measuring the beta-lipoprotein area, so that it included the neutral fat 
band. This gave higher values for the beta:alpha ratio than the standard method 
'adopted for this thesis. Secondly in assessing the incidence of myocardial 
ischaemia in each of the experimental groups, I have included symptoms as well as 
E.C.G. findings. Thus one man in the gastrectomy group (No. U2) who had a 
normal exercise electrocardiogram complained of chest discomfort during the 
test, while another (No. 53) with a normal E.C. G. and no test symptoms gave 
a history of exertional dyspnoea and occasional effort angina. On this basis
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of assessment the former interpretation of the experimental findings requires 
modification. This revised view of the significance of the study, which I 
believe is more likely to be the correct one, is presented here.
The incidence of myocardial ischaemia in the gastrectomy group (11 cases) 
is less than in the control group (15 cases), but the difference is not sig­
nificant ("X ^ = 0.91; P y  0.10). Likewise there is no significance in the 
difference between the ulcer patients with ischaemia (21 cases) and the cont­
rols. ( X  2 = 2.59; P >  0.10). But the difference between the ulcer and 
gastrectomy patients is greater than either of these and may have a degree of 
significance ( X 2 = 5.21; 0.05>P > 0.02). However it is clear that no claim
can be made that the cardiac status of any one of these 3 groups is fundamen­
tally better than another. Nevertheless there is an interesting trend in the 
figures which a larger and more detailed study might confirm.
Lipoproteins
The lipoproteins are more directly involved in alterations in fat metabo­
lism and one might have expected greater differences between the groups in res­
pect of their lipoproteins. This aspect of the problem is examined briefly in 
the following paragraphs.
Lipoproteins of the Clinical Groups
The beta:alpha lipoprotein ratio of the gastrectomy group was 1.59, and 
pre-beta lipoprotein was present in 14 cases. The corresponding figures for 
the control group were 1.70 and 19, and for the ulcer group 1.73 and 24. Again
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TABLE XXIX. Lipoprotein data of 120 subjects grouped according 
to weight.
Standard weight 
-15 lb3.or more
Standard weight 
± 14 lbs.
Standard weight 
+15 lbs.or more
No. in group 52 58 10
Average
betaralpha 1.56 1.69 2.08
ratio
Ko.with
prebeta 19 30 8
lipoprotein (36.6f) (5i.e£) (80.0?-)
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there is no definite significance between any pair of figures (e.g. comparing 
ulcer and gastrectomy beta:alpha ratios t = 0.95 and P > 0.10) but the trend 
of the values follows the incidence of group ischaemia. However the subsequent
alignments of the figures show that in certain specific respects this similar­
ity of trends breaks down.
Lipoproteins and Ischaemia:
The lipoproteins were next examined with reference to the individual 
occurrence of ischaemia. The figures can be broken down as follows:
a) Average beta:alpha ratio of 47 ischaemic patients = 1.63
Average beta:alpha ratio of 73 non-ischaemic patients = 1.69
b) Of the 47 ischaemic cases 27 had a pre-beta lipoprotein band and 20 had 
none.
c) Of 57 patients with a pre-beta lipoprotein band 27 had evidence of myocar­
dial ischaemia and 3 0  had none.
It is obvious from these figures that no correlation can be established 
between either the beta:alpha or pre-beta:beta lipoprotein ratios, and the 
presence or absence of myocardial ischaemia.
Lipoproteins and Weight:
The 120 patients were divided into 3 groups; those whose weights were 15 
lbs. or more below their expected weight (group I), those whose weights were 
15 lbs. or more above their expected weight (group III) and those between (group 
II). The results are shown in Table XXIX. The average beta:alpha lipoprotein 
ratios of the groups in ascending order of weight is 1.56, 1.69 and 2.08 while 
the incidence of the occurrence of pre-beta bands is 3 6 .6 , 5L8  and 80.0 per cent
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respectively. Unfortunately group III is rather small for statistical compari­
son with the other groups, but the figures do suggest that these two lipopro­
tein parameters are related to an individuals over or under weightness. As 
a matter of interest, statistical comparison between the incidence of pre-beta 
lipoprotein in the under and overweight groups gives these values: ‘X.-6.08 
p C0.02. Examination of weight with reference to the distribution of ischae­
mia among the groups showed no ostensible correlation.
None of the other aspects investigated showed any significant difference 
between the groups, apart from the lower average haemoglobin level of the gas­
trectomy patients (88.2 per cent). This is actually an adverse factor which 
would tend to increase the number of positive electrocardiograms in this group.
DISCUSSION
The incidence of abnormal electrocardiograms in this study seems to be 
unduly high, and one wonders if the criteria of abnormality are stringent enough. 
Certainly Master et al. (1942) found no significant changes in the electrocar­
diogram following the double two-step test in 3 4  normal subjects of unspecified 
age. Against this, Riseman et al. (1940) employing criteria of abnormality 
more severe than Master's and comparable to those used here, found significant 
changes in 10 of 15 normal patients whose ages ranged from 25 to 73 years. In 
a review of the literature they draw attention to the divergent findings of a 
number of authors. Such differences cannot be reconciled. The results reported 
here were obtained from a standard test consistently applied to each of the 
clinical groups. But it is true that the reporting of electrocardiograms is
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more of an art- than a science and rigid mathematical standards are probably 
misleading m  the realm of marginal alterations. Certainly on having a second 
look at the electrocardiograms of this study there are some which in spite of 
significant metrical alterations I would be less inclined to regard as abnormal.
Although there are no lipoprotein changes which seem to be characteristic 
of the clinical groups, an analysis of the lipoproteins in other respects 
suggests that both the beta:alpha lipoprotein ratio and the incidence of the 
pre-beta band bear some relation to weight, not absolute weight, but to the 
degree of over or underweight ness, of the individual patient. It will be rem­
embered that higher lipoprotein ratios and a greater incidence of pre-beta lipo­
protein occurred in pregnant women whose weight gain was regarded as abnormally 
high.
No relationship has been demonstrated between the lipoprotein parameters 
and myocardial ischaemia. But for the reasons given above this should not be 
regarded as contradicting the work of Besterman (1957, 1958) who in his analysis 
of lipoproteins is dealing with patients with gross coronary artery disease.
Finally although there is no statistical proof of the fact it seems possi­
ble that lower lipoprotein values occur in patients who are underweight and higher 
values in those who are overweight. Whether this is due to a specific dietary 
factor such as fat absorption, or a non specific factor such as total calorie 
intake, cannot be determined from this study. But it is an observation which 
tends to confirm that weight reduction is a valuable contribution to the control 
of blood lipids•
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C H A P T E R  1 4  
GENERAL CONCLUSIONS
1 * There is good evidence that the blood lipids are implicated in athero­
sclerosis, probably implicated in thrombosis and are perhaps concerned with 
impaired fibrinolysis. It is generally agreed that some kind of lipid modi­
fication might advance the therapy of atherosclerosis and its clinical seque­
lae. The main lipid derangements usually, but not always, found in affected 
subjects are a raised total serum cholesterol; an increase in the low density 
lipoproteins, especially pre-beta lipoprotein; an elevated cholesterol5 phos­
pholipid ratio; and delayed clearing of post-prandial lipaemia.
2. The lipid parameter most frequently used as an index of therapeutic 
effectiveness is the total serum cholesterol level. An understanding of the 
metabolism and synthesis of cholesterol, and some knowledge of physiological 
and ethnic variations, suggest possible methods of control.
3. Experimental hypercholesterolaemia in the chicken and rat is associated 
with the formation of an unusual alpha 2-lipoprotein. In rat serum this lipo­
protein, which carries almost all of the extra cholesterol, is deficient in 
protein and is highly unstable in vitro. Comparable in vivo instability would 
partly account for the speed with which tissue lipidosis develops. The sub­
stances most necessary for the surface stability of lipoproteins are protein 
and phospholipid.
4. When a rise or fall in the cholesterol level is the primary change in 
human blood lipids it is usually accompanied by a rise or fall in the beta:
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alpha lipoprotein ratio. This is because beta lipoprotein seems to be the 
main carrier—receptor for the "tidal11 cholesterol of human serum. But when 
the serum lipid changes are complex, as when hypocholesterolaemia is achieved 
by the ingestion of fatty acids or accompanied by changes in serum phospholipid, 
the lipoprotein response is not simply or directly related to cholesterol 
change.
5. Pre-beta lipoprotein is found almost invariably in patients who have had 
a myocardial infarction, but it is also found in clinically normal individuals 
and in primi g ravidae. It increases relative to beta lipoprotein in subjects 
receiving corn oil for long periods. This may indicate some change in the 
esterification of the cholesterol contained in this lipoprotein complex.
Other explanations are of course possible.
6 . Oestrogens affect the serum cholesterol in different ways in different 
species. One consistent effect seems to be an increase in circulating phos­
pholipid relative to cholesterol. This may stabilise the hypercholesterol- 
aemic lipoprotein complex and so diminish its pathogenicity. Although oestro­
gens are effective as long term hypocholesterolaemic agents in adult males 
there is no evidence yet of clinical benefit, and frequently side effects are 
troublesome•
7. Thyroid extract and a number of thyroid analogues are powerful hypochol­
esterolaemic agents, but none has yet been found which is devoid of hypermeta— 
bolic tissue effects. This vitiates their use in patients with myocardial 
ischaemia. It may be that the hypocholesterolaemic and hypermetabolic effects 
of thyroid compounds reside in a common molecular group and are indivisible.
-  H3 -
But it is nevertheless clear that a dissociation of the degree of activity 
of these separate functions can be achieved by molecular alterations.
S. Certain marine and vegetable oils are effective hypocholesterolaemic
substances, both in man and in the experimental animal. Their degree of 
unsaturation is related to their effectiveness in this respect. There may be 
a non-lipid factor (l: 2 -dienolglucose or something else) which augments the 
effect. Extracted maize germ is a potent hypercholesterolaemic agent in chick­
ens • This suggests an important interplay of cholesterol promoting and inhibi­
ting factors in this particular food raw material.
9* The hypocholesterolaemic effect of these oils enhances, or is enhanced by,
the cholesterol reducing effect of a low animal fat diet. Such a diet, supple­
mented by 2  ozs. of corn oil per day is acceptable as a long term dietary mode 
and approaches the dietary pattern of certain racial groups or societies in 
whom atherosclerotic vascular disease is unusual and serum cholesterol levels 
are low or normal, compared with British and American figures. Such a regime 
is available to all, is free of the risks which limit the usefulness of anti­
coagulants and requires no laboratory control. However no assessment has yet 
been made of its clinical success.
Corn oil consumed without restriction of dietary animal fat will usually 
produce hypercholesterolaemia. If large enough quantities are taken patients 
will gain weight and myocardial ischaemia or strain will be aggravated.
0* Heparin is a powerful anti—lipaemic substance, but does not lower the
serum cholesterol. Any merit which heparin may have in the treatment of angina 
is unlikely to be due to the effect of its anti-lipaemic action on blood visoosity.
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For post-—prandial lipaemia does not increase blood visoosity, and may actually 
reduce it, and although blood viscosity is further reduced by the intravenous 
injection of heparin during the lipaemic state, the effect is so slight as to 
be clinically insignificant* Heparin, 50 mg. I.V. has no effect on the blood 
viscosity of fasting subjects.
1 1 . Tissue mast cells are an important source of heparin. There is some 
evidence in the literature that their concentration in human perivascular tissue 
is low in the presence of atherosclerosis. But on the basis of experimental 
work reported here there is no evidence that they are affected by, or that their 
absence predisposes vascular tissue to, the early stages of lipid infiltration. 
Also the clearing of arterial lipidosis is not delayed by total body depletion 
of mast cells •
12. The serum cholesterol level and betasalpha lipoprotein ratio bear some
relationship to weight, tending to be lower in underweight subjects and higher 
in those who are overweight. The maintenance of ideal weight is probably an 
important contribution towards the control of blood lipids•
13. The ultimate value of attempts to correct the lipid derangements associ­
ated with atherosclerosis depends on the capacity of affected tissues to recover 
from the lesions. This will of course depend on the severity of the individual 
lesion. Calcified atheromatous plaques are probably too resistant to normali­
sing processes. But with less severe degrees of arterial damage there is con­
vincing evidence that regression of lesions does occur in the experimental .animal. 
There is only indirect evidence that similar changes occur in humans.
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14-• Because of the difficulty which is likely to be experienced in persua­
ding a nation to alter its eating habits it is a matter of urgency that an 
effective cheap, palatable and non-toxic agent for the control of blood 
lipids be discovered. A dietary principle or food factor is the substance 
most likely to satisfy these requirements.
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APPENDIX I I .  MONTHLY BETAiALPHA LIPOPBOTEIN HATIOS OP 42 BOHMAL PR1MIGRAVIDAE 
AND THE BABIES' BIRTH WEIGHTS ( in  pounds and ounces)
P atie n t
No.
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33-36
Weeks
37-38
Week
39
Labour Post-natal 
5-7 days
P ost-nata l 
5-7 Weeks
Babies' 
weights 
Lbs. Ozs.
46 2.00 2.31 1.40 1-56 1.47 8 5
11 " T -<r
17 1.50 1.80 2.20 1.77 £> 5
2 1.25 1.33 2.40 1.49 1.55 8 14
$ 2.38 2.70 2.87 1.94 1.77 1.20 7 11
28 1.87 2.08 1.93 2.10 1 .15 7 1
29 1.73 1 .85 1.32 2.39 1 .50 6 11
33 I .64 1.52 2.42 2.48 2.35 2 .28 6 7
1 2.35 2.62 2.27 I .64 2.21 3 4
5 1.29 1 .45 1.32 6 4
16 1.45 1.45 1.85 1.56 1.37 7 9
25 1.38 1.82 1.40 1.14 1.93 1.50 i . 4 1 6 14
34 1.35 1.41 1.56 1.53 1.10 0 .94 7 6
35 l.l8 1.54 2.16 1-93 1 .94 1.98 6 1
40 I .08 1.73 2.lS 1.88 1.77 1.32 7 9
8 I .64 1.76 I .87 1.85 2.02 1.76 6 11
26 2.29 2.75 2.82 1.92 1.59 7 10
42 2.03 1.80 2.38 1.87 1 .80 1.95 1.32 8 13
47 1.39 0.90 1.30 1.41 1 .34 1.36 1.27 5 12
8 1 .14 O.85 1.25 1 .04 1.15 0.97 1.10 0 .80 7 11
12 1.40 l . l 8 1.31 1.31 1.68 1 .34 1.32 7 6
14 1.20 1.38 I .83 2 .14 2.50 1.84 1.80 2.16 8 0
21 0.93 1.37 1.28 1.22 0.98 1.03 1.29 1.08 7 8
30 1.84 1.27 1.98 1.65 2.18 1.52 2.36 1.26 1.93 8 3
32 1.56 1.37 2.30 2 .14 1.31 1 .44 1 .44 8 1
39 1.11 1.43 1.09 1.28 1.03 7 12
50 1.48 1.34 1.63 1.50 1-57 1.62 1.39 1.76 1.65 5 15
52 0.89 1.35 2.06 2.12 2.00 2.56 2.24 1.96 7 3
53 1.08 0.97 0.79 0 .90 1.10 1.31 1.36 1 .54 1.50 7 9
54 0.79 0.77 1.05 1.45 1.25 1.22 1.14 1.05 6 15
7 1.02 1.03 1.44 1.31 1.30 1.28 1.60 1.83 1.75 2.24 0.95 8 2
15 1.30 1.23 1.72 1.92 1.60 1.52 1.50 1.66 1.28 7 0...
0.62 0.66 1.27 I .18 1.82 1.00 1.17 0.98 1.30 7 0
19 1.20 1.45 0.78 1.26 2.00 2.06 1.30 1.96 1.72 1.00 7 4
31 1.14 1.26 l . l 8 1.90 1.98 2.11 2.30 1.40 1.18 7 12
36 1.06 1.19 1.05 1.00 1.75 1.85 1.12 1.36 1.15 1.23 8 7
37 0.95 1.24 1.12 1.13 1.08 1.16 1.24 1.00 8 15
38 1.11 1.19 2.01 1.8l 1.54 1.75 1.84 1.45 0.97 1.31 6 14
43 0.95 0.93 1.28 1.68 1.72 1.15 1.28 1.44 2.00 1.32 0.78 8 7
44 1.6o 1.47 1.13 ■ l.w 1.55 1.52 1.75 1.39 1.50 1.46 7 14
4 8 '" 1.10 1.28 1.25 ’ 1.18 1.85 1.21 1.60 1.58 1.28 1 .88 1.54 8 4
51 0 .75 0.91 1.03 0.94 1.01 1.00 1.39 1.08 6 10
Uean 1.14 1.20 1.26 1.44 1.62 1.72 1.85 1.43 1.70 1.59 1.37
APPEHDIX ni. ULCEa GBOUP
Case . Age Hb. B.P.
Exp.
wt.
(lbs',
Wt.
(lbs')
Beta/
alpha
Prebeta/
beta E.C.G.
1 51 103 139 128 1.73 0.14 -
2 49 85 I64 171 1.60 -
3 54 88 140 119 0.94 -
4 55 100 200/100 157 130 1.84 0.15 Lat.ischaemia or left vent.strain Pulmonary T.B. 
1948-55
5 47 94 146 136 0.79 -
6 48 101 155 157 O.71 Posterior ischaemia after exercise
7 51 101 174 166 1.38 0.10 - Tinge of cyanosis 
Exertional dyspnoea
8 61 98 162 157 1.20 0.12 Lat.ischaemia after exercise
9 55 97 140 142 0.91 0.10 Post.ischaemia after exercise
10 62 98 140/95 172 175 1.06 0.12 -
11 58 80 149 112 I.85 0.14 Praecordial pain 
1 mth.before test
17 47 112 155 117 1.32 0.14 Post.ischaemia after exercise taild anrina
21 50 94 165 176 2.43 0.10 -
23 53 100 144 110 0.96 Post.ischaemia after exercise .Exertional dyspnoea
24 58 91 160/120 157 146 1.52 0.16 Left vent.strain and/or ant.lat. 
ischaemia
25 56 100 140 138 2.88 0.24 Ant.ischaemia after exercise
26 56 90 200/100 181 142 1.42 0.13 Post.ischaemia after exercise I)y3pnoea and oedema 
Apex beat displaced 
to left
27 58 96 153 118 0.59 -
28 63 91 180/110 167 169 2.50 0.19 Left B.B.3. Antero-lateral 
ischaemia after exercise
29 49 100 147 132 1.24 -
37 64 106 140 150 1-55 0.09 Lateral ischaemia after exercise Test abandoned because 
of dyspnoea
38 52 100 170 178 1.17 Post.ischaemia after exercise
39 58 97 153 144 1.61 -
40 55 100 210/120 140 135 1.27 Post.ischaemia after exercise Cardiac enlargement 
Exertional dyspnoea
54 53 115 170/95 161 189 5.02 0.17 Lat.ischaemia after exercise
55 56 97 181 158 2.12 0.10 Post.lat.ischaemia after exercise
56 47 103 168 202 2.95 0.14 -
57 54 97 140 155 I.87 0.12 Healed posterior myocard.infarction Myocardial infarction
in 1949 & 1957- 
Not exercised
59 54 97 140 141 2.59 -
65 63 112 162 189 2.63 0.10 -
~ S S ~ 54 97 166 156 1.60 0.07 -
87 51 97 156 166 1.04
69 52 100 160/95 152 152 I.87 0.12 -
75 52 100 152 126 2.01 0.16 Post.lat.ischaemia after exercise
104 48 100 159 154 1.10 -
105 51 91 155/90 144 130 4.25 0.09 -
106 47 ■ m  ' 163 168 I.38 Post.ischaemia after exercise
107 52 97 160/80 149 128 1.78 Post.ischaemia after exercise
108 49 97 143 130 1.13 -
151 47 97 150/100 138 122 1.59 0.09 Post.ischaemia after exercise
Av. 53.5 97.7 147.5 1.73
APPEHDIX III. GASTRECTOMY GROUP
Case Age Hb. B.P.
Exp, 
wt . 
(lbs)
wt.
(lbs)
Beta/
alpha
Prebeta/
beta E.C.G. Remarks
12 56 91 157 114 I.65 -
13 53 85 144 123 1.43 “
14 51 91 170 I64 1.13 -
15 45 32 158 133 1.12 -
16 47 100 145/100 173 140 2.46 0.11 -
18 58 97 149 123 1-35 0.10 Occasional vent.extrasystoles Exertional.dyspnoea. Slight 
ankle swelling.
19 56 94 140/90 140 138 1.35 0.11
20 49 97 139 128 1.72 0.11
22' 53 88 166 126 1.16 Post.Ischaemia after exercise
30 51 77 150/100 139 134 1.59 0.11 -
31 58 91 153 128 1.26 -
32 52 91 165 130 1.14 " Slight exertional dyspnoea.
33 51 M 170 151 3.16 0.08 “
34 49 63 155 142 1.28 0.16 -
35 64 79 160/85 145 118 1.36 Vent.ertrasystoles.
36 49 91 155 121 I.07 “
41 55 103 153 110 1.0° Vent.extrasystoles after exercise.
42 54 85 160/90 140 118 1.09 tformal. Angina during test.
43 50 77 160 142 1.32 0.19 -
44 52 68 149 136 0.56
45 56 94 176 161 1.78 Post.ischaemia after exercise.
46 48 94 138 102 2.10 -
47 51 80 M C
D CD 165 1.04 Post.ischaemia after exercise.
43 52 59 156 130 0.92 “
49 50 85 148 126 2.02 ? Low volt, of emphysema. Exertional dyspnoea. Slight 
ankle swelling.
50 63 97 162 138 2.64 0.23
51 62 94 140 111 1.11 “
52 49 91 183 152 1.37 -
53 50 94 139 122 1.62 0.23 "
Exertional dyspnoea. 
Occasional angina.
60 46 91 154 136 3.95 0.17 “
61 47 103 159 154 2.52
62 45 88 150/90 162 138 1.60 ”
63 65 W 149 103 1.44 “
64 48 91 180/120 155 142 1.17 Frequent V.S.3.after exercise. Angina during test.
"68 ' 50 97 139 ll6 2.36 0.13 “ Exertional dyspnoea.
70 49 85 139 130 0.94 Effort angina.
96 63 94 157 133 1.50
97 65 91 162 168 1.8T 0.17 Post.lat.ischaemia after exercise.
98 57 100 157 108 1.80 "
99 57 91 149 122 1.34 0.13 Exertional dyspnoea.
Av. 53.2 88.2" 132 1.59
APPENDIX III. CONTROL GBOUP
Case Age Hb. B.P.
Exp.
wt.
(lbs)
Wt.
(lbs)
Beta/
alpha
Prebeta/
beta E.C.G. Remarks
71 54 100 140/90 171 I65 1.12 0.10 Postero-lat.ischaemia after exercise Patients in this
72 53 77 160/100 171 168 2.23 0.11 - group were
73 61 115 140/100 162 l'6'6 2.3"6 0.15 - selected because
74 52 97 140/100 149 172 1.37 0.11 Postero-lat.ischaemia after exercise they had no
76 52 100 156 160 1.00 - symptoms
77 64 91 170/125 176 160 1.68 0.10 attributable to
78 56 85 153 156 1.92 0.17 cardi ovas cular
80 52 97 156 140 2.82 0.13 disease.
81 53 94 171 172 1.82 0.18
82 60 77 145 127 1.46 Posterior ischaemia after exercise
S'3 80 82 145/90 145 114 1.26 Postero-lat.ischaemia after exercise
84 48 106 143 170 1.35 0.08 Anterior ischaemia and/or left vent, 
strain
85 52 94 175 160 1.27 Post.ischaemia after exercise
86 47 94 150 168 1.95 0.15 Postero-lat.ischaemia after exercise
87 59 97 153 I65 1.52 “
88 56 99 153 135 1.33
89 56 94 176 140 0.97
90 47 103 150 161 1.93 0.12 Posterior ischaemia after exercise
94 57 109 150/90 162 176 2.70 0.13
95 56 97 166 151 2.46 -
100 53 91 161 144 2.42 0.15 Posterior ischaemia after exercise
101 60 91 176 171 1.46 0.14 Fosterior ischaemia after exercise
102 47 88 146 138 0.93
109 60 91 160/90 149 162 1.26 -
110 50 91 180/130 156 l6l 2.08 -
111 48 103 140/90 143 138 1.49 Postero-lateral ischaemia after 
exercise
112 57 88 167 178 1.99 0.17
113 55 106 150/90 176 180 O .82 Right ventricular strain pattern
114 47 91 138 138 1.96 0.13 Posterior ischaemia after exercise
115 46 97 146 140 1.58 Posterior ischaemia after exercise
116 52 97 152 115 0.90
117 59 97 190/90 145 ll6 1.02 Left ventricular strain pattern
118 49 80 150/80 155 146 1.58
119 51 94 139 136 2.28 -
120 49 112 260/145 160 208 2.17 0.11 -
121 57 100 153 149 1.21 0.09
122 53 106 144 140 2.83 0.10 Posterior ischaemia after exercise
123 48 103 140/100 173 189 2.54 “
124 54 ll8 160/100 144 138 1.78 Posterior ischaemia after exercise
130 54 103 200/110 161 154 1.20 “
Av. 53.6 96.7 154 1.70
